<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">AI in Oncology: Transforming Cancer Detection through Machine Learning and Deep Learning Applications</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Muhammad</forename><surname>Aftab</surname></persName>
							<email>maftab@gs.zzu.edu.cn</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Pathophysiology Department</orgName>
								<orgName type="department" key="dep2">School of Basic Medical Sciences</orgName>
								<orgName type="institution">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Tianjian Laboratory of Advanced Biomedical Sciences</orgName>
								<orgName type="institution" key="instit1">Academy of Medical Sciences</orgName>
								<orgName type="institution" key="instit2">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="laboratory">State Key Laboratory of Esophageal Cancer Prevention and Treatment</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Faisal</forename><surname>Mehmood</surname></persName>
							<email>faisalmehmood685@uaf.edu.pk</email>
							<affiliation key="aff1">
								<orgName type="department">School of Electrical and Information Engineering</orgName>
								<orgName type="institution">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou Henan</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chengjuan</forename><surname>Zhang</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Center of Bio-Repository</orgName>
								<orgName type="institution" key="instit1">The Affiliated Cancer Hospital of Zhengzhou University</orgName>
								<orgName type="institution" key="instit2">Henan Cancer Hospital Zhengzhou</orgName>
								<address>
									<settlement>Henan</settlement>
									<country key="CN">P. R. China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alishba</forename><surname>Nadeem</surname></persName>
							<email>alishbah44@gmail.com</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Pathophysiology Department</orgName>
								<orgName type="department" key="dep2">School of Basic Medical Sciences</orgName>
								<orgName type="institution">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zigang</forename><surname>Dong</surname></persName>
							<email>dongzg@zzu.edu.cn</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Pathophysiology Department</orgName>
								<orgName type="department" key="dep2">School of Basic Medical Sciences</orgName>
								<orgName type="institution">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Tianjian Laboratory of Advanced Biomedical Sciences</orgName>
								<orgName type="institution" key="instit1">Academy of Medical Sciences</orgName>
								<orgName type="institution" key="instit2">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">China-US (Henan) Hormel Cancer Institute</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="laboratory">State Key Laboratory of Esophageal Cancer Prevention and Treatment</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yanan</forename><surname>Jiang</surname></persName>
							<email>yananjiang@zzu.edu.cn</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Pathophysiology Department</orgName>
								<orgName type="department" key="dep2">School of Basic Medical Sciences</orgName>
								<orgName type="institution">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Tianjian Laboratory of Advanced Biomedical Sciences</orgName>
								<orgName type="institution" key="instit1">Academy of Medical Sciences</orgName>
								<orgName type="institution" key="instit2">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">China-US (Henan) Hormel Cancer Institute</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="laboratory">State Key Laboratory of Esophageal Cancer Prevention and Treatment</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kangdongs</forename><surname>Liu</surname></persName>
							<email>kdliu@zzu.edu.cn</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Pathophysiology Department</orgName>
								<orgName type="department" key="dep2">School of Basic Medical Sciences</orgName>
								<orgName type="institution">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Tianjian Laboratory of Advanced Biomedical Sciences</orgName>
								<orgName type="institution" key="instit1">Academy of Medical Sciences</orgName>
								<orgName type="institution" key="instit2">Zhengzhou University</orgName>
								<address>
									<postCode>450001</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">China-US (Henan) Hormel Cancer Institute</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="laboratory">State Key Laboratory of Esophageal Cancer Prevention and Treatment</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">AI in Oncology: Transforming Cancer Detection through Machine Learning and Deep Learning Applications</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">77A45F5333BB0F21B1A44EA89D9415BC</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-09-28T13:57+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=0, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=false, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Artificial Intelligence</term>
					<term>Machine Learning</term>
					<term>Cancer</term>
					<term>Medical Imaging</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Artificial intelligence (AI) has potential to revolutionize the field of oncology by enhancing the precision of cancer diagnosis, optimizing treatment strategies, and personalizing therapies for a variety of cancers. This review examines the limitations of conventional diagnostic techniques and explores the transformative role of AI in diagnosing and treating cancers such as lung, breast, colorectal, liver, stomach, esophageal, cervical, thyroid, prostate, and skin cancers. The primary objective of this paper is to highlight the significant advancements that AI algorithms have brought to oncology within the medical industry. By enabling early cancer detection, improving diagnostic accuracy, and facilitating targeted treatment delivery, AI contributes to substantial improvements in patient outcomes. The integration of AI in medical imaging, genomic analysis, and pathology enhances diagnostic precision and introduces a novel, less invasive approach to cancer screening. This not only boosts the effectiveness of medical facilities but also reduces operational costs. The study delves into the application of AI in radiomics for detailed cancer characterization, predictive analytics for identifying associated risks, and the development of algorithm-driven robots for immediate diagnosis. Furthermore, it investigates the impact of AI on addressing healthcare challenges, particularly in underserved and remote regions. The overarching goal of this platform is to support the development of expert recommendations and to provide universal, efficient diagnostic procedures. By reviewing existing research and clinical studies, this paper underscores the pivotal role of AI in improving the overall cancer care system. It emphasizes how AI-enabled systems can enhance clinical decision-making and expand treatment options, thereby underscoring the importance of AI in advancing precision oncology</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Recent updates from International Agency for Research on Cancer reveal that cancer is a major global health concern, affecting nations worldwide and posing a huge burden on healthcare systems. Global cancer-related mortality exceeded 10.0 million in 2020, while the number of newly diagnosed cancer cases reached approximately 19.3 million <ref type="bibr" target="#b0">[1]</ref>. AI has transformed cancer research and treatment by leveraging its capability to detect complex patterns in medical data and provide accurate quantitative assessments of clinical conditions <ref type="bibr" target="#b1">[2]</ref>. The influence of AI is evident in various fields today, such as banking, healthcare, and transportation, and it is anticipated to continue expanding. AI has been employed in academia to create intelligent tutoring systems, computer programs designed to address the unique needs of individual students. These methods have improved learning outcomes in various subjects, including science and math. However, AI's outstanding analytical abilities have potential to profoundly transform medical research, diagnosis, and treatment. The use of big data in healthcare research offers a unique opportunity to integrate data with complex study findings, requiring significant computational expertise <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</p><p>Healthcare institutions face a variety of complex challenges, particularly those related to biological abnormalities like cancer. AI employs computational mathematical models that mimic human brain functions. Progress in combinatorial chemistry, genomics, and proteomics has made numerous databases of biological and chemical data available. These advancements could greatly deepen our understanding of molecular biology of cancer. A better grasp of cancer biology can substantially impact the evaluation and treatment of cancer patients in clinical settings. However, clinical oncologists face a significant challenge in choosing therapeutically relevant information from extensive raw genomic data now available <ref type="bibr" target="#b4">[5]</ref>. Researchers have utilized AI to identify subgroups in various cancers based on gene, mRNA, and miRNAs clusters. The mRNA expression, miRNAs expression, and DNA methylation data were integrated using stacked autoencoders and deep flexible neural forest network models to categories tumors in breast cancer, glioblastoma, and ovarian cancer into subcategories <ref type="bibr" target="#b5">[6]</ref>.</p><p>By utilizing RNA transcriptomics, miRNA transcriptomics, and DNA methylation data, the analysis of hepatocellular carcinoma (HCC) employed both supervised and unsupervised learning techniques. This approach identified consensus driver genes linked to patient survival and delineated two distinct patient subgroups with significantly different survival rates <ref type="bibr" target="#b6">[7]</ref>. The integration of proteomics and metabolomics data analysis effectively classified a healthy group into low-risk and high-risk subcategories in breast cancer, as revealed by multi-omics data integration <ref type="bibr" target="#b7">[8]</ref>. Two techniques, multiple-kernel frameworks and autoencoders, have been employed to integrate multi-omics datasets for the purpose of breast cancer sub typing <ref type="bibr" target="#b8">[9]</ref>. AI plays a crucial role in cancer assessment because it can recognize smaller groups of patients within larger groups based on data related to survival and prognosis. This enables the early detection of cancer and the prediction of its future course. AI was employed to categories patients into subgroups in neuroblastoma by identifying significant characteristics through the analysis of gene expression and copy number alteration data <ref type="bibr" target="#b9">[10]</ref>.</p><p>Biomarkers for relapse in colorectal cancer were identified through a combination of copy number variation, metabolomics, miRNA expression, and gene expression. Similarly, researchers used the MRMR approach to determine significant features for predicting patient survival in ovarian cancer cases <ref type="bibr" target="#b10">[11]</ref>. Neural networks trained with DL have also been applied to predict breast cancer survival. The SALMON survival analysis technique identifies relevant feature genes and cytobands by integrating multi-omics data with traditional cancer biomarkers using eigengene matrices of co-expression network modules <ref type="bibr" target="#b11">[12]</ref>. Additionally, the predictive value of genomic, epigenomic, and transcriptomic data for various cancers was evaluated using a kernel-based ML method <ref type="bibr" target="#b12">[13]</ref>. This approach has shown significant improvements when incorporating clinical parameters, with its efficacy varying by cancer type <ref type="bibr" target="#b13">[14]</ref>.</p><p>Like other cell types, cancer cells respond to environmental signals that influence DNA transcription, cell behavior, and overall function. However, tumor cells are just one component of the cancer development process. <ref type="bibr" target="#b14">[15]</ref>. Owing to technological advancements, health researchers and software engineers can collaborate closely to employ multi-factor analysis to improve prediction <ref type="bibr" target="#b15">[16]</ref>. According to reports, these analyses are significantly more precise than the actual estimates. Researchers are increasingly prioritizing the development of models that employ AI algorithms for the purpose of cancer detection and prognosis <ref type="bibr" target="#b16">[17]</ref>. Currently, these strategies are being utilized to enhance the precision of survival, recurrence, and diverse cancer prognosis <ref type="bibr" target="#b17">[18]</ref>.</p><p>The primary emphasis of research in clinical oncology is to comprehensively comprehend the mechanisms underlying the growth of cancer cells, with the aim of gaining valuable knowledge about the molecular foundation of the disease. Furthermore, its objective was to address the rising global mortality rate attributed to cancer by employing computational biology to handle vast amounts of data from millions of pertinent cases <ref type="bibr" target="#b18">[19]</ref>. Moreover, the integration of AI into clinical decision-making is expected to enhance the use of high-resolution imaging and Next Generation Sequencing (NGS) for early detection and prediction of diseases. By leveraging these advanced technologies, AI can significantly improve the accuracy and timeliness of disease diagnosis and prognosis AI can be utilized to generate novel biomarkers for the purpose of diagnosing cancer <ref type="bibr" target="#b19">[20]</ref>. The objective of AI functionality is to construct a system that is adequately trained to accurately determine if a patient will require immunotherapy. AI has capability to identify patients who require further testing, such as Whole Genome Spectroscopy, and determine the immunotherapy medicine that will have the most influence on a patient's recovery <ref type="bibr" target="#b20">[21]</ref>. The increasing utilization of AI in the medical domain, supported by verified real-world case studies, aims to effectively overcome the limitations and constraints in accurately identifying different types of cancer. Included is a thorough explanation of the framework required for AI to function as intended.</p><p>The main objective of the present study was to examine the potential application of AI in enhancing cancer prognoses, with a specific focus on top 10 most prevalent malignancies globally. A range of imaging techniques is concisely examined, alongside a diverse array of DL algorithms and models they generate. Researchers are currently examining the utilization of AI in the field of digital pathology and diagnostics to gain a better understanding of how AI could potentially influence cancer treatment in future.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.1">Role of AI in Cancer Diagnosis by using medical imaging</head><p>Imaging tests such as MRIs, CT scans, and PET scans formed the basis of the previous cancer diagnosis procedure <ref type="bibr" target="#b21">[22]</ref>. These traditional techniques may result in invasive or uncomfortable diagnostic procedures, and various healthcare professionals may have differing interpretations of the imaging data <ref type="bibr" target="#b22">[23]</ref>. AI systems, especially those utilizing DL techniques, demonstrate exceptional proficiency in interpreting medical images and identifying abnormalities that are frequently overlooked by human observers.</p><p>By leveraging extensive cancer databases, it is possible to identify individuals at high risk of developing cancer by analyzing their health characteristics, thereby enabling early screenings. AI has potential to revolutionize cancer detection. For instance, Google's DeepMind project, in collaboration with the UK's National Health Service, developed an AI system capable of outperforming human doctors in accurately detecting over 50 eye diseases using 3D scans <ref type="bibr" target="#b23">[24]</ref>. Furthermore, PathAI incorporates AI into the field of pathology in order to assist in the detection of various diseases, such as cancer. It ensures comprehensive detection of all possible elements, aiding pathologists in quickly recognizing patterns <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref>.</p><p>AI is also revolutionizing the field of medicine by offering exceptional precision the detection of many forms of cancers <ref type="bibr" target="#b26">[27]</ref>. AI employs sophisticated algorithms and ML techniques to effectively and swiftly identify malignancies, a skill that was previously unattainable.</p><p>AI algorithms provide a chance to enhance the precision of medical imaging, hence decreasing the amount of time physicians need to spend on patient care. A recent study published in Academic Radiology reveals that radiologists must assess an average of one image every three to four seconds in order to manage their daily workload. The integration of AI capabilities in image processing and radiography has the potential to enhance productivity in both domains. Mammography is the predominant technique used to identify breast cancer in its early stages, with more than 200 million women undergoing this procedure annually on a global scale.</p><p>The scientists proved their statement by examining 500 randomly selected cases and comparing them to previous assessments made by six professional radiologists, concluding that the AI system outperformed the radiologists' conclusions <ref type="bibr" target="#b27">[28]</ref>. Overall, the US experienced a 5.7% reduction in false-positive results, while UK as a whole observed a 1.2% decline. Additionally, there was a 9.4% decrease in false negatives in US and a 2.7% decrease in UK. The findings of this first study open the path for larger clinical studies with the potential to improve the accuracy and efficacy of cancer diagnosis utilizing digital technologies <ref type="bibr" target="#b28">[29]</ref>.</p><p>AI technology with human radiologists' assessments can be utilized to detect cancer screening tests, hence improving their precision.</p><p>People are still more capable of reasoning than AI, even if AI systems may be able to detect subtle changes in tissues that are hidden from the human eye. The ultimate goal is to determine the best strategy for combining the two to transform the radiology industry <ref type="bibr" target="#b32">[33]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.2">Clinical Applications of AI and Machine Learning</head><p>Clinical applications of cancer employ a diverse array of tactics and processes to effectively diagnose, treat, and manage the disease. These applications utilize advanced diagnostic technologies such as molecular profiling and genetic testing to detect specific cancer subtypes and develop personalized treatment recommendations. The application of AI, ML and DL are shown in Figure <ref type="figure" target="#fig_0">2</ref>. In addition, new therapeutic options such as targeted therapies and immunotherapies have arisen, which precisely aim at cancer cells or enhance the body's immune system to combat the disease. Clinical studies are crucial for assessing innovative cancer therapies and drugs as they have the potential to improve outcomes and increase survival rates. Alongside treating physical symptoms, palliative care and supporting services assist cancer patients live better lives by taking care of their psychological and emotional needs. Overall, new clinical applications in oncology are constantly being developed, which facilitates more effective cancer management and enhances patient care.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.2.1">Clinical Advantage of AI and Precision Oncology</head><p>Prior studies have unequivocally demonstrated the substantial benefits of AI in healthcare, with advancements occurring at an exceptionally rapid pace. For AI systems to be successfully integrated into clinical practice, they must perform at least as well as, if not better than, human intervention. In clinical settings, next-generation sequencing (NGS) offers numerous benefits for identifying prognostic or predictive biomarkers <ref type="bibr" target="#b33">[34]</ref>. Over the past decade, NGS has significantly advanced in terms of speed, accuracy, affordability, and efficiency. Additionally, NGS has incorporated both short-read and long-read platforms. Short reads can be employed in precision medicine to detect polymorphisms that provide clinical advantages and for screening large populations, while long reads facilitate full-length isoform sequencing. The utilization of sophisticated algorithms to analyze complex datasets will unveil new opportunities for targeted therapies in precision oncology <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref>. AI-driven integration of genomics, transcriptomics, and proteomics data, as shown in Figure <ref type="figure" target="#fig_1">3</ref>, distinguishes cancer subtypes, predicts disease progression, and identifies therapeutic targets, enhancing personalized cancer diagnosis and treatment The image shows AI-based machine for analyzing multi-omics cancer patients' and healthy donors' data to improve cancer diagnosis and treatment. By integrating genomics, transcriptomics, and proteomics data, the AI algorithm achieves several key outcomes: meeting new challenges related to identification of cancers subtypes, predicting diseases progression and survival probabilities and discovering new drug targets. This multifaceted approach integrates these advanced mathematical methods to improve the comprehension of the cancer exhaustion as well as to create the individually-targeted therapies.</p><p>Automation of the healthcare system is particularly vital in regions with little resources. An important issue in developing nations is the need for more adequately trained healthcare personnel and specialists. This problem can be addressed by introducing AI systems that can identify diseases at a faster rate. AI provides an extra advantage by reducing the costs associated with managing health records and eliminating monotonous administrative tasks. AI systems enhance the organization and examination of patient health information through automated processes, assisting physicians in making clinical decisions and reducing their documentation workload. Furthermore, patient health records can be used to precisely forecast future disease risk <ref type="bibr" target="#b37">[38]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.2.2">From Lab to Clinic: AI's Rapid Advancements in Cancer Care</head><p>For almost 20 years, AI has been used in cancer research. The area of cancer research has shown encouraging advancements, and noteworthy accomplishments at the level of expertise <ref type="bibr" target="#b38">[39]</ref>. AI is also being used by a growing number of businesses and industry research groups to identify, diagnose, and treat cancer. IBM is leading the effort to incorporate AI into medical facilities. IBM introduced Watson, an AI system, in 2014 to provide cutting-edge medical support in the area of cancer research <ref type="bibr" target="#b39">[40]</ref>. Corresponding to this, a group of researchers and computer scientists at Microsoft are working to use ML and NLP to create a programming framework that will allow them to manipulate biological processes in order to treat cancer. However, there are concerns over the regulation of AI tools. In 2022, the FDA authorized more than sixty medical devices or algorithms powered by AI, as determined by Jaber's research <ref type="bibr" target="#b40">[41]</ref>.</p><p>AI is positioned to transform the medical industry by facilitating suggestions and recommendations for treatment options, improving the accuracy and speed of diagnosis, and advancing prognostic outcomes <ref type="bibr" target="#b41">[42,</ref><ref type="bibr" target="#b42">43]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.2.3">Consensus regarding the AI procedure in clinical cancer research</head><p>AI is presently employed exclusively in an adjunctive capacity within medicine. However, there remains uncertainty regarding the potential for technology to eventually supplant human expertise in diagnostic imaging, treatment decision-making, and other areas. Currently, AI encounters numerous challenges in cancer research, particularly in the development and evaluation of solutions. To verify the capabilities of AI effectively, meticulously designed testing protocols are paramount. Consequently, an ideal framework is essential to facilitate the advancement of AI methodologies. Prior to the implementation of an AI solution, it is crucial to define and characterize the specific issues to be addressed and to evaluate whether addressing these issues is both feasible and beneficial <ref type="bibr" target="#b43">[44]</ref>. Multiple clinical data sets reveal an inherent disparity in the allocation of samples among different classes. When dealing with distinguishing features like asymmetry, classification algorithms which are typically built to handle balanced classes may encounter difficulties <ref type="bibr" target="#b44">[45]</ref>. Three separate categories training, validation, and testing sets are used to group the available data. This category facilitates an impartial assessment of the AI model. The typical ranges are 60-70%, 15-20%, and 15-20%. AI employs three separate datasets: training, validation, and testing. The former is used for model training, while the later is used for feature selection and parameter modification.</p><p>The diagnostic workflow of AI is shown in Figure <ref type="figure" target="#fig_2">4</ref>. Some characteristics may have a detrimental impact on the classifier's performance as a result of noise or irrelevance, and not all of them are valuable for generating AI models. Feature selection can be used to highlight the most crucial features for discovering suitable bioactivity <ref type="bibr" target="#b45">[46]</ref>. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Role of Al in various cancers</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Lung Cancer Detection and AI</head><p>Lung cancer is primary cause of cancer-related fatalities on a global scale and is among the most commonly diagnosed malignancies. About 2.20 million new patients receive a lung cancer diagnosis each year <ref type="bibr" target="#b46">[47]</ref>. Additionally, 75% of people with a diagnosis die within five years <ref type="bibr" target="#b47">[48]</ref>. The challenge in treating cancer has arisen due to intricate nature of cancer cells and the significant intra-tumor heterogeneity (ITH), which results in the development of medication resistance <ref type="bibr" target="#b48">[49]</ref>.</p><p>The progressive development of technologies in cancer research in recent decades has enabled the establishment of multiple clinical and medical imaging methods <ref type="bibr" target="#b49">[50]</ref>, and genomic databases through various large-scale collaborative cancer projects in recent decades <ref type="bibr" target="#b50">[51]</ref>. These databases assist researchers in analyzing extensive patterns of lung cancer, encompassing its diagnosis, therapy, responses, and clinical outcomes <ref type="bibr" target="#b51">[52]</ref>. Recent studies in -omics analysis, encompassing genomics, transcriptomics, proteomics, and metabolomics, have significantly enhanced our research methodologies and capabilities <ref type="bibr" target="#b52">[53]</ref>. Currently, there is a prevailing tendency in cancer research to integrate vast quantities of data from several categories <ref type="bibr" target="#b53">[54,</ref><ref type="bibr" target="#b54">55]</ref>.</p><p>Although dimension reduction techniques such as tensor and matrix factorizations can be helpful, the use of various and high-dimensional data types for clinical applications requires significant time and expertise <ref type="bibr" target="#b55">[56]</ref>. Analyzing the datasets linked to cancer, which are growing exponentially, presents a major challenge for researchers <ref type="bibr" target="#b56">[57]</ref>. Therefore, it is now more important than ever to utilize ML models that independently identify the inherent characteristics of different forms of data to assist doctors in their decision-making process <ref type="bibr" target="#b57">[58]</ref>.</p><p>This article presents a comprehensive examination of primary ML methods that have been employed to integrate intricate biomedical data, such as sequencing or imaging data, pertaining to various facets of lung cancer. Additionally, it explores significant obstacles and prospects for the future utilization of ML in the realm of clinical research and the treatment of lung cancer. The purpose of this review is to improve understanding of the capabilities and potential applications of ML in this specific field.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Application of Machine learning (ML) for lung cancer early detection and supplementary diagnosis</head><p>Applying ML techniques facilitates early diagnosis and detection by analyzing medical imaging datasets. Timely identification is crucial in reducing lung cancer mortality rates <ref type="bibr" target="#b58">[59]</ref>. The primary method for monitoring individuals at high risk of developing lung cancer is low-dose computed tomography (CT) for chest screening <ref type="bibr" target="#b59">[60]</ref>. The main objective of developing computer-aided diagnosis (CAD) systems is to enhance efficiency of medical diagnostics. These systems assist clinicians in analyzing medical imaging data, providing a valuable additional perspective <ref type="bibr" target="#b60">[61]</ref>. Traditional feature-based CAD tasks consist of three phases: nodular segmentation, feature extraction and selection, and clinical judgment inference (classification). Various techniques are available for predicting the probability of cancer using ML classifiers, including logistic regression (LR) <ref type="bibr" target="#b61">[62]</ref> or linear discriminant analysis (LDA) <ref type="bibr" target="#b62">[63]</ref>, which consider the observed textural properties of specific nodules in CT images along with the patient's clinical data.</p><p>CT images commonly provide factors such as nodule size, type, location, count, border, and emphysema information. Clinical variables include the patient's age, gender, time of specimen collection, family history of lung cancer, and smoking history, among others. However, these traits are typically based on subjective assessments and lack well-defined, comprehensive, and quantifiable descriptions of the look of the malignant nodule.</p><p>The implementation of DL based models within CAD systems has been the focus of increasing research efforts due to advancements in DL techniques, particularly CNNs. The goal is to improve system precision, reduce false positives, and decrease detection time for lung cancers <ref type="bibr" target="#b63">[64]</ref>. The application of ML techniques for predicting lung cancer prognosis is demonstrated in Tables <ref type="table" target="#tab_3">4</ref> and <ref type="table" target="#tab_4">5</ref>. Similar to feature-based CAD systems, these models typically follow three stages: identifying and separating nodules, extracting their features, and making conclusions based on clinical judgment <ref type="bibr" target="#b64">[65]</ref>.</p><p>Unlike traditional feature-based systems, DL-based CAD systems can accurately represent the three-dimensional structure of a nodule and independently identify and extract inherent characteristics of potentially abnormal nodules <ref type="bibr" target="#b65">[66,</ref><ref type="bibr" target="#b66">67]</ref>. For instance Tyagi et al. <ref type="bibr" target="#b67">[68]</ref> developed a model by extracting three 3D-view feature vectors (axial, coronal, and sagittal) of the nodule from CT scans. These feature vectors were derived from OverFeat <ref type="bibr" target="#b68">[69]</ref>.</p><p>Recently, a comprehensive global evaluation of nodules to define their properties using CT images has been made possible by incorporation of CNN models. Shariaty et al. <ref type="bibr" target="#b69">[70]</ref> developed a complementary CNN model in which shape descriptions (the "shape" feature) of the segmented nodule were obtained using a spherical harmonic model <ref type="bibr" target="#b70">[71]</ref> for nodule segmentation and the texture and intensity features (the "appearance" feature) of the nodule were extracted using a DCNN based model <ref type="bibr" target="#b71">[72]</ref>. Based on the addition of "shape" and "appearance" attributes, the following classification was made. Venkadesh et al. <ref type="bibr" target="#b72">[73]</ref> employed an ensemble model comprised of two distinct models 2D-ResNet50-based <ref type="bibr" target="#b73">[74]</ref> and 3D-Inception-V1 <ref type="bibr" target="#b74">[75]</ref> to extract two different aspects of a lung nodule. Subsequently, these two characteristics were combined and employed as input characteristics for the classification procedure.</p><p>Applying the ensemble CNN model to raw CT scans offers several benefits, including the ability to distinguish between cancerous and non-cancerous nodules. By leveraging features from stateof-the-art CNN models, common ML techniques such as support vector machines (SVM), neural networks (NNs), and LR can be applied to clinical decision inference. Notably, some studies also utilized CNN models for conclusive clinical assessments. Mikhael et al. <ref type="bibr" target="#b75">[76]</ref> presented a thorough approach for systematically simulating the classification of lung cancer risk and localization tasks using only the input CT data.</p><p>Their approach to forecasting the likelihood of malignancy relied on a fusion of three CNN models: a Mask-RCNN <ref type="bibr" target="#b76">[77]</ref> model for segmenting lung tissue, a modified U-Net <ref type="bibr" target="#b77">[78]</ref> model for detecting cancer regions of interest (ROI), and a full-volume model derived from 3Dinflated Inception-V1 <ref type="bibr" target="#b78">[79]</ref> for estimating the likelihood of cancer. Beyond their use in CT images, CNN-based models are widely used in histology imaging to assist in the diagnosis of lung cancer. Histological imaging offers a greater depth of cellular-level biological data on malignancy compared to CT imaging.</p><p>Abdul-Jabbar et al. <ref type="bibr" target="#b79">[80]</ref> achieved this by segmenting individual cells from hematoxylin and eosin (H&amp;E)-stained and immunohistochemistry (IHC) images using a Micro-Net <ref type="bibr" target="#b80">[81]</ref> model for identifying tissue boundaries and a SC-CNN <ref type="bibr" target="#b81">[82]</ref> model for the same purpose. Although ML algorithms are widely used in CAD, the challenge lies in the fact that only a limited number of images are actually used.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">AI in Lung Cancer detection and subtype Differentiation</head><p>It is challenging to implement periodic medical imaging scans, which are advised for high-risk groups, due to a high probability of false detection <ref type="bibr" target="#b82">[83,</ref><ref type="bibr" target="#b83">84]</ref>. That is why it is essential to develop more effective methods for early detection of lung tumours. The numerous applications of AI and ML are illustrated in Figure <ref type="figure" target="#fig_3">5</ref>. Advancements in sequencing technologies have enabled the creation of an abundance of instruments for the early detection of lung cancer. <ref type="bibr" target="#b84">[85]</ref>. However, it is crucial to precisely classify different subtypes of lung cancer in order to guide the selection of the most efficient treatment strategies. Except for targeted therapy, the management of the two most common subtypes of lung cancer, LUAD (45%) and LUSC (25%), is often done in a similar manner <ref type="bibr" target="#b85">[86]</ref>. Nevertheless, studies have shown that LUAD and LUSC have distinct biological characteristics, indicating that these two forms of cancer should be classified and treated as separate entities <ref type="bibr" target="#b86">[87]</ref>. Early detection and subtype identification using a computer approach are both included in the classification job.</p><p>To ascertain the relative abundances of each cell type in the images, the segmented cells were then employed in cell type classification. This model allows for the precise differentiation of immune evasion mechanisms and differential evolution between lung LUAD and LUSC with exceptional precision.</p><p>A subsequent analysis <ref type="bibr" target="#b87">[88]</ref> categorized tissue as LUAD, LUSC, or normal based on H&amp;E-stained Histopathological whole-slide pictures using the Inception-V3 network <ref type="bibr" target="#b88">[89]</ref>. An important feature of this research is that the model shows the ability to predict the occurrence of somatic mutations in different driver genes of lung cancer, including STK11, EGFR, FAT1, SETBP1, KRAS, and TP53, in a specific tissue. Several studies utilized transfer learning to improve the effectiveness and resilience of their novel model training procedures <ref type="bibr" target="#b89">[90]</ref>, considering the significant resources and complex nature of the datasets. The graphic demonstrates a full AI method for tailored lung cancer care, encompassing early identification, prediction of treatment effectiveness, and adjustment of immunotherapy protocols. Table <ref type="table" target="#tab_0">1</ref> and Table <ref type="table" target="#tab_1">2</ref> provided a concise summary of how Al integration contributes to detection, utilizing Image and sequencing data, respectively.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">AI in Cancer Immunotherapy: Enhancing Treatment Predictions and Personalized Approaches in lung cancer</head><p>Immunotherapy is currently a crucial component of cancer treatment. Immunocheckpoint inhibitors (ICIs), which target pmd1 (PD-L1) and programmed cell death protein 1 (PD-1) are used in blockade treatment. <ref type="bibr" target="#b115">[116]</ref>, have demonstrated efficacy in treating non-small cell lung cancer (NSCLC) <ref type="bibr" target="#b116">[117,</ref><ref type="bibr" target="#b117">118]</ref>. Immunotherapy has shown significant effectiveness and is now more widely used than traditional therapies including radiation therapy, surgery, and chemotherapy. The various responses observed across people can be attributed to the distinct characteristics of the tumor immune microenvironment (TIME) of each patient. Therefore, it is fundamental to accurately forecast whether a patient will exhibit a positive response to immunotherapy to efficiently manage cancer. The development of AI technology has made it possible to create systems that can predict how a patient will respond to immunotherapy. AI-based methods utilize signatures obtained from medical imaging and immunological sequencing <ref type="bibr" target="#b118">[119]</ref>. Wiesweg et al. <ref type="bibr" target="#b119">[120]</ref> utilized gene expression patterns and cell type-specific genes to train an auxiliary support vector machine (SVM) classifier for RECIST categorization in response to PD-1/PD-L1 blocking therapy. Moreover, studies have investigated the utilization of contrast-enhanced computed tomography (CE-CT) scans and radiomics biomarkers and imaging features to educate classifiers for RECIST classification <ref type="bibr" target="#b120">[121,</ref><ref type="bibr" target="#b121">122]</ref>. Some well-known classifiers in this category include logistic regression (LR) and random forest (RF). Evaluating tumorinfiltrating lymphocytes (TILs) is an essential part of assessing the response to immunotherapy.</p><p>The CIBERSORT model was refined by DeepTIL <ref type="bibr" target="#b122">[123]</ref> to determine the amount of leukocyte subsets in a tumor sample. In contrast, alternative studies utilized radiomics characteristics derived from CE-CT images and RNA sequencing data to predict the prevalence of specific T cell subsets <ref type="bibr" target="#b123">[124]</ref>. In addition, a DL model was developed to identify tumor-infiltrating lymphocytes (TILs) in digitized pictures by including CNNs. This model employs distinct CNN modules to categorize lymphocyte infiltration and delineate necrotic segmentation <ref type="bibr" target="#b124">[125]</ref>. ML algorithms have made significant advances to the prediction of immunotherapy response and the prognosis of neoantigens for immunotherapy. Tumor-specific peptides called neoantigens are altered and crucial for inducing antitumor-immune responses.</p><p>ML models, including NetMHC <ref type="bibr" target="#b125">[126,</ref><ref type="bibr" target="#b126">127]</ref> and NetMHCpan <ref type="bibr" target="#b127">[128,</ref><ref type="bibr" target="#b128">129]</ref>, have been utilized to assist in the identification of immunogenic neoantigens <ref type="bibr" target="#b129">[130,</ref><ref type="bibr" target="#b130">131]</ref> by estimating the binding ability of mutant peptides to human leukocyte antigen (HLA) alleles. The aforementioned technologies have been useful in studying the neoantigens landscape in lung cancers, making substantial contributions to the progress and improvement of immune treatments targeting neoantigens <ref type="bibr" target="#b131">[132,</ref><ref type="bibr" target="#b132">133]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">Limitation for Lung Cancer detection</head><p>Even with notable progress in the use of ML in clinical lung cancer research, there are still issues that will likely influence the direction of further studies in this area.</p><p>Accurately obtaining sensitive information from imaging data is essential for therapeutic applications. Unlike its predecessors, which used arbitrary feature extractions <ref type="bibr" target="#b133">[134]</ref>, DL-based CAD systems employ CNN models <ref type="bibr" target="#b134">[135]</ref>. Significantly, the advent of Vision Transformer (ViT) <ref type="bibr" target="#b135">[136]</ref> demonstrates potential in the analysis of imaging data, surpassing the efficiency and precision of conventional CNNs. On the other hand, DL models have shown effectiveness in other types of omics analysis. Genomics data analysis utilizes approaches such RNNs and CNNs.</p><p>In addition, to dealing with the complexity of omics data with many dimensions, autoencoders, deep generative models, and self-supervised learning models improve the process of extracting important features and reducing the number of dimensions. While it is typical to gather many kinds of information from one patient, the process of combining data from different platforms is still difficult because of the interference caused by platform noise. Various medical classification networks aid in the analysis of a diverse array of medical pictures, while the incorporation of data integration and the removal of batch effects help reduce noise in sequencing data. In spite of continuous efforts to create integrative tools, batch effects continue to be a major source of worry and full answers to the problems unique to each platform in clinical investigations are still elusive.</p><p>The implementation of medical studies is hampered by the lack of robustness and generalizability in ML models. The differences observed in various researches regarding the choice of marker genes for categorization highlight the need for markers that are both biologically meaningful and applicable across different contexts. The efficiency and strength of models may be enhanced by employing transfer learning with pre-existing models. This approach provides a practical solution to create unified and standardized DL frameworks for analyzing lung cancer data. To ensure the ongoing advancement of ML in lung cancer research, it is crucial to address these challenges. This will ultimately result in better clinical results and individualized treatments for cancer <ref type="bibr" target="#b136">[137]</ref><ref type="bibr" target="#b137">[138]</ref><ref type="bibr" target="#b138">[139]</ref><ref type="bibr" target="#b139">[140]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">AI In the prognosis of Breast Cancer</head><p>One of the most common and well-researched cancers is breast cancer, which has several subtypes identified by their molecular profiles <ref type="bibr" target="#b140">[141]</ref>. The mortality rate for breast cancer among diagnosed women in 2022 was roughly 29.1%, resulting in 670,000 fatalities out of 2.3 million recorded cases <ref type="bibr" target="#b141">[142]</ref>. Although there have been improvements in identifying and treating breast cancer, it continues to be a major issue in world health <ref type="bibr" target="#b142">[143]</ref>.</p><p>The primary focus of efforts to prevent and manage breast cancer is on secondary prevention, which entails improving screening for those who are at a high risk. Timely identification and medical intervention for breast cancer are also crucial in implementing these measures <ref type="bibr" target="#b143">[144,</ref><ref type="bibr" target="#b144">145]</ref>. The most significant benefit of AI in breast cancer screening is its ability to alleviate the workload of imaging specialists by efficiently identifying tumor lesions within the extensive image dataset of healthy individuals <ref type="bibr" target="#b145">[146]</ref>. CADe/CADx systems serve as the basis for the advancement of AIassisted breast imaging diagnostics. Radiologists depend on CAD, which is a prominent form of ML, to aid them in identifying small tumor lesions that may otherwise be overlooked. This is accomplished through the incorporation of mathematics, statistics, image processing, and computer analysis.</p><p>However, the use of CAD identification in clinical practice is limited due to the high occurrence of false positive results and the need for biopsies <ref type="bibr" target="#b146">[147,</ref><ref type="bibr" target="#b147">148]</ref>. The input picture data is used as a training set to build a model in order to improve the functioning of CAD. The system is capable of obtaining clinical data sets, standardizing the data sets using neural networks, choosing ML classification algorithms, and assessing its overall performance <ref type="bibr" target="#b148">[149]</ref>. A substantial quantity of high-resolution breast examination photos is required as the training dataset for a deep learningbased AI application tool for the diagnosis of breast cancer <ref type="bibr" target="#b149">[150]</ref>. Furthermore, it is imperative to create a DL system that maintains uniformity across different users, devices, and modes of operation. Tumor images can be annotated either manually or using DL techniques to label the characteristics and boundaries of the lesions. Annotating images manually necessitates the proficiency and understanding of an imaging specialist. The manually designated lesions act as reference points for the automatic segmentation process.</p><p>However, it can be difficult to distinguish between normal breast tissue and tumors that have small sizes or unclear characteristics. Furthermore, endo breast is more prevalent in Asian women, namely those who are premenopausal or have undergone estrogen replacement therapy <ref type="bibr" target="#b150">[151]</ref> which further complicates tumor segmentation. Consequently, the lesions identified by experts do not accurately and thoroughly represent the true size and extent of the lesion, and the level of consistency in terms of being able to repeat the results is insufficient <ref type="bibr" target="#b151">[152,</ref><ref type="bibr" target="#b152">153]</ref>. Clustering-based, thresholding-based, region-based, edge-based, and other segmentation approaches are commonly used in automatic image segmentation methods. Currently, there is no widely recognized benchmark for image segmentation algorithms. DL algorithms are commonly linked with neural network algorithms.</p><p>CNN is distinguished among the most sophisticated DL algorithms because of its convolutional, nonlinear, pooling, and fully connected layers along the computation path (Figure <ref type="figure" target="#fig_4">6</ref>). Applying AI to breast cancer screening has the ability to reduce or prevent the occurrence of errors or misinterpretations in identifying specific visible abnormalities <ref type="bibr" target="#b153">[154]</ref>. Conversely, picture interpretation systems using DL are primarily used for the secondary assessment of negative cases that are evaluated by humans <ref type="bibr" target="#b154">[155,</ref><ref type="bibr" target="#b155">156]</ref>. Furthermore, there is a lack of randomized controlled studies that directly evaluate the accuracy of AI as an independent system for assessing breast cancer screenings with the interpretations made by radiologists. Subsequent examinations have revealed that AI systems exhibit worse accuracy compared to radiologists when it comes to interpreting data <ref type="bibr" target="#b156">[157]</ref>. However, with the utilization of DL and training models on image data, AI still holds the potential to be employed in the future for the purpose of doing early breast cancer screening <ref type="bibr" target="#b149">[150]</ref>.Figure <ref type="figure" target="#fig_4">6</ref> explain the role of Al in the detection of breast cancer. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Challenges in the current detection methods and Role of AI in Breast Cancer</head><p>Medical imaging is the most effective method for identifying breast cancer, utilizing various modalities such as MRI, CT, PET, mammography, radiographic ultrasonography, and duplex ultrasound. Medical images are essential for diagnosing diseases, identifying abnormal areas, providing patient treatment, and suggesting various disorders. AI and ML may be responsible for the most recent advancements in medical image analysis. Breast cancer diagnoses are now more precise than ever before as a result of these advancements in early detection and evaluation of malignancies. Breast cancer detection methods include computed tomography, positron emission tomography, magnetic resonance imaging (MRI), ultrasonography, X-ray mammography, and breast temperature measurement <ref type="bibr" target="#b157">[158]</ref>. Typically, pathology diagnosis is considered the most reliable method for detecting breast cancer. In this process, extracted tissue is stained in the laboratory to enhance visibility in the resulting images, with hematoxylin and eosin being commonly used stains <ref type="bibr" target="#b158">[159]</ref>. There are two primary approaches for diagnosing breast cancer: genomics and histological image analysis. Histopathological images, which are microscopic photographs of breast tissue, are particularly valuable for early-stage cancer treatment. The limitations of current diagnostic methods are summarized in Table <ref type="table" target="#tab_2">3</ref>.  <ref type="bibr" target="#b159">[160]</ref>. High accuracy in distinguishing between benign and malignant breast tumors has been proven by advanced DL models, including ResNet and VGG architectures <ref type="bibr" target="#b160">[161,</ref><ref type="bibr" target="#b161">162]</ref>.</p><p>Furthermore, the use of CNN designs like Inception V3, ResNet50, and VGG-19, as well as support vector machines (SVM) and fuzzy C-means (FCM) algorithms, highlights the revolutionary role that AI is playing in the detection of breast cancer <ref type="bibr" target="#b162">[163,</ref><ref type="bibr" target="#b163">164]</ref> utilized a variety of models (DT, SVM, RF, K-NN) to reliably differentiate benign lesions from unsettling ones. Byraet al. <ref type="bibr" target="#b162">[163]</ref> employed three convolutional layers and two connected layers to categories 166 individual tumors, of which 292 were non-cancerous lumps, as breast cancer. The accuracy rate attained was 83%. Xu et al. <ref type="bibr" target="#b164">[165]</ref> proposed CNN to separate adipose tissue, epidermis, fibro glandular tissue, and 3D masses from breast ultrasound pictures. The quantitative metrics used to evaluate the effect of segmentation, such as precision, recall, and F1 scores, all exceed 80%. This demonstrates that the suggested method can correctly identify functioning tissue in a breast ultrasound image. To determine the most accurate method for classifying mammography images related to breast cancer, most researchers have utilized multiple strategies to categories ML for mammography photographs. Vijayarajeswari et al. <ref type="bibr" target="#b165">[166]</ref> employed a Support Vector Machine (SVM) classifier to categories mammography images using features extracted from the Hough transformation, in order to determine the attributes of the mammograms.</p><p>The SVM algorithm was employed on a dataset of 95 clinical images. The findings demonstrate that the proposed approach successfully categorizes the challenging classes of mammograms; however, the accuracy is not precisely mentioned.</p><p>Hamoud et al. <ref type="bibr" target="#b166">[167]</ref> applied the Fuzzy C-Means (FCM) method to the DDSM and MIAS datasets in order to classify tumors as either benign or malignant. The accuracy rate has been confirmed to be 87%, with a sensitivity value of 90.47% and a specificity value of 84.84%. The MIAS dataset was analyzed by <ref type="bibr" target="#b167">[168]</ref> using CNN architectures including Inception V3, ResNet50, VGG-19, VGG-16, and Inception-V2 ResNet. The results of the classification technique for mammography breast pictures are as follows: The 10-fold cross-validation method and the 80-20 method achieved high precision, sensitivity, accuracy, and specificity. Specifically, the precision, sensitivity, accuracy, and specificity for the 10-fold cross-validation method were 0.995, 97.83%, 99.13%, and 97.35% respectively. Similarly, the 80-20 method achieved a precision, sensitivity, accuracy, and specificity of 0.995, 97.66%, 99.13%, and 97.35% respectively. The author obtained an accuracy of 92.84% by utilizing approaches on the DDSM dataset and incorporating transfer learning into CNN architecture. Table <ref type="table" target="#tab_3">4</ref> provides a summary of the research that employ many machine learning models, such as SVM classifier, Artificial Neural Network (ANN), K-Nearest Neighbours (K-NN), Fuzzy C-Means, and CNN. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">AI in Colorectal Cancer (CRC)</head><p>Colorectal cancer (CRC) is the third most prevalent type of cancer in 2020, behind lung and breast cancers. It occupies the top position for males and the second position for girls. Annually, approximately 1,931,590 new cases of CRC are detected, accounting for 10.01% of all cancer cases.</p><p>CRC accounts for 17.6% of all cases in Asia. Contributes to 8.7% of all cancer-related fatalities.</p><p>The rising incidence of CRC is a significant health issue in developing nations. Environmental factors contribute to the development of CRC, as shown by the variations in global incidence rates and the increased risk among immigrants who move from regions with low prevalence to regions with high prevalence within the same generation <ref type="bibr" target="#b171">[172]</ref>.</p><p>CRC manifests as an abnormal proliferation of epithelial cells, forming a tumor in either the colon or rectum <ref type="bibr" target="#b172">[173]</ref>. The global incidence of cancer, specifically CRC, is on the rise. Genetic variations and environmental factors contribute to the probability of getting CRC. Furthermore, those diagnosed with colitis and Crohn's disease are inclined to get cancer, specifically CRC, as they age. Multiple academic research have revealed that diet and lifestyle choices, family history, and persistent inflammation are factors that add to the chance of developing cancer <ref type="bibr" target="#b173">[174]</ref>. CRC is more prevalent in modern cultures, primarily due to the adoption of Western diets and lifestyles characterized by high consumption of meats, fats, and overall calorie intake. Changes in population composition and increased longevity are contributing to a wider range of factors affecting the situation <ref type="bibr" target="#b174">[175]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1">Traditional Methods for the Detection of Colorectal Cancer</head><p>People over 50 are advised to have a digital rectal examination (DRE) at least once by the Indonesian Ministry of Health. If symptoms manifest, it may be necessary to do another examination <ref type="bibr" target="#b175">[176]</ref>. The goal of DRE is to detect any abnormalities in the perianal region, the lower portion of the rectum, the anal canal, and the area between the rectum and vagina in females. Additionally, it assesses the functionality of the anal sphincter and examines the dimensions, connection, and mobility of any tumors located in the lower two-thirds of the rectum. This examination primarily focuses on the specific characteristics of colorectal cancer, such as the extent of its spread on the rectal wall, its location in respect to vital bodily structures, its mobility, and its metastasis. This information is vital for the purpose of surgical planning <ref type="bibr" target="#b176">[177]</ref>.</p><p>When performing a DRE, health care providers start by inquiring about any rectal symptoms, such as tumors, bleeding, or pain. Next, they thoroughly examine the region surrounding the anus and feel the bottom portion of the rectum as well as the inside of the anal canal. This efficient and costeffective approach often requires less than one minute and is particularly effective in detecting tumors near the distal end of the rectum <ref type="bibr" target="#b176">[177]</ref>.</p><p>FOBTs are essential for the early identification of colorectal cancer as they detect occult blood in faces. Presently, there exist three types of FOBTs, distinguished by their methods of blood detection: chemical tests, immuno-chromatography testing, and DNA-based tests <ref type="bibr" target="#b177">[178]</ref>. The guaiac-based faecal occult blood test (gFOBT) is a diagnostic test that detects the presence of haemoglobin in stool by assessing its pseudo-peroxidase activity. Although the gFOBT is beneficial, its specificity is relatively low, often requiring further tests for a correct diagnosis of colorectal cancer <ref type="bibr" target="#b178">[179]</ref>. The 3,3,5,5-tetramethylbenzidine (TMB) test using a test paper, offers a simpler approach for patients as it undergoes a color change upon reacting with certain components in the stool. While this method is designed to be easy for users, it can only identify blood that is visible on the surface of the faces. This limitation increases the risk of errors in interpretation since it relies on visual assessment <ref type="bibr" target="#b179">[180]</ref>.</p><p>Endoscopic procedures are essential for screening CRC as they enable direct visualisation of the inner surface of the colon and rectum. Out all these options, colonoscopy is the most comprehensive method, as it involves a direct inspection and is linked to significant reductions in the risk of CRC and mortality rates.</p><p>Studies conducted in Canada and Germany have revealed that following a colonoscopy, there is a 67% reduction in death rates and a 77% decreased risk of acquiring CRC <ref type="bibr" target="#b180">[181]</ref>. Colonoscopy negative results were associated with a 56% decreased overall risk of colorectal cancer in the United States, according to a long-term study that followed participants for over 22 years <ref type="bibr" target="#b181">[182]</ref>.</p><p>Although there are differences in the effectiveness of identifying proximal versus distal CRC, depending on things like the operator's expertise, the difficulty of visualizing the condition, and the thoroughness of the inspection. Notwithstanding its advantages, colonoscopy has several disadvantages as well, such as the discomfort of preparing the intestine, the dangers of anesthesia, and the possibility of procedural complications such as bleeding and perforation. The risks of bleeding after surgery and perforation are highlighted by meta-analyses, which emphasize the importance of careful patient selection and operational preparation <ref type="bibr" target="#b182">[183]</ref>. <ref type="bibr" target="#b183">[184]</ref>.</p><p>A long-term study conducted in the United States that tracked participants for over 22 years discovered that those who had negative colonoscopy results had a 56% decreased overall risk of colorectal cancer <ref type="bibr" target="#b184">[185]</ref>. For CRC screening, the FDA is in favor of stool-based testing, especially when it comes to the combination of faecal immunochemical test (FIT) and multitarget stool DNA (Fit-DNA). Fit-DNA is more sensitive than FIT alone in detecting colorectal cancer (CRC), but it is less specific, which could lead to more false positives and require additional colonoscopy research <ref type="bibr" target="#b185">[186]</ref>. The optimal screening frequency for FIT-DNA is yet unknown, but it is recommended to be performed every three years in the United States. Its greater price in comparison to FIT may also prevent it from being used in less developed areas <ref type="bibr" target="#b180">[181]</ref>. The development of CT colonography stands out as a noteworthy advancement in radiology-focused colorectal cancer (CRC) screening.</p><p>Its efficacy exceeds that of conventional barium enemas; with a sensitivity rate of 67-94% and a specificity of 86-98%, it demonstrates greater sensitivity in detecting adenomas of at least 1 cm in size <ref type="bibr" target="#b186">[187]</ref>. The excellent sensitivity of CT colonography, which is on par with colonoscopy for identifying polyps larger than 5 mm, is highlighted by research conducted in Europe. It also highlights a noticeably reduced perforation risk related to this technique. The capacity of CT colonography to identify tiny polyps is inferior to that of colonoscopy. The need for intestinal preparation and radiation exposure are two major disadvantages. Despite these problems, CT colonography is recommended, especially for individuals who are more likely to experience colonoscopy-related difficulties <ref type="bibr" target="#b178">[179]</ref>.</p><p>A new method for CRC screening called liquid biopsy examines blood samples for protein markers, circulating tumor cells (CTCs), and cell-free tumor DNA (ctDNA) <ref type="bibr" target="#b187">[188]</ref>. The FDA has granted approval for the methylation DNA septin9 test, which is the first serum test for CRC screening. This test has a sensitivity of 48.2% and a specificity of 91.5%. The sensitivity of CRC stages I-IV ranges, with percentages of 35.0%, 63.0%, 46.0%, and 77.4%, respectively. However, for advanced adenomas, the sensitivity is significantly low at only 11.2% <ref type="bibr" target="#b188">[189]</ref>. The Septin9 test offers the benefit of being both uncomplicated and non-invasive, hence increasing the likelihood of more participation among individuals <ref type="bibr" target="#b189">[190]</ref>. The following are the conventional techniques employed for the identification of CRC.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2">Limitations of Current Detection Methods for CRC:</head><p>Early detection of CRC is crucial for enhancing patient outcomes and increasing survival rates. Healthcare professionals must have a comprehensive understanding of the various traditional methods that have been developed in recent years to detect CRC at its earliest stages. This knowledge is crucial for determining the most suitable screening strategy for each patient, considering their individual needs and circumstances. Additionally, it is important for healthcare professionals to stay informed about the current and future advancements in CRC screening. Table <ref type="table" target="#tab_4">5</ref> provides a comprehensive summary of the various methods used to CRC globally. These methods include endoscopic, radiologic, and stool-based tests, as well as physical examination and emerging blood-based screening tests. The table also includes information on the applications and limitations of each method, along with primary references. This overview aims to offer a clear understanding of the current landscape of CRC screening strategies. Discomfort from bowel preparation, risks of sedation, perforation, and bleeding. Sigmoidoscopy does not assess the entire colon. <ref type="bibr" target="#b184">[185]</ref> Stool-based Testing FDA endorses multitarget FIT-DNA combined with FIT for CRC screening, recommended at three-year intervals in the US.</p><p>FIT-DNA shows higher sensitivity but lower specificity than FIT alone, leading to more false positives. Higher cost could hinder adoption. <ref type="bibr" target="#b185">[186]</ref> Radiologic Method:</p><p>CT Colonography Superior sensitivity in detecting adenomas of at least 1 cm compared to traditional barium enemas. Recommended every 5 years for individuals at elevated risk of colonoscopy-related complications.</p><p>Exposure to radiation, need for bowel preparation, and lower sensitivity for smaller polyps compared to colonoscopy. <ref type="bibr" target="#b190">[191]</ref> Blood-based Screening Tests (Liquid Biopsy) Analyzes circulating tumor cells, cellfree tumor DNA, and protein markers in the blood. The FDA approved the methylated DNA septin9 test for CRC screening.</p><p>Low sensitivity for detecting CRC and advanced adenomas, hindering early detection efforts. <ref type="bibr" target="#b189">[190]</ref> 4.3 The Role of AI in Enhancing CRC Detection AI, particularly utilizing ML and DL techniques, has substantial potential in overcoming the limitations of conventional approaches for identifying CRC, as depicted in Figure <ref type="figure" target="#fig_5">7</ref>. By examining large datasets obtained from colonoscopy images, radiological scans, and genetic tests, AI systems may accurately detect signs of CRC.</p><p>This system decreases reliance on human operations in endoscopic procedures by providing standardized assessment tools, while also improving early detection capabilities by combining data from various sources.</p><p>Furthermore, AI has the capacity to improve the accuracy and precision of non-invasive testing and can offer personalized screening schedules based on individual risk factors. This can lead to better utilization of resources and improved outcomes for patients <ref type="bibr" target="#b191">[192]</ref>. The application of AI in the clinical field of CRC is facilitated by its capacity to identify patients at high risk, choose accurate and personalized treatment strategies, and forecast prognoses. This demonstrates the present and future therapeutic relevance of AI technologies in the management of CRC <ref type="bibr" target="#b190">[191]</ref>. Implementing these methods in clinical practice has the capacity to enhance colorectal cancer (CRC) screening, detection, and management. This can result in earlier detection, decreased burden from screening procedures, and improved outcomes for individuals at risk of CRC.</p><p>AI technology has lately made significant advancements in the diagnosis of CRC. Despite being a long-standing cornerstone of early colorectal cancer (CRC) screening, colonoscopy has faced considerable difficulties in detecting polyps and adenomas due to inconsistencies among operators and inadequate preparation. Computer-aided detection (CADe) systems, along with AI techniques such as DL, have been proven to overcome these challenges and improve the adenoma detection rate (ADR) <ref type="bibr" target="#b192">[193]</ref>. The use of AI technology, specifically YOLOV3 AI, in colonoscopy has significant potential, particularly in enhancing real-time ADR.</p><p>The use of AI technology, specifically YOLOV3 AI, in colonoscopy has significant potential, particularly in enhancing real-time ADR. This solution could also resolve the identified limitation of not being able to completely utilize high-definition endoscopy due to limited adoption of HD technology or integration with colonoscopies <ref type="bibr" target="#b190">[191]</ref>. Furthermore, developments such as YOLOV3 might provide a substitute for current techniques that find it difficult to obtain significant ADR improvements using CADe and colonoscopies <ref type="bibr" target="#b192">[193]</ref>. The end result might be an easier-to-use, more affordable system for improving ADR that can be implemented more widely and with limited resources, especially in situations with limited resources <ref type="bibr" target="#b193">[194]</ref>. An expanded innovation pipeline in place of the current flat colonoscopy monitor may also greatly enhance the identification of tiny, easily missed polyps. Increased utilization of CADe technology has the potential to reduce the occurrence of colorectal cancer by up to 53 percent by ensuring that every polyp is recognized and not missed <ref type="bibr" target="#b194">[195]</ref>. The recent implementation of the CNN algorithm has reduced the adenoma miss rate (AMR) to 7%. This indicates an improvement in the accuracy of AI-enabled detection of lesions that were previously overlooked by traditional methods <ref type="bibr" target="#b173">[174]</ref>.</p><p>AI has extensive promise that extends beyond its use in endoscopic applications. Non-invasive approaches for colorectal cancer (CRC) screening provide a promising approach to detect tumor indicators in bodily fluids. These methods offer a safer alternative to traditional colonoscopy, as they do not require the same strict preparation procedures <ref type="bibr" target="#b195">[196]</ref>. ML-type technologies have been used to find new potential markers for early colorectal cancer diagnosis as well as to increase the sensitivity and specificity of well-established markers including faecal occult blood tests (FOBT) and carcinogenic embryonic antigen (CEA) <ref type="bibr" target="#b192">[193]</ref>. AI has also provided benefits to the field of diagnostic histopathology. The combination of DL and pattern recognition in digital pathology has improved diagnostic accuracies in this sector. This has resulted in a decrease in wrong diagnoses and an enhancement in the efficiency of pathologists' workflow <ref type="bibr" target="#b196">[197]</ref>. AI-enhanced radiomics have revolutionized medical imaging for colorectal cancer by enabling the accurate identification and measurement of tumors, leading to greater diagnostic and prognostic capacities <ref type="bibr" target="#b197">[198]</ref>.</p><p>The advancements mentioned highlight the significant impact that AI can have on the diagnosis and treatment of CRC. This includes enhancing the accuracy of endoscopic procedures, enabling non-invasive screening, and improving Histopathological and radiological assessments. It is reasonable to anticipate that AI will continue to advance CRC management as these skills develop quickly, democratizing and optimizing the benefits of early identification and treatment. The development of AI has brought a fresh perspective to the treatment of CRC, adding a new dimension to established techniques including chemotherapy, targeted therapy, surgery, and their combination.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.1">Surgical Innovations of CRC by AI</head><p>In recent years, there have been significant breakthroughs in minimally invasive surgical techniques. However, the integration of AI has emerged as a revolutionary development in lung cancer surgeries and is now gaining recognition in the complicated field of CRC surgery <ref type="bibr" target="#b174">[175]</ref>.</p><p>The latest advancement in surgical practices in Japan involves groundbreaking AI research; specifically in the field of computer vision (CV) applied to laparoscopic surgery videos. Researchers in Japan have analyzed extensive video data from laparoscopic colorectal surgeries to enhance the performance of CNN in computer vision <ref type="bibr" target="#b178">[179]</ref>. Simultaneously, South Korean research has shown nearly flawless precision in the study of microcirculation. This was achieved by employing AI to develop versatile and very advanced learning models for the examination of indocyanine green (ICG) angiography in laparoscopic surgeries <ref type="bibr" target="#b198">[199]</ref>.</p><p>AI has had significant growth in the field of robotic surgery, namely in the domain of rectal surgery. The advantages of using a robotic system compared to traditional approaches include a decrease in perioperative problems and an enhancement in postoperative quality of life. Robotic systems are currently advancing, specifically in relation to the da Vinci platform. Subsequent generations have enhanced the accuracy and adaptability options for patients. Nevertheless, further efforts are required to address the issues of operation time and range of motion <ref type="bibr" target="#b199">[200]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.2">Chemo-radiotherapy Advances of CRC by AI</head><p>AI has significant effects on the field of chemoradiotherapy. Significantly, a significant amount of the decision-making and assessment of effectiveness in the treatment of neoadjuvant chemoradiotherapy (NCRT) patients is impacted by AI. The utilisation of AI in the construction of Clinical Decision Support Systems (CDSS) is a significant achievement that improves clinical decision-making. An example of this is seen in South Korea's utilisation of a CRC chemotherapy prescription system, which displayed a remarkable level of precision (AUC &gt; 0.95).</p><p>Moreover, AI-powered systems that aid in risk assessment following colectomy are enhancing the capacity to detect individuals who can safely skip NCRT, a characteristic that is expected to have a substantial impact on improving survival rates <ref type="bibr" target="#b200">[201]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.3">Personalized Medicine through AI in CRC</head><p>AI has greatly influenced personalized medicine, specifically in identifying individuals who could potentially benefit from targeted medicines aimed at EGFR sensitivity for KRAS mutations. The use of DL to non-invasively determine the status of KRAS mutations demonstrated good prediction abilities (AUC = 0.90). Further obstacles in treating CRC include the emergence of drug resistance and the need to create targeted drug delivery systems and predictive models for treatment resistance. These challenges pave the way for precision medicine, which aims to provide the most suitable treatment to each patient at the optimal time <ref type="bibr" target="#b201">[202]</ref>. Table <ref type="table" target="#tab_5">6</ref> summarizes the CAD method. CAD systems have been developed to improve colorectal cancer diagnostics. They represent a significant advancement in colorectal cancer diagnosis and treatment, providing a combination of imaging techniques and computational algorithms to improve polyp detection, classification, and histological analysis. Table <ref type="table" target="#tab_6">7</ref> presents a summary of the most innovative works in the past decade, encompassing personalized and multimodal CAD programmers for analyzing endoscopic pictures and narrow-band imaging samples. This compilation aims to advance the area. To develop a CAD system based on deep learning imaging (DLI) methods to assist in the diagnosis of early-stage polyps by analyzing cell patterns.</p><p>Processing of input images, feature extraction from CNN to HOG and bag-of-visual words, k-means clustering, SVM classification using a heat map orientation, and identification using a CNN.</p><p>Highdefinition white-light imaging samples Sensitivity = 83.5%, Specificity = 81%, PPV = 79.3%, NPV = 72.1% <ref type="bibr" target="#b217">[218]</ref> AI significantly enhances the diagnostic armamentarium, although non-invasive screening remains limited by marker constraints. Ethical and methodological challenges, such as data privacy, algorithmic bias, and the need for thorough clinical validation, highlight the complexities of AI integration into colorectal cancer (CRC) management. Continued interdisciplinary collaboration and ethical oversight are crucial for responsibly harnessing AI's full potential.</p><p>The incorporation of AI into CRC screening marks a significant turning point with far-reaching implications. AI effectively resolves the issues associated with traditional screening approaches. Machine-learning and deep-learning models enhance the precision of diagnoses in endoscopy, increase the rates at which adenomas are detected (ADR), and decrease the occurrence of missed adenomas (AMR). The use of AI improves the accuracy of non-invasive screening in detecting tumor markers. Upon the detection of CRC, AI enables the development of customized treatment strategies, resulting in enhanced patient outcomes. AI enhanced robotic and laparoscopic surgeries are improving accuracy and lowering risks. AI streamlines the process of making decisions about chemoradiotherapy in medication development by using a variety of data sources to enhance the assessment of effectiveness. In addition, the predictive analytics of AI are transforming targeted therapy, overcoming the longstanding problem of drug resistance that has posed a significant barrier to oncologists. Although AI has had a significant influence on the detection and management of CRC, its integration into clinical practice must be approached with careful consideration of scientific and ethical issues.</p><p>Important priorities include of establishing strong data protection regulations, tackling potential biases in algorithms, and guaranteeing thorough clinical validation. The increasing utilizations of AI in the detection and treatment of colorectal cancer highlights the importance of interdisciplinary collaboration and ethical evaluation in order to fully achieve its clinical potential.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Liver Cancer and AI</head><p>The most prevalent form of primary liver cancer is hepatocellular carcinoma (HCC), which is one of the leading causes of cancer-related fatalities worldwide. Liver fibrosis can result from chronic inflammation, which in turn creates an environment where profibrogenic extracellular matrix (ECM) proteins accumulate excessively. This leads to a disruption of the liver's structure and function, which is then replaced by immunologically inert matrix. This process can progress to cirrhosis and ultimately liver failure, with the associated morbidity and mortality that make liver transplantation the most common reason for liver replacement <ref type="bibr" target="#b218">[219]</ref>. The importance of early identification of HCC is evident due to its direct correlation with enhanced patient outcomes, particularly in persons at high risk, such as those with a previous record of chronic hepatitis B or C virus infection.</p><p>Utilizing non-invasive biomarkers such as AFP, DCP, and GPC3 in conjunction with state-of-theart imaging techniques such as MRI and ultrasound <ref type="bibr" target="#b219">[220]</ref>, have revolutionized the early detection landscape, increasing sensitivity and specificity for diagnosis of HCC and leading to multimodality algorithms which are optimum for predicting early tumor recurrence Imaging technology has made considerable advancements in the past decade, and one promising option is contrastenhanced ultrasound (CEUS). The technology offers a clear and detailed view of the liver and its blood vessels in real-time, with high resolution. It also gives enhanced accuracy in detecting HCC and allows for precise measurement of tumor margins during surgery, surpassing the capabilities of standard ultrasound <ref type="bibr" target="#b220">[221]</ref>.</p><p>Furthermore, in addition to conventional imaging techniques, radiomics features can serve as a supplementary tool to enhance the precision of HCC diagnoses by assisting AI-based algorithms <ref type="bibr" target="#b221">[222]</ref>. The von Willebrand factor (vWF) is now a critical prognostic indicator that influences the efficacy of systemic treatment, the progression of conditions after HCC removal, and the risk of HCC in cirrhotic patients. There is a possibility that vWF may affect acute liver failure and noncirrhotic portal hypertension due to its involvement in the production of portal microthrombi. Nonselective beta-blockers, statins, anticoagulants, and antibiotics that are not ingested by the body are among the medications that have the capacity to regulate vWF levels. <ref type="bibr" target="#b222">[223]</ref>. Recent advancements in radiomics models, particularly those utilizing multi-sequence MRI, have demonstrated potential in predicting the expression of PD-1/PD-L1 in HCC). This predictive capability could be valuable in informing decisions on immunotherapy treatment <ref type="bibr" target="#b223">[224]</ref>. These are a few examples of the changing ways in which AI could have a significant impact, not just in identifying HCC, but also in using biomarkers to diagnose it.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1">Current Diagnostic Approaches for the Detection of Liver Cancer</head><p>Appropriate screening methods are essential for detecting HCC early on, as this improves patient outcomes. While there is no universally acknowledged screening strategy for HCC, ultrasound has proven to be the most cost-effective and commonly used tool for early diagnosis of HCC, particularly in high-risk categories such patients with cirrhosis <ref type="bibr" target="#b224">[225]</ref>. As a result, efforts to find more accurate and fast early HCC detection and diagnosis tools, including enhanced biomarkers and cutting-edge imaging methods, have persisted <ref type="bibr" target="#b225">[226]</ref>.</p><p>Various biomarkers have been extensively studied in the ongoing pursuit of enhancing diagnostic precision. Alpha-fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), and glypican-3 (GPC3) have demonstrated encouraging outcomes as diagnostic or prognostic indicators for hepatocellular carcinoma (HCC). More accurate and early identification of HCC may be possible with the emergence and development of additional new biomarkers like long non-coding RNAs and microRNAs.</p><p>Advancements in targeted medicine and bioengineering have revolutionized the treatment of hepatocellular carcinoma, allowing for personalized therapy. Utilizing biomarkers, genetics, nanotechnology, and drug delivery technologies in the creation of customized treatment plans yields improved patient outcomes. Two urgent problems that demand attention are the need for more accurate diagnostic techniques and the advancement of innovative targeted therapies for HCC <ref type="bibr" target="#b226">[227]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1.1">Diverse Screening Approaches for liver Cancers Detection</head><p>Several screening methods have been studied for the identification of HCC, such as ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and serum biomarkers like AFP and DCP. The American Association for the Study of Liver Diseases (AASLD) state that ultrasound, with or without AFP, is the recommended bi-annual screening test for populations at high risk of HCC. Ultrasound (US) in conjunction with AFP using ML algorithms have both shown significant improvements in sensitivity and specificity for HCC detection <ref type="bibr" target="#b227">[228]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1.2">Molecular Biomarkers for Liver Cancer</head><p>It has been discovered that more novel serum indicators are helpful for HCC screening. For instance, plasma glypican-3 (GPC3) is a novel biomarker for HCC screening that shows tremendous promise in the identification of early-stage HCC <ref type="bibr" target="#b228">[229]</ref>. In fact, compared to various serum AFP readings, plasma GPC3 has a diagnostic sensitivity that is noticeably higher for identifying early-stage HCC. Additionally, serum hepatocyte growth factor (HGF) levels are inversely linked with prothrombin time and albumin concentration in individuals with cirrhosis; as a result, serum HGF may be utilized as an extra helpful biomarker for HCC screening <ref type="bibr" target="#b229">[230]</ref>. CtDNA analysis has become a highly sensitive and specific diagnostic technique for HCC diagnosis <ref type="bibr" target="#b230">[231]</ref>. Moreover, a combined radiomics model that incorporates DL-informed multisequence MRI produces excellent discriminatory performance in anticipating early recurrence for early-stage HCC as well as PD-1/PD-L1 expression <ref type="bibr" target="#b231">[232]</ref>. AI algorithms and ML models have the potential to significantly improve diagnostic efficacy and accuracy for even less experienced physician readers, in addition to their ability to detect HCC early <ref type="bibr" target="#b232">[233]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1.3">Imaging Techniques for Liver Cancer Detection</head><p>Imaging modalities play a critical role in the early diagnosis and detection of (HCC), the second most common cause of cancer-related deaths globally, as well as in the prediction of treatment outcomes and evaluation of treatment response. A review of the research published in the Journal of Hepatology in May 2021 states that MRI and CT scans are essential for the diagnosis of HCC.</p><p>Particularly, three-dimensional multifrequency magnetic resonance elastography and multisequence MRI are becoming useful instruments to enhance preoperative evaluations and forecast PD-1/PD-L1 expression in HCC <ref type="bibr" target="#b220">[221,</ref><ref type="bibr" target="#b233">234]</ref>. Therapeutic decision-making and treatment stratification depend on this interpretation. Long recognized for its capacity to create preoperative prediction models for macro trabecular-massive HCC, contrast-enhanced CT has also made a substantial contribution to diagnostic accuracy by acting as the gold standard for numerous complex and real-world scenarios, such as the United Network for Organ Sharing's imaging criteria for HCC when screening liver transplant candidates <ref type="bibr" target="#b234">[235]</ref>. Furthermore, using baseline MRI data, deep machine learning models demonstrated high prediction accuracy for early-stage HCC tumor recurrence, demonstrating the possibility of combining AI with imaging data to improve diagnosis <ref type="bibr" target="#b233">[234]</ref>.</p><p>With the use of microbubble contrast agents, contrast-enhanced ultrasound (CEUS) has shown to be a valuable diagnostic tool for HCC. This technique is especially helpful for patients with cirrhosis, for whom other forms of imaging may not be as helpful <ref type="bibr" target="#b235">[236]</ref>. It has shown to have good sensitivity and specificity in identifying tiny HCC nodules and distinguishing HCC from other liver lesions. It has been shown to be very helpful in determining the course of treatment after locoregional therapy <ref type="bibr" target="#b236">[237]</ref>. CEUS surveillance has been proven to be more sensitive than CT and MRI in detecting tiny nodules in the early stages of HCC. It has also been demonstrated to detect early alterations in liver perfusion that take place throughout the development of HCC <ref type="bibr" target="#b237">[238]</ref><ref type="bibr" target="#b238">[239]</ref><ref type="bibr" target="#b239">[240]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1.4">Liquid Biopsy in Liver Cancer Detection</head><p>A developing non-invasive method for diagnosing HCC is called liquid biopsy, and it entails looking for cancer-related biomarkers for HCC in extracellular vehicles (EVs), circulating tumor cells (CTCs), and cell-free DNA (cfDNA). Compared to traditional tissue biopsy, it has many benefits, such as a lower risk of complications and the ability to monitor disease development and therapeutic response more dynamically <ref type="bibr" target="#b225">[226]</ref>. When it comes to detecting HCC, CTCs are quite accurate; their sensitivities and specificities are frequently greater than 80% <ref type="bibr" target="#b239">[240]</ref>," Dr. Wong elaborated. "Likewise, it has recently been discovered that increased ctDNA levels are linked to the development of HCC as well as noticeably worse results <ref type="bibr" target="#b227">[228]</ref>, providing key proof of concept and a potential biomarker for early diagnosis. EVs have also demonstrated outstanding diagnostic accuracy for HCC <ref type="bibr" target="#b240">[241]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1.5">Histopathological Analysis for Liver Cancer</head><p>Nothing is more accurate than using liver biopsy samples for histological investigation to diagnose hepatocellular carcinoma (HCC). This technique looks deeply into the liver's cellular structure to identify HCC rather than merely examining cells under a microscope. Its capacity to provide the full picture of cellular morphology-including the sizes, shapes, and configurations of cells that are indicative of HCC sets it apart. This data is not only essential for verifying the existence of a tumor, but it is also critical for establishing the tumor's levels, which in turn directs the course of treatment. Histopathological examination is another method that can be used to assess the degree of fibrosis, which is crucial in determining the optimal course of treatment. Furthermore, this method also provides security in disclosing diagnoses of liver-related disorders other than HCC (such as necrosis, steatosis, or inflammation). Considering the high threshold for confirming HCC, liver biopsy carries inherent risks and potential consequences.</p><p>The process of confirming HCC may involve several problems, including substantial discomfort and the potential for bleeding, infection, and mortality, which occurs in less than 0.1% of patients. Additionally, 5% of the patients necessitate an extended hospitalization period for observation <ref type="bibr" target="#b241">[242]</ref>.The hunt for alternate, less invasive methods to diagnose HCC is gaining traction. Traditional liver biopsy has been replaced by more advanced imaging techniques and liquid biopsy, which are newer methods of detecting HCC. It is highly prospective that these secure, noninvasive methods can be employed to diagnose HCC <ref type="bibr" target="#b220">[221,</ref><ref type="bibr" target="#b225">226]</ref>. These changes could significantly reduce the hazards associated with the resolution of biopsy operations and increase the chances of early detection and timely intervention. Although non-invasive diagnostics have made significant advancements, histopathological analysis remains necessary for a comprehensive characterization of HCC. This is because it is the sole method for identifying prognostic biomarkers such as tumor grade and vascular invasion, which play a crucial role in assessing the severity of the disease and guiding treatment decisions <ref type="bibr" target="#b224">[225]</ref>.</p><p>There are multiple unusual variations of HCC, and the assessment of these variations relies heavily on histological examination. Cirrhotomimetic hepatocellular carcinoma is a rare type of HCC that imitates the characteristics of cirrhosis. This poses a diagnostic challenge, highlighting the need for thorough imaging and pathological testing to ensure accurate diagnosis and suitable treatment <ref type="bibr" target="#b242">[243]</ref>. Due to its remarkable ability to replicate the pseudocirrhotic pattern of HCC, cirrhotomimetic HCC is very intriguing. The repercussions of failing to identify these unusual patterns in the differential diagnosis of liver masses are amplified in a patient with a documented history of chronic liver disease.</p><p>To accurately characterize and treat these rare cases, a comprehensive strategy that combines thorough cross-sectional imaging with histopathologic examination is necessary. The limited and incomplete evidence we have on the origin of cirrhotomimetic HCC, whether it arises from hepatic adenoma or develops spontaneously, contributes to the overall occurrence of HCC. Amidst the era of swiftly expanding treatment alternatives, the timely identification and accuracy in diagnosis play an increasingly crucial part in enhancing patient outcomes <ref type="bibr" target="#b243">[244]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2">Limitations of the Current Traditional Detection Method for Liver Cancer</head><p>The diagnostic approaches for HCC exhibit varying limits across a range of modalities. Ultrasonography is a cost-effective and non-invasive technique. However, it may be challenging to detect small lesions of early-stage HCC in patients with cirrhosis <ref type="bibr" target="#b224">[225]</ref>. Advanced imaging methods such as MRI and CT provide higher levels of sensitivity and specificity. However, they need significant resources and are not easily accessible in places with limited resources. Additionally, there are possible dangers connected with the use of contrast agents <ref type="bibr" target="#b220">[221,</ref><ref type="bibr" target="#b234">235]</ref>. Gastrointestinal endoscopy has included contrast-enhanced ultrasonography (CEUS) to enhance the identification of HCC, although its efficacy is significantly influenced by the skill of the operator and the characteristics of the patient <ref type="bibr" target="#b238">[239]</ref>. Histopathological examination is the established and authoritative method for diagnosing HCC. The invasiveness of liver biopsies is correlated with the likelihood of complications <ref type="bibr" target="#b242">[243,</ref><ref type="bibr" target="#b243">244]</ref>. The biological attributes of the tumor can influence the accuracy and precision of identifying biomarkers, presenting obstacles to the use of liquid biopsy as a non-invasive diagnostic alternative <ref type="bibr" target="#b242">[243]</ref>. Collectively, these diagnostic modalities emphasize the importance of integrated approaches that prioritize effectiveness, safety, and availability in the management of HCC. Table <ref type="table" target="#tab_7">8</ref> presents an overview of the existing detection techniques and their limitations. Low sensitivity and specificity for early-stage HCC.</p><p>[245]</p><p>Multiphasic computed tomography (CT) or magnetic resonance imaging (MRI):</p><p>High cost, limited access, and requires contrast that may have contraindications <ref type="bibr" target="#b245">[246]</ref> Hepatocellular carcinoma Early detection Screening (HES) algorithm Slight improvement over AFP alone; further validation required <ref type="bibr" target="#b246">[247]</ref> Circulating biomarkers (e.g., AFP, AFP-L3, DCP)</p><p>Single biomarkers often lack the needed sensitivity and specificity for early detection <ref type="bibr" target="#b244">[245]</ref> Novel multi-target blood test incorporating methylation biomarkers and proteins</p><p>Requires additional, large-scale validation before widespread clinical adoption <ref type="bibr" target="#b247">[248]</ref> Liquid biopsy technologies (e.g., circulating tumor DNA)</p><p>Still in the research phase with challenges concerning standardization and sensitivity for early HCC.</p><p>[249]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3">Role AI in the Liver Cancer Detection</head><p>AI is becoming increasingly crucial in the identification of liver cancer, with a diverse range of applications that greatly enhance the field of medical imaging analysis, predictive modeling, diagnosis, treatment planning, and even the continuous management of patients' care. A recent study provides valuable insights into the application of AI in the diagnosis and treatment of liver cancer. The article emphasized the utilization of AI in the identification and control of liver cancer. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.1">Advancements in AI for Liver Cancer</head><p>AI has the potential to significantly enhance future healthcare, particularly in the realm of diagnosing and treating liver illnesses like HCC. Due to technological innovations, clinicians can employ AI algorithms that not only forecast the likelihood of colon cancer spreading to the liver but also assess the effectiveness of treatment and identify any deviations. This intelligent assistant technology is revolutionizing the process of selecting the most appropriate treatment, ensuring that each patient receives optimal care. Table <ref type="table" target="#tab_8">9</ref> displays many applications of artificial AI in the field of cancer management. Uses ML to predict the risk of liver metastasis in T1 colorectal cancer patients. <ref type="bibr" target="#b249">[250]</ref> Evaluating Treatment Response Applies AI for volumetric evaluation and assessment of HCC treatment response.</p><p>[251]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Precision</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Diagnosis and Treatment</head><p>Contributes to liver cancer management in six application scenarios including risk and treatment response prediction.</p><p>[252]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hepatitis Evaluation</head><p>Predicts the incidence and progression of hepatitis, which is a key risk factor for HCC.</p><p>[253]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AI in Cancer Prognosis and Treatment Selection</head><p>Predicts cancer prognosis and assists in selecting appropriate treatments for liver cancer.</p><p>[254]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Risk Prediction Model for Liver Cancer</head><p>Develops and validates a risk prediction model for liver cancer based on available risk factors.</p><p>[255]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Diagnosis and Management of Hepatocellular Carcinoma</head><p>Aids in diagnosing and managing liver diseases, especially HCC, through ML.</p><p>[256]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Increased Cancer Risk in Autoimmune Hepatitis</head><p>Examines cancer risks in autoimmune hepatitis patients, focusing on the risk of HCC.</p><p>[257]</p><p>AI-integrated medical imaging represents a major advancement in the diagnosis of liver cancer. AI algorithms utilize DL techniques to analyze pictures obtained from CT scans, MRIs, and ultrasounds.</p><p>They demonstrate a superior ability to identify biomarkers of liver cancer compared to even the most skilled radiologists. This capability for detection expedites and enhances the diagnostic process. Zhou et al. <ref type="bibr" target="#b257">[258]</ref>. The use of AI has revolutionized medical imaging detection, especially when it comes to DL algorithms <ref type="bibr" target="#b258">[259]</ref>. The application of AI in ultrasonography has demonstrated encouraging outcomes in the assessment of liver disorders. Studies have shown that AI is exceptionally precise in distinguishing between benign and malignant liver lesions, as well as in assessing the severity of liver fibrosis. The implementation of this technology holds the capacity to significantly enhance ultrasound diagnoses, a crucial factor in the development of effective and personalized treatment strategies for liver cancer. AI) is increasingly utilized in hepatic ultrasonography to differentiate severe liver lesions, evaluate diffuse liver conditions, and conduct screenings for liver illnesses.</p><p>This enhances the precision of diagnosis and contributes to the delivery of improved and efficient patient care <ref type="bibr" target="#b258">[259]</ref>. Development of an AI system for the identification of HCC. A preliminary single-centre study has successfully demonstrated the construction of an AI system capable of diagnosing hepatocellular cancer using CT imaging data using CT to Ultrasonography Fusion Imaging. The newly developed system utilizes a fully convolutional network and can be trained by both specialized radiologists and general radiologists. It demonstrates accurate diagnostic performance that is equivalent to prior studies. Ultimately, we can expect the implementation of AI systems such as this in a healthcare environment <ref type="bibr" target="#b259">[260]</ref>.</p><p>AI is now making significant progress in the field of liver cancer pathology, particularly in automating the processing of tissue sections to identify abnormal biomarkers and pathways linked to cancer. These technologies enhance the effectiveness of liver biopsies in diagnosing various illnesses and improve the productivity of pathologists in examining thousands of slides each patient. Table <ref type="table" target="#tab_9">10</ref> presents a comprehensive overview of the distinct tasks that AI carries out in the fight against liver cancer, with each task being more specialized than the one before it. The tasks encompassed are risk assessment, diagnosing liver tumors with a degree of proficiency similar to that of human experts, interpreting complex histopathology images, and providing valuable information about the liver microenvironment. Extracts complex information from histopathology images to aid pathologists. <ref type="bibr" target="#b260">[261]</ref> Differentiating Common Liver Carcinomas Diagnoses common primary liver tumors, comparing AI performance with pathologists. <ref type="bibr" target="#b261">[262]</ref> Impact on Histopathologic Classification Develops a deep learning assistant for differentiating between HCC and cholangiocarcinoma.</p><p>[263]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Increased Cancer Risk in Autoimmune Hepatitis</head><p>Examines cancer risks in autoimmune hepatitis for AIassisted risk stratification. <ref type="bibr" target="#b256">[257]</ref> Exosomal miRNAs in Liver Injury Automates detection of liver cancer in whole-slide images for pathology advancements.</p><p>[264]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bibliometric Analysis on AI in Liver Cancer</head><p>Investigates the role of exosomal miRNAs in liver injury and implications in liver cancer. <ref type="bibr" target="#b264">[265]</ref> Immunological and Metabolic Landscape in Liver Cancer Provides a bibliometric analysis on AI research in liver cancer for guiding future applications. <ref type="bibr" target="#b265">[266]</ref> Research in the field of oncology has demonstrated a growing demand for efficient biomarkers in the context of liver cancer. Table <ref type="table" target="#tab_10">11</ref> provides a concise overview of the latest advancements in Biomarker detection. Identifying biomarkers for liver cancer is essential for enhancing early identification in those at high risk, achieving effective targeted therapies, and advancing personalized medicine. AI technologies are transforming the process of identifying and applying biomarkers in liver cancer research <ref type="bibr" target="#b223">[224]</ref>. Identifies a set of genes as potential biomarkers for liver cancer stem cells using ML. <ref type="bibr" target="#b266">[267]</ref> Multiplex Detection of MicroRNA and Protein Biomarkers Developed a mass spectrometric method for the simultaneous detection of nucleic acid and protein biomarkers. <ref type="bibr" target="#b267">[268]</ref> Multi-Omics Strategy for Biomarker Detection Reviewed the integration of multi-omics technology in biomarker screening for hepatocellular carcinoma. <ref type="bibr" target="#b268">[269]</ref> Quantum Dot Nanoprobes for Biomarker Detection Suggests employing serological biomarker panels for liver cancer detection using fluorescent quantum dot nanoprobes. <ref type="bibr" target="#b269">[270]</ref> High-Throughput Proteomics Highlights the synergy between high-throughput proteomic technology and AI in developing next-generation biomarkers.</p><p>[271]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sensitive Electrochemical Immunoassay for Biomarker Detection</head><p>Reports on the development of an effective electrochemical immunosensor for liver cancer biomarkers. <ref type="bibr" target="#b271">[272]</ref> The studies conducted by Shahini et al. <ref type="bibr" target="#b272">[273]</ref> examine the clinical use of blood biomarkers and integration algorithms in hepatocellular carcinoma, a type of primary liver cancer that commonly occurs in individuals with chronic liver disease. These studies demonstrate the potential of AI in improving diagnostic and surveillance tools for this disease.</p><p>Several investigations currently concentrate on the methodical utilization of biomarkers in primary liver cancer, as well as the potential of AI to create reliable biomarkers for diagnosis, prognosis, and treatment <ref type="bibr" target="#b273">[274]</ref>. AI is transforming the field of liver cancer detection and treatment by providing unmatched levels of accuracy, precision, and speed. Table <ref type="table" target="#tab_11">12</ref> presents contemporary AI methodologies that illustrate the revolutionary capacity of AI in examining various data platforms, ranging from intricate medical scans to tiny cellular investigations. The integration of AI in the management of HCC represents a significant change in how liver cancer is diagnosed and treated. AI improves the assessment of tissue samples, increases the effectiveness of diagnoses, and offers precise analysis of medical images, resulting in higher levels of specificity, sensitivity, and predictive capability. This leads to treatment regimens and prognoses that are tailored to each individual. The utilization of AI in HCC care represents a paradigm shift in the field of oncology, where technology plays a pivotal role in enhancing patient outcomes and streamlining operations.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Role of AI in Gastric Cancer</head><p>Cancer is a disorder that shows a correlation with age, with the typical age of cancer diagnosis being about 70 years in developed countries.</p><p>By 2030, the proportion of cancer diagnoses in individuals aged 65 and above is projected to exceed 70% <ref type="bibr" target="#b280">[281]</ref>. The increasing geriatric population will therefore significantly augment the global burden of cancer. In 2020, there were 1.089 million new instances of gastric cancer (GC) diagnosed worldwide, making it the sixth most often diagnosed cancer. It also ranked as the third greatest cause of cancer-related deaths, with 0.769 million fatalities <ref type="bibr" target="#b281">[282]</ref>. The median age at the time of diagnosis is 70 years. Glycogen storage disease (GC) impacts several physiological systems within the body. Helicobacter pylori infection, older age, smoking, high salt intake, and inadequate consumption of fruits and vegetables are risk factors that increase the probability of developing gastric cancer. Men have a significantly higher incidence of GC compared to women, with a rate that is more than twice as high. The rates of incidence and mortality vary significantly worldwide, with the highest rates observed in East Asia, Eastern Europe, Western Asia, and South America. <ref type="bibr" target="#b282">[283]</ref>.</p><p>Siegel et al. <ref type="bibr" target="#b141">[142]</ref>, report that although there is a general decrease in cancer mortality rates, including stomach cancer, the advancement in this area may face obstacles due to the rising incidence of specific types of cancer. This underscores the significance of progress in medical interventions and emphasizes the necessity for ongoing endeavour in timely identification and mitigation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.1">Traditional Detection Methods for the detection of Gastric Cancer</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.1.1">Second-generation narrow band imaging (2G-NBI)</head><p>Although the prognosis for gastric cancer is generally not good, if the disease is identified early, there is a significant increase in the probability of survival for five years (99.3% for mucosal cancer and 97.2% for submucosal cancer) <ref type="bibr" target="#b283">[284]</ref>. Therefore, early detection should be considered as one of the optimal approaches to improve survival rates of stomach cancer. Nevertheless, there are currently no recognized and effective screening methods available for the early detection of stomach cancer, even in regions with a high incidence of the disease such as Asia, Russia, and South America. Currently, the standard method for identifying stomach cancer is endoscopy using white light imaging (WLI) <ref type="bibr" target="#b284">[285]</ref>. The sensitivity of white light imaging (WLI) in detecting early gastric cancer (EGC) is inadequate <ref type="bibr" target="#b284">[285]</ref>. Narrow band imaging (NBI) endoscopy is an advanced optical technique that enhances the visualisation of surface features and micro vasculature more effectively than conventional WLI. For example, first-generation NBI (1G-NBI) increased the detection rate of superficial head and neck and esophageal cancers over WLI <ref type="bibr" target="#b285">[286]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.1.2">Serum Screening System</head><p>The role of Helicobacter pylori (HP) infection in the onset and advancement of GC is extensively acknowledged. Correa reported the progression of GC from HP-induced atrophic gastritis to intestinal metaplasia, which is a recognized precursor of intestinal type GC <ref type="bibr" target="#b286">[287]</ref> and subsequently by Uemura et.al <ref type="bibr" target="#b287">[288]</ref>. The significant function of HP in GC was recently elucidated, highlighting its crucial involvement in the early diagnosis of GC by detecting HP-induced atrophic gastritis.</p><p>Serum pepsinogen (PG) levels have been demonstrated to accurately indicate the inflammatory condition of the gastric mucosa, namely atrophic gastritis. Recently, the diagnostic capability of PG to identify persons who are at risk for GC has been established <ref type="bibr" target="#b288">[289,</ref><ref type="bibr" target="#b289">290]</ref>.</p><p>Subsequently, Miki et al. <ref type="bibr" target="#b290">[291]</ref> employed these discoveries to create the ABC-classification system, a serum screening method that categorizes the likelihood of gastric cancer, referred to as the ABC classification system. This is achieved by assessing serum anti-HP antibody titers and PG levels.</p><p>The technique proved to be valuable in assessing the individual susceptibility to stomach cancer <ref type="bibr" target="#b291">[292]</ref> Furthermore, it is anticipated that this technique will be valuable for widespread screening in order to identify cases of stomach cancer.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.1.3">Liquid Biopsy Signature</head><p>In the field of oncology, liquid biopsy is becoming a game-changing instrument. Liquid biopsy offers a non-intrusive method for identifying many types of malignancies and assessing a patient's response to treatment. Early identification and dynamic monitoring of malignancies are crucial for improving patient outcomes. Research has mostly concentrated on three specific biomarkers: extracellular vehicles (EVs), circulating tumor cells (CTCs), and circulating tumor DNA (ctDNA).</p><p>The primary application of CTCs and ctDNA as biomarkers has been limited to tracking the advancement of disease because they are extremely uncommon and difficult to detect technically <ref type="bibr" target="#b292">[293]</ref>. On the other hand, EVs have greater potential due to their stability and their release by cells throughout the body, which allows them to serve as a valuable source of information on the significant biological changes happening inside the tumor microenvironment <ref type="bibr" target="#b293">[294,</ref><ref type="bibr" target="#b294">295]</ref>.</p><p>Recent studies emphasize the clinical importance of long noncoding RNAs (LRs) found in circulating extracellular vehicles (EVs). These researchers have identified multiple LR candidates originating from EVs that could serve as diagnostic biomarkers for cancer <ref type="bibr" target="#b295">[296,</ref><ref type="bibr" target="#b296">297]</ref>. These LRs provide a separate and distinctive biological perspective that is different from the information provided from tissue and circulating cell profiles. This highlights their potential to improve our understanding of cancer biology <ref type="bibr" target="#b297">[298]</ref>. The carcinogenic function of lncRNA GClnc1 has been well-documented due to its capacity to enhance tumor progression. Moreover, the stability of LR expression in different body fluids makes it a prospective candidate for liquid biopsy biomarkers in the diagnosis of cancer <ref type="bibr" target="#b298">[299]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.1.4">Fecal Screening</head><p>H. pylori (Hp) infection is acknowledged as a significant risk factor for the development of stomach cancer according to Correa's model <ref type="bibr" target="#b299">[300]</ref>. Additionally, sophisticated treatments for Hp eradication have been found to potentially have a partial protective impact in relation to GC <ref type="bibr" target="#b300">[301]</ref>. Nevertheless, the likelihood of infected persons developing GCa is minimal, ranging from 2% to 3% <ref type="bibr" target="#b301">[302]</ref>. This implies that additional elements, such as unidentified organisms <ref type="bibr" target="#b301">[302]</ref> are necessary for the development of GCa.</p><p>Therefore, it is necessary to identify specific bacteria linked with GCa in order to create monitoring techniques that are based on risk categorization <ref type="bibr" target="#b302">[303]</ref>. While multiple studies have identified different compositions of gastric microbiota in patients with gastric cancer (GCa) compared to those with chronic gastritis (ChG) <ref type="bibr" target="#b303">[304]</ref>, our understanding of the involvement of non-Helicobacter pylori (Hp) bacteria in GCa remains restricted. Several recent research, including our own, have found an increased presence of Streptococcus anginosus (Sa) in the tumor tissues of individuals with gastric cancer (GCa) <ref type="bibr" target="#b304">[305,</ref><ref type="bibr" target="#b305">306]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.2">Limitations of Current Techniques for the detection of Gastric Cancer</head><p>Table <ref type="table" target="#tab_12">13</ref> presents a thorough summary of the advantages and disadvantages of different methods used to identify stomach cancer. The visualization of possible stomach problems is now more evident with the improved narrow band imaging (NBI), however its effectiveness in comparison to the conventional white light approach is still unknown.</p><p>The blood test system categorizes individuals into different risk groups based on particular markers, although it still produces some incorrect negative results. Even though liquid biopsy is less intrusive, it is not always successful in identifying disease indicators such circulating tumor DNA.</p><p>Ultimately, the identification of certain pathogenic bacteria in stool samples seems to be a more favorable option compared to endoscopy or biopsy. However, its practical usefulness is still being assessed. Each of these methods offers useful insights into the benefits and limitations of various diagnostic procedures for early identification of stomach cancer. Challenges include the rarity and unreliable detection of primary targets like CTCs and ctDNA. <ref type="bibr" target="#b306">[307]</ref> Fecal Screening Identifies specific bacteria (e.g., Streptococcus anginosus) in fecal samples for noninvasive GCa screening.</p><p>Specificity and sensitivity in differentiating GCa from other gastrointestinal diseases need to be fully determined.</p><p>[305]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.3">Role of Ai in the Detection of Gastric Cancer</head><p>AI is introducing a new era in the diagnosis of stomach cancer, facilitating the investigation and creation of inventive approaches for early identification and treatment. Recent research has shown that AI has greatly enhanced the precision of early gastric cancer (EGC) diagnosis when compared to traditional endoscopic pictures, pathology evaluations, and other diagnostic methods. DL algorithms, known for their effectiveness in diagnosing EGC, have demonstrated exceptional accuracy in detecting the condition, even when its visual aspects are difficult for human experts to perceive.</p><p>Timely detection is particularly vital during the initial phases of diagnosing stomach cancer, as it can greatly impact the course of the disease and enhance patient prognosis. The application of AI in stomach cancer imaging goes beyond just cancer diagnosis, encompassing a wide range of diagnostic purposes. AI has the capability to not only detect lymph node metastases, but also to simulate medication responses and provide prognostic forecasts. The implementation of an all-encompassing strategy for early identification and categorization is essential for the precise management of stomach cancer in the field of precision medicine, facilitating exceptionally precise disease control <ref type="bibr" target="#b307">[308]</ref>. Table <ref type="table" target="#tab_13">14</ref> provides a concise overview of AI research conducted in the field of medical diagnostics, specifically focusing on the analysis of CT images to forecast the spread of cancer to lymph nodes and the overall survival rate. Several models, such as DL, DCNN, ResNet-18, and S-Net, routinely perform better than older approaches, offering superior prognostic evaluation in comparison to the TNM staging system.</p><p>Since determining the extent of invasion is crucial for determining the appropriate treatment, it is important to present this assessment to the patient during the diagnostic phase <ref type="bibr" target="#b312">[313]</ref>. Nowadays, EUS is a commonly used technique for predicting the depth of invasion. However, it has drawbacks such as being time-consuming, expensive, reliant on the operator's skills, and occasionally resulting in a greater percentage of misdiagnosis <ref type="bibr" target="#b313">[314]</ref>. Comparing with experienced endoscopists, a retrospective study by Zhu et al. <ref type="bibr" target="#b314">[315]</ref> demonstrated a notable level of precision, sensitivity, and specificity in the diagnosis of invasion depth by CAD <ref type="bibr" target="#b315">[316]</ref>. In a referral centre, a study was conducted by the same group using AI (ENDOANGEL). The results showed that AI had lower but still excellent accuracy, sensitivity, and specificity compared to previous imagebased studies: 84.6%, 86.7%, 82.3% versus 84.6% to 94.8%, 78.3% to 85.3%, 80.8 to 90.6% . Additionally, the use of AI significantly reduced the time required for diagnosis <ref type="bibr" target="#b316">[317]</ref>.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Endoscopic ultrasound (EUS)</head><p>AI systems for depth prediction using endoscopic images AI achieved similar accuracy in T staging and assessing serosal involvement as EUS <ref type="bibr" target="#b312">[313]</ref> White-light imaging (WLI), No magnifying narrow-band imaging (NBI), Indigocarmine dye contrast imaging Development of AI systems for predicting the invasion depth of gastric cancer using WLI, NBI, and Indigo High lesion-based accuracy and no significant difference between the WLI, NBI, and Indigo AI systems <ref type="bibr" target="#b322">[323]</ref> Magnifying endoscopy with narrow-band imaging (ME-NBI) AI-assisted convolutional neural network (CNN) computer-aided diagnosis (CAD) system based on ME-NBI images Improved diagnostic accuracy of the AI-assisted CNN-CAD system for EGC diagnosis <ref type="bibr" target="#b323">[324]</ref> Conventional histopathology AI-driven histopathological diagnosis system for gastric cancer detection using deep learning Near 100% sensitivity and an average specificity of 80.6% on a real-world test dataset <ref type="bibr" target="#b324">[325]</ref> Fluorescence hyperspectral imaging DL combined with spectralspatial classification method for early diagnosis of gastric cancer Overall accuracy of 96.5% for differentiating no precancerous, precancerous, and gastric cancer groups <ref type="bibr" target="#b325">[326]</ref> The implementation of AI in the field of GC screening and personalized treatment provides a greater likelihood of achieving positive results. Although these technologies hold potential in the management of gastric cancer, additional optimization is necessary to improve their efficacy in fighting the illness.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.">Esophageal squamous cell carcinoma (ESCC) and AI</head><p>One of the most prevalent forms of cancer that affects the digestive system is esophageal cancer (EC), which develops from the epithelial cells that line the mucosa of the esophagus. EC shows notable variations in occurrence and distribution throughout different regions, with East Asia having the highest incidence rates. In this region, the incidence rates are approximately double the global average of 12.2 cases per 100,000 people <ref type="bibr" target="#b326">[327]</ref>. ESCC is the predominant histological subtype of EC in China, representing over 90 percent of all EC cases <ref type="bibr" target="#b327">[328]</ref>. Conversely, adenocarcinoma is the most common subtype in regions such as the United States and Europe with lower incidence rates <ref type="bibr" target="#b328">[329]</ref>. In 2015, China, which plays a significant role in the global burden of esophageal cancer, reported 246,000 newly diagnosed cases and 188,000 deaths, as stated in a 2019 report by the National Cancer Centre.</p><p>These statistics rank sixth and fourth, respectively, in terms of their prevalence among all types of malignancies worldwide <ref type="bibr" target="#b329">[330,</ref><ref type="bibr" target="#b330">331]</ref>. However, at the time of diagnosis, 70% of EC patients are deemed unsuitable for surgical intervention <ref type="bibr" target="#b329">[330]</ref>. Early-stage ESCC and precancerous diseases can often be effectively treated with endoscopic methods, which have a 5-year survival rate of up to 90% <ref type="bibr" target="#b331">[332,</ref><ref type="bibr" target="#b332">333]</ref>. The early identification rate of EC is still far too low <ref type="bibr" target="#b329">[330]</ref>. The majority of EC patients are diagnosed in an advanced stage, underscoring the significance of early detection <ref type="bibr" target="#b333">[334,</ref><ref type="bibr" target="#b334">335]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.1">Conventional Diagnostic Approaches and Limitations in ESCC</head><p>The issue of rising demands and diagnostics issues may be addressed by AI-enhanced diagnostics <ref type="bibr" target="#b335">[336,</ref><ref type="bibr" target="#b336">337]</ref>. The limitations of the widely employed current diagnostic method for ESCC are presented in Table <ref type="table" target="#tab_16">17</ref>. Limited by macroscopic judgment and expertise.</p><p>[338]</p><p>White Light Imaging (WLI)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Endoscopy</head><p>The routine examination method aids in biopsy.</p><p>This may lead to missed diagnoses of precancerous lesions.</p><p>[339] Lugol Chromo endoscopy (LCE) Enhances detection of early cancer. Some patients experience discomfort after iodine staining. [338] Narrow-Band Imaging (NBI) Endoscopy Improves sensitivity in early EC diagnosis.</p><p>Specificity may need improvement. <ref type="bibr" target="#b339">[340,</ref><ref type="bibr" target="#b340">341]</ref> Magnifying Endoscopy Defines lesion range, and aids observation.</p><p>Efficient but may require additional expertise.</p><p>[341]</p><p>Electronic Staining Imaging Enhances mucosal surface display.</p><p>No adverse reactions but may not be widely available.</p><p>[341]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AI-Assisted Endoscopic</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Diagnosis</head><p>Addresses high workload and low efficiency.</p><p>Emerging technology, limited clinical application.</p><p>[336, 337, 342]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.2">AI-Based Solutions Transforming ESCC Diagnosis</head><p>AI is becoming a crucial tool for the early detection of ESCC, enhancing the accuracy of diagnoses by analyzing both photographs and video Data.</p><p>Image-based data can be influenced by bias when selecting the proper sections of imaging for research. On the contrary, AI diagnostics that utilize video enable immediate assessment, making them more applicable in clinical environments and offering vital insights into the system's performance under realistic conditions. The figure labelled as Figure <ref type="figure" target="#fig_9">10</ref> illustrates the mechanism by which the Ai model functions to delete ESCC. A multitude of researchers are currently trying to integrate the latest technology into the diagnosis of ESCC and devise novel techniques to address the limitations, as depicted in Table 18. Guo et al. developed a CAD system capable of rapidly identifying precancerous lesions and earlystage ESCCs. In order to train the system, a total of 3,703 NBI photos were used from 358 cases that were noncancerous. Additionally, 2,770 Narrow-Band Imaging (NBI) images were included from 191 cases of early ESCC or precancerous lesions. The test dataset comprised 80 video segments obtained from 33 cases of normal oesophagus and 27 cases of precancerous or early ESCC. The dataset exhibited a sensitivity of 99.9% per frame and a specificity of 91.5% per frame. The diagnostic sensitivity for non-magnified videos was 60.8%, while for magnified videos it was 96.1% [343]. Fukuda et al. have developed an AI system that can detect ESCC in real-time. The system was trained using a dataset of 23,746 images taken from 1,544 cases of superficial ESCC and 4,587 photos of noncancerous tissues. The technique was validated using Blue Laser Imaging (BLI) and NBI video clips acquired from 144 patients. The findings demonstrated that the AI had higher sensitivity (91% for non-magnified NBI footage) compared to expert endoscopists, but had worse specificity [344]. Tajiri et al. used 25,048 photos from 1,433 superficial ESCC patients to construct an AI system focused on real-time early ESCC diagnosis; these photos were verified against NBI recordings of probable superficial ESCC. The AI system exhibited a specificity of 75.0%, a sensitivity of 85.5%, and an accuracy of 80.9% in diagnosing ESCC, surpassing the diagnostic abilities of non-ESCC specialised endoscopic professionals [345].</p><p>Shimamoto et al. developed an AI system that can diagnose the depth of invasion in ESCC in realtime. The system was trained using over 20,000 photos of ESCC that were pathologically confirmed. The system was validated using 102 ESCC video images. The study showed that it had higher accuracy, sensitivity, and specificity compared to trained endoscopists in both nonmagnified and magnified videos <ref type="bibr" target="#b345">[346]</ref>.</p><p>Although many studies rely on historical data from a single center, AI-based diagnostic algorithms have demonstrated performance that corresponds to, or even superior to, that of endoscopic professionals. The effectiveness of these AI systems in practical medical settings may be limited by the accuracy and consistency of the training datasets in relation to real-life endoscopic conditions. Yuan et al. presented an AI system capable of identifying and outlining flat abnormalities in real-time during endoscopic surgeries. This system functions as a model for possible use in clinical settings to diagnose ESCC <ref type="bibr" target="#b346">[347]</ref>.  <ref type="bibr" target="#b366">[367]</ref> The integration of AI into early ESCC detection shows promise, although facing hurdles. It has the ability to decrease the burden of endoscopists and enhance diagnostic efficiency.</p><p>The invasiveness of endoscopic diagnosis, along with the diversity of pathological diagnosis, has generated a growing interest in the field of early gene diagnosis for EC. Xing et al. <ref type="bibr" target="#b367">[368]</ref> utilized RNA transcriptome data from ESCC patients to identify distinctive secretary proteins, with the aim of constructing a diagnostic model. While the model showed a significant level of sensitivity, its ability to accurately diagnose early ESCC was considered insufficient.</p><p>In addition, Shen et al. <ref type="bibr" target="#b368">[369]</ref> examined the application of developing diagnostic models employing microRNAs and protein markers that are particularly present in the plasma of patients with ESCC. Based on their analysis, these models effectively differentiate between esophageal squamous dysplasia (ESD) and healthy controls. However, there has been relatively little attention given to the use of AI-assisted gene identification for identifying dysplasia associated to Barrett's esophagus (BE) and early Esophageal Adenocarcinoma (EAC). Slaby et al. <ref type="bibr" target="#b369">[370]</ref> showed that certain microRNAs in BE tissues can distinguish between BE with dysplasia and BE without dysplasia. The early identification of ESCC poses a challenge due to the absence of initial symptoms and the necessity of a diagnosis from a specialist. AI systems that use advanced algorithms to identify ESCC using image and dynamic video data have demonstrated superior sensitivity and specificity when compared to experienced endoscopists. The utilizations of real-time AI diagnostics can enhance the early identification of ESCC. Despite the existing constraints, endoscopists can benefit from a decrease in their workload and an improvement in diagnostic efficiency by integrating AI into the diagnosis of ESCC <ref type="bibr" target="#b346">[347]</ref>. The main objectives of future endeavours should focus on incorporating AI into healthcare workflows, validating AI models across diverse populations, and enhancing specificity. AI has the ability to drastically revolutionize the prognosis and diagnosis of ESCC, offering hope for improved outcomes in the battle against this deadly cancer. Long-term surveillance and education for healthcare professionals are additional areas where AI can be applied.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.">Role of AI in Cervical Cancer</head><p>Cervical cancer (CC) is a significant worldwide public health issue, particularly prevalent in numerous low-income and middle-income countries (LMICs) <ref type="bibr" target="#b370">[371]</ref>. CC arises from the tissue of the uterine cervix and is characterized by uncontrolled proliferation and death of cervical cells <ref type="bibr" target="#b370">[371]</ref>. Cancer ranks fourth in terms of both the number of new cases and the number of deaths it causes <ref type="bibr" target="#b371">[372]</ref>. Young ladies have the highest occurrence rate <ref type="bibr" target="#b372">[373]</ref>. In 2018, there were around 570,000 reported instances of cervical cancer, resulting in 311,000 fatalities. These figures represent 6.6% of all newly diagnosed cases and 7.5% of all female cancer-related deaths <ref type="bibr" target="#b373">[374]</ref>. The estimated greatest prevalence of CC was found in Eswatini, while the average age of diagnosis and death varies greatly worldwide, demonstrating the disease's extensive impact. Despite lower incidence and death rates in some areas as a result of widespread prevention efforts, it is anticipated that the global incidence of CC will increase by about 50% by 2030 <ref type="bibr" target="#b374">[375]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.1">Causes, Prevention, and Diagnosis</head><p>The primary histological classifications of CC consist of squamous cell carcinoma (SCC) and adenocarcinoma (ADC), which account for the majority of CC cases <ref type="bibr" target="#b375">[376]</ref>. The prognosis of various types of individuals varies, with certain studies suggesting a less favourable prognosis for people with ADC <ref type="bibr" target="#b376">[377]</ref>. Chronic infections with high-risk human papillomavirus (HPV) are a major contributing factor to the development of CC, responsible for the majority of cases <ref type="bibr" target="#b374">[375]</ref>. Persistent infection with carcinogenic HPV variants has been linked to the development of cancer, presenting new opportunities for primary and secondary prevention <ref type="bibr" target="#b377">[378]</ref>. Various risk factors, including cigarette smoking, early marriage, engaging in sexual activity with multiple partners, having unprotected intercourse, giving birth multiple times, and using oral contraceptives, have been associated with an elevated risk of CC <ref type="bibr" target="#b378">[379,</ref><ref type="bibr" target="#b379">380]</ref>. Although there are difficulties, CC may mostly be prevented by implementing efficient measures such as HPV vaccination and screening, especially with methods that are based on HPV.</p><p>Nevertheless, the global efforts to decrease the occurrence and death rates of CC have not been consistent, particularly in low-and middle-income countries (LMICs) where progress has been slower and, in certain instances, there have been rises in the rates of occurrence or death during the previous decade <ref type="bibr" target="#b380">[381]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.2">Traditional Methods for Detection Cervical Cancer</head><p>The methods for cervical screening consist of the HPV DNA test, the liquid-based Pap smear test, the traditional Pap smear test, and visual inspection with acetic acid (VIA) or Lugol's iodine (VILI) <ref type="bibr" target="#b381">[382]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.2.1">Papanicolaou (PAP) smear Screening Test</head><p>The Papanicolaou (PAP) smear is the most prevalent method used for cervical cancer screening. In order to identify any complications, the procedure entails extracting cells from the cervix and examining them using a microscope.</p><p>In addition to detecting cervical cancer, the PAP smear test can also detect precancerous lesions, which can be treated before they progress into cancer. Research has shown that the PAP smear test can significantly reduce the likelihood of dying from cervical cancer by 70%.In underdeveloped nations, the average percentage of cervical cancer screening coverage is 19%, while in industrialised countries, it is 63% <ref type="bibr" target="#b382">[383]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.2.2">HPV testing</head><p>The World Health Organisation (WHO) recommends HPV testing as the initial screening method, followed by the treatment of precancerous lesions or referral of patients for further evaluation and therapy for invasive malignancy.</p><p>A Pap test and an HPV test are similar in terms of their diagnostic capabilities. When a Pap test detects abnormal changes in the cervix, the practitioner may opt to conduct an HPV test in conjunction with the Pap test using a sample of cervix cells.</p><p>The WHO has officially supported a worldwide plan to expedite the elimination of cervical cancer by the year 2030. The objectives are to immunise 90% of females against HPV, conduct highperformance screening on 70% of women, and provide treatment to 90% of women with cervical disease <ref type="bibr" target="#b383">[384]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.2.3">Colposcopy Method</head><p>Colposcopy has gained widespread usage globally as an essential diagnostic tool and for the management of cervical cancer <ref type="bibr" target="#b384">[385]</ref>. Colposcopy, in addition to its emphasis on cervical imaging, also includes the application of chemical staining to cervical epithelial cells. The quality of the solution, the technique used during the procedure, and the techniques of observation can all impact the staining process. Consequently, there are substantial discrepancies in the agreement among and within operators when it comes to colposcopy impressions and pathology. The results range from 52% to 66% <ref type="bibr" target="#b385">[386]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.2.4">Liquid based cytology technique</head><p>Liquid-based cytology (LBC) is a modern technique that improves the quality of samples and the interpretation of results, when compared to standard smears <ref type="bibr" target="#b386">[387]</ref>. These slides are more straightforward to evaluate compared to standard smears, and the remaining sample can be utilized for extra testing, namely for HPV. Furthermore, it has been recognized that LBC is beneficial in the field of automation. Implementing automation in the slide preparation process reduces the likelihood of human mistakes and ensures consistent quality in the final outcomes.</p><p>Moreover, LBC can be employed in conjunction with automated image processing systems, hence facilitating screening and initial diagnosis <ref type="bibr" target="#b387">[388]</ref>. By reducing the number of inadequate samples, LBC can enhance the sensitivity of endometrial cancer detection <ref type="bibr" target="#b388">[389]</ref>. In relation to ovarian cancer, the precision of cytologic diagnosis can be enhanced by utilizing Liquid-Based Cytology (LBC) to assess pelvic washings or samples of ascitic fluid <ref type="bibr" target="#b389">[390]</ref>.</p><p>The Food and Drug Administration has approved the initial LBC technologies, namely ThinPrep and SurePath. Regrettably, the utilization of these LBC techniques, which necessitate a costly automated apparatus, is limited in developing countries due to the high expenses associated with testing. LiquiPrep, a more advanced version of LBC technology, reduces the requirement for the majority of devices used in first-generation LBC procedures <ref type="bibr" target="#b390">[391]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.2.5">Cone Biopsy</head><p>Cone biopsy screening is employed to promptly detect abnormal cells in the cervix. The Pap smear, or Papanicolaou test, is the most widely used screening test that involves the collection of a small sample of tissue from the lining of the cervix using a brush. This sample is then examined under a microscope to detect any abnormalities in the cells. This type of test can be conducted to ascertain the presence of HPV in the cervix. The images obtained from the procedure are often known as Pap smear images, and they play a vital role in the early identification and categorization of cervical cancer <ref type="bibr" target="#b391">[392]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.3">Limitations in the current Detection methods of Cervical Cancer</head><p>Table <ref type="table" target="#tab_19">19</ref> provides a concise overview of conventional techniques used for screening cervical cancer. It outlines their uses in identifying the disease at an early stage and managing it, as well as any restrictions they may have. This essay compares commonly employed tests, such as the Pap smear and HPV testing, with more specialist techniques like colposcopy and liquid-based cytology. Each of these methods has its own importance and restrictions when considering global health issues. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Papanicolaou (PAP) Smear Test</head><p>Used for screening to detect cervical cancer and precancerous lesions; significantly reduces cervical cancer mortality. Time-consuming and requires expert review; subject to manual errors and interpretation inconsistencies; may miss some lesions. <ref type="bibr" target="#b382">[383]</ref> HPV Testing WHO's primary screening recommendation; part of a strategy to eliminate cervical cancer by testing for HPV presence or absence in cervical cells.</p><p>High costs, requires laboratory processing, and results may take time. <ref type="bibr" target="#b383">[384]</ref> Colposcopy Method Used for diagnosis and management of cervical cancer through imaging and staining; focuses on detailed cervical examination.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Variability</head><p>in diagnostic impressions due to operator differences; accuracy depends on technique and observation quality. <ref type="bibr" target="#b385">[386]</ref> Liquid Based Cytology (LBC) Enhances sample quality and accuracy over conventional smears; suitable for automation and compatible with image analysis systems for better diagnosis.</p><p>Higher procedure costs than conventional cytology; although it reduces unsatisfactory samples, it doesn't eliminate them completely. <ref type="bibr" target="#b386">[387]</ref> Cone Biopsy Utilized for early detection when abnormal cells are suspected, through tissue removal for microscopic examination; aids in early cervical cancer detection. Specific limitations are not detailed, but the procedure is typically reserved for cases where abnormal cells are suspected and requires surgical intervention.</p><p>[392]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.4">Integration of AI in the prognosis of Cervical Cancer</head><p>AI is transforming the field of cervical cancer detection and treatment by improving diagnostic methods like PAP smear analysis, disease segmentation, and non-invasive staging. Table <ref type="table" target="#tab_20">20</ref> demonstrates the incorporation of AI into imaging technologies such as CT and MRI, which enhances the precision of diagnosis and has the potential to be utilized for tailored patient care. AI has been increasingly applied to various disease diagnoses, improving the segmentation of cells and identification of dysplasia. Its performance in population-based screening is still being evaluated. <ref type="bibr" target="#b393">[394]</ref> CAD Systems CAD systems automate the detection of cervical cancer, improving screening efficacy and reducing human error and subjectivity.</p><p>[395]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cervical Cytology Limitations</head><p>Traditional cytology screening is limited in identifying tumor path and scope, leading to inaccurate cervical cancer assessment. <ref type="bibr" target="#b395">[396]</ref> Imaging Technologies CT and MRI are widely used for their high-resolution imaging capabilities in female malignant tumors. MRI, in particular, is valuable for pre-operative staging of cervical cancer and response evaluation in treatment. <ref type="bibr" target="#b396">[397]</ref> Imaging Limitations MRI and CT have limitations, such as false-positive findings posttreatment. MRI is generally more accurate for early stages of cervical cancer. Other modalities like TRUS and TVU are used for specific invasion detections.</p><p>[</p><p>Machine Learning (ML) ML improves cancer detection and treatment, offering a new perspective and broader prognosis capabilities. The trend towards personalized and predictive medicine in oncology is reflected in the use of ML. <ref type="bibr" target="#b398">[399]</ref> Deep Learning (DL) DL technologies improve with larger datasets, recognizing complex features in medical imaging for disease diagnosis. CNN and RNN are notable DL algorithms used in this field.</p><p>[400]</p><p>Treatment Guidelines The NCCN guidelines recommend surgery or radiotherapy for earlystage cervical cancer and CCRT for advanced stages without metastasis.</p><p>[401]</p><p>Figure <ref type="figure" target="#fig_10">11</ref> demonstrates the crucial importance of AI in the management of cervical cancer, emphasizing the substantial influence of DL in the process of diagnosing and treating the disease. This integration facilitates accurate diagnosis, individualized prognostics, and enhanced treatment effectiveness, highlighting the significant role of AI in advancing oncological healthcare. The image highlights the significant importance of technology, specifically AI, in the treatment of prostate cancer. The initial diagnostic inputs consist of computer analytics, radiological imaging, in situ hybridization, and genomic profiling. These inputs are then processed using either guided or autonomous AI training.</p><p>These functions aid in the process of diagnosing and classifying diseases, predicting outcomes, and determining characteristics, ultimately improving clinical results such as assessing the severity of tumors, evaluating the effectiveness of treatments, and predicting survival rates. Significant progress has been made in the incorporation of AI in the field of cervical cancer. The table below provides a summary of many multidimensional applications of AI in the field of Cervical Cancer. Development of real-time, minimally invasive tools for early detection. <ref type="bibr" target="#b376">[377]</ref> Conventional methods for detecting cervical cancer, such as PAP smears and HPV testing, are time-consuming, expensive, and necessitate specialized analysis. AI-enabled techniques have the potential to greatly enhance cervical cancer care by improving detection and diagnosis, ultimately leading to personalized treatment. These methods involve improving the precision of screening, aiding in clinical decision-making, and creating diagnostic instruments that provide real-time results. By utilizing deep learning, AI has the potential to transform cervical cancer care by analyzing intricate data to enhance diagnosis accuracy, therefore tailoring patient care to individual needs. The combination of AI and its inherent capacity for tailored treatment in the management of cervical cancer presents the rising possibility of predictive, personalized therapy at the point-of-care, skipping the need for laboratory testing. This offers a promising approach to reducing the worldwide impact of this cancer.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.">Thyroid Cancer and AI</head><p>The thyroid gland, situated in the lower neck, is the largest endocrine gland in an adult and has a distinctive butterfly shape. It controls cellular metabolism by producing hormones and regulating calcium balance in the human body. An effectively functioning thyroid gland is crucial for maintaining the precise hormonal equilibrium required to regulate metabolism at an ideal rate <ref type="bibr" target="#b402">[403]</ref>. The connection of this gland to the most common endocrine tumors is making it more and more well-known worldwide <ref type="bibr" target="#b403">[404]</ref>.</p><p>Thyroid tumors are frequently encountered in adults. Thyroid nodules are found in up to 50% of people <ref type="bibr" target="#b404">[405]</ref>. Thyroid cancer has shown a continuous increase in occurrence since the beginning of the 20th century, and it currently has the highest rate of occurrence among all types of cancer <ref type="bibr" target="#b405">[406]</ref>. Recent research shows that roughly 43,800 new cases of thyroid cancer will be reported in the United States in 2022 <ref type="bibr" target="#b406">[407]</ref>. Thyroid cancer ranked as the fourth most commonly diagnosed ailment among females in China <ref type="bibr" target="#b407">[408]</ref>. Identifying the cause of thyroid cancer, improving diagnostic methods, and providing personalized treatments to reduce the likelihood of the disease returning are difficult efforts because to the clear impact of greater rates of illness and death associated with this condition.</p><p>Therefore, it is crucial to perform a methodical examination of relevant established procedures. Analyses are anticipated to be performed on research that employ statistical and ML methods to investigate the development of thyroid cancer, create personalized treatment recommendation systems, and enhance diagnostic accuracy and efficiency. The workflow of the AL based system utilized for the identification of Thyroid cancer is illustrated in Figure <ref type="figure" target="#fig_11">12</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.1">Thyroid Cancer Pathogenesis</head><p>Clinicians encounter difficulties in identifying the etiology of thyroid cancer due to the complex nature of its pathogenesis, which is influenced by various factors including dietary patterns, medical history, genetic predisposition, and recurrent health conditions. It is a common decision made by clinicians to assess one component for its potential link to thyroid cancer development. After taking this first step, a number of possible co-morbidities and risk factors for thyroid cancer were identified: For example, a deficiency in vitamin D <ref type="bibr" target="#b408">[409]</ref>, exposure to radiation <ref type="bibr" target="#b409">[410]</ref>, obesity <ref type="bibr" target="#b410">[411]</ref>, diabetes <ref type="bibr" target="#b411">[412]</ref>, iodine consumption <ref type="bibr" target="#b412">[413]</ref>, smoking status <ref type="bibr" target="#b413">[414]</ref>, and familial history <ref type="bibr" target="#b414">[415]</ref>, among others. Assessing individual risk factors for thyroid cancer based on previous research is inefficient and fails to account for their interrelationships, leading to misconceptions about the disease's origins. The existing approaches employed to evaluate the complex interaction among several risk factors in thyroid cancer exhibit shortcomings, hence amplifying the knowledge gaps about its etiology. Thus, there is a substantial need for an automated approach that can effectively integrate complex medical data to uncover the fundamental, multifactorial causes of thyroid cancer.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.2">Limitation in the current Prognosis of Thyroid Cancer</head><p>Thyroid cancer is a multifaceted and contentious topic within the medical field. Well-established factors, such as exposure to radiation and genetic inheritance, are recognized to play a role in the development of thyroid cancer <ref type="bibr" target="#b415">[416]</ref>. Table <ref type="table" target="#tab_1">22</ref> highlighted the limitation of current diagnostic techniques in Thyroid cancer.</p><p>Table 22: Current diagnostics techniques and limitations.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.3">Role of AI Based techniques in Thyroid cancer detection</head><p>Artificial neural networks (ANN), which are ML techniques, are commonly used in the field of thyroid cancer to predict mortality, survival, and recurrence <ref type="bibr" target="#b423">[424]</ref>. Prediction of survival rates is accomplished by utilizing ML algorithms such as Multilayer Perceptron (MLP), logistic regression, and decision trees. These algorithms consider variables such as age, tumor size, and health status <ref type="bibr" target="#b424">[425]</ref>. Among the methods used to assess recurrence rates are ensemble algorithms, random forests, decision trees, and XGBoost <ref type="bibr" target="#b425">[426]</ref>. When trying to forecast the likelihood of recurrence, factors such as lymph node ratio are taken into account <ref type="bibr" target="#b426">[427]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Diagnostic Technique</head><p>Use of Technique Limitations Ref.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Thyroid Function Examination</head><p>Measures hormones produced by the thyroid gland (TSH, T3, T4, FT3, FT4). Ultrasonography suggested for abnormal results. TIRADS scoring used for risk assessment based on ultrasound features. TIRADS scores alone cannot provide precise decisions for thyroid cancer diagnosis. Further FNAC needed for nodules with TIRADS scores 2-5. <ref type="bibr" target="#b416">[417,</ref><ref type="bibr" target="#b417">418]</ref> Fine-Needle Aspiration Cytology Biopsy from thyroid nodules using needles guided by ultrasonography. Biopsy assessed by pathologists for malignancy risk stratification.</p><p>Results easily affected by the expertise of pathologists, leading to potential unnecessary surgeries for nodules later determined as non-malignant. <ref type="bibr" target="#b418">[419,</ref><ref type="bibr" target="#b419">420]</ref> Thyroid Surgery Required for thyroid cancer patients, includes partial thyroidectomy, total thyroidectomy, Over-treatments and post-therapy hypothyroidism may occur. Customized treatment plans based on individual factors lacking. <ref type="bibr" target="#b420">[421,</ref><ref type="bibr" target="#b421">422]</ref> Radiation Therapy (Iodine-131)</p><p>Mitigates recurrence risks by performing Iodine-131 treatment post-thyroidectomy.</p><p>Adverse effects, such as salivary gland dysfunction, can occur if iodine dosage is not carefully determined. Lack of studies proposing customized treatment recommendation systems. <ref type="bibr" target="#b422">[423]</ref> The Al data set and Al model utilised for detecting Thyroid cancer are presented in Tables <ref type="table" target="#tab_23">23</ref> and <ref type="table" target="#tab_24">24</ref>, respectively. The determination of treatment procedures for thyroid cancer is based on risk stratification, which differs according to the subtype of the cancer (such as papillary and anaplastic), with anaplastic being the most severe <ref type="bibr" target="#b427">[428]</ref>. Integrating patient-specific factors such as weight, age, and medical history is an essential element of personalized treatment decision support systems <ref type="bibr" target="#b428">[429]</ref>. The fuzzy cognitive map technique is supplemented by the utilisation of the Apriori and DeepSurv models in the construction of personalized treatment procedures <ref type="bibr" target="#b429">[430,</ref><ref type="bibr" target="#b430">431]</ref>. The extraction methods employed DL and the performance of different thyroid cancer types are evaluated in Table <ref type="table" target="#tab_25">25</ref> and <ref type="table" target="#tab_26">26</ref> The research highlights the persistent challenges, chief among which is the lack of clean datasets, even if it also recognizes their crucial significance in real-world applications. The existing AIbased systems possess specific constraints that necessitate attention, as outlined in Table <ref type="table" target="#tab_26">26</ref>.  Additional research should address these shortcomings to enhance the efficacy of cancer detection. Enhanced diagnostic accuracy and novel techniques are necessary to differentiate between malignant nodules of different sizes. The study acknowledges the significance of state-of-the-art technologies, such as explainable AI, edge computing, remote sensing systems, and predictive modelling, in making diagnostic procedures more efficient. In order to facilitate a progressive transformation in cancer detection, there is a focused endeavour to develop advanced technologies that priorities privacy. These technologies aim to identify individuals with thyroid cancer and are also being utilized in broader applications such as telemedicine.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.">Role of AI in the Prostate Cancer</head><p>When it comes to cancer, prostate cancer (PC) is the most common type in men (apart from skin cancer) and the third leading cause of cancer-related death overall. Roughly twenty percent of American men will at some point in their lives encounter the same medical problem <ref type="bibr" target="#b486">[487]</ref>.</p><p>Another clinical issue resulting from the condition is the increased need for prostate biopsies and the shortage of urological pathologists, both of which provide challenges for treating the disease <ref type="bibr" target="#b487">[488]</ref>. The process of clinical decision-making is further complicated by the inconsistency in assessing pathology indicators, leading to the potential for both overtreating and undertreating this condition <ref type="bibr" target="#b488">[489]</ref>. By the year 2024, almost 50% of cancer cases in males will be prostate cancer (PC), with colorectal and lung cancers emerging as the three most common types <ref type="bibr" target="#b489">[490]</ref>. The digital rectal examination (DRE) is a widely employed screening method, however its diagnostic precision for prostate cancer remains uncertain due to inconsistent study findings on its sensitivity and specificity rates. Especially in primary care settings, there is not enough data to support its use as a test on its alone or in combination with other technologies <ref type="bibr" target="#b490">[491]</ref>. In addition, Ying and his co-authors assess the precision of DRE in a group of patients suspected to have prostate cancer. Ultimately, it is recognized that DRE plays a crucial function in delivering information regarding prostate cancer <ref type="bibr" target="#b491">[492]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.2">The Prostate-Specific Antigen (PSA) Test</head><p>Benign prostate cells produce a protein known as the prostate specific antigen, or PSA. There has been debate on the efficacy of blood testing as a screening method for prostate cancer. PSA blood levels that are elevated can be a sign of prostate cancer, benign prostatic hyperplasia (BPH), or inflammation. This could start conversations regarding the validity of PSA testing and raise concerns about the potential for overdiagnosis. Merriel along with others. <ref type="bibr" target="#b492">[493]</ref> a group of researchers who conducted a study to assess the efficacy of PSA in symptomatic patients. Ultimately, it is discovered that while PSA exhibits a significant level of sensitivity, what renders this marker ineffective is its lack of specificity, which therefore renders this test unable of differentiating between benign and malignant diseases.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.3">Prostate Cancer Antigen 3</head><p>The gene responsible for prostate cancer antigen 3 (PCA3) produces a non-coding RNA molecule that is significantly more expressed in malignant prostate tissue compared to normal prostate tissue in humans. PCA3 is specifically and dramatically upregulated in patients of prostate cancer. PCA3 RNA is a good tumor marker due to its suppressed expression profile. A meta-analysis of thirteen trials assessed the diagnostic efficacy of urine PCA3 in prostate cancer.</p><p>The research revealed sensitivities and specificities of 75% and 62%, respectively <ref type="bibr" target="#b493">[494]</ref>. Furthermore, the effectiveness of this method in diagnosing conditions has been confirmed in multiple countries and across various ethnicities <ref type="bibr" target="#b494">[495]</ref>. PCA3 demonstrates effectiveness in predicting a positive biopsy result, particularly in cases when serum levels of prostate-specific antigen (Sr. PSA) range from 4 to 10 ng/ml. When PSAD is paired with it, the predictive accuracy is further increased <ref type="bibr" target="#b495">[496]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.4">OPKO 4K Test</head><p>The OPKO 4K test quantifies four kallikreins present in the serum: tPSA, fPSA, iPSA, and hk2 (total PSA, free PSA, intact PSA, and human kallikrein 2). These kallikreins are used in combination with age, previous biopsies, digital rectal examination (DRE), and prior biopsies to calculate a likelihood score for prostate cancer.</p><p>The presence of this substance was in the blood serum of individuals with ERSCP who underwent prostatectomies, and it seemed to serve as a predictive marker for the presence of a severe form of the disease.</p><p>The OPKO 4K test accurately forecasts the presence of aggressive prostatic cancer that has spread outside the prostate, has a tumor volume larger than 0.5 cm3, or has a Gleason grade of four or higher. The test has a high level of accuracy, with an area under the curve (AUC) value of 0.84 <ref type="bibr" target="#b496">[497]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.5">Multiparametric MRI</head><p>Prostatic cancer multiparametric MRI is used to both detect and stage the disease. The technology combines high-resolution T2-weighted images (T2WI) to assess anatomy, diffusion-weighted imaging (DWI), and MR spectroscopic imaging (MRSI) to accurately characterize lesions <ref type="bibr" target="#b497">[498]</ref>. DCE-MRI is highly effective in detecting cancer. It utilizes magnetic resonance imaging (MRI) with the addition of contrast dye to visualize the movement of blood within tissues. Malignant tumors frequently exhibit distinct flow patterns compared to healthy tissues <ref type="bibr" target="#b498">[499]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.6">PIRADS</head><p>Prostate Imaging Reporting and Data Systems (PIRADS), which was established by the European Society of Urogenital Radiology (ESUR) in 2012, is a tool used to classify the likelihood of prostate cancer <ref type="bibr" target="#b499">[500]</ref> employs multiparametric MRI images to develop a grading system for lesions. Each measure, including T2WI (differential descriptions of the peripheral zone (PZ) and transition zone (TZ)), DWI, DCE-MRI, and MRSI, is given a score of five on this scoring system. Subsequently, a medically significant abnormality can be anticipated by assigning a comprehensive score to each abnormality. A score is awarded to each variable <ref type="bibr" target="#b500">[501]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.7">Histo-Scanning</head><p>The PHS technology utilizes characterization algorithms to analyses distinct patterns found in both benign and malignant tissues. It mathematically processes the raw ultrasonic data using Histo-Scanning, an ultrasound-based technique. A volumetric equipment is used to get a precise measurement of the total volume of the prostate and any tumor lesions. Preliminary studies yielded promising results <ref type="bibr" target="#b501">[502]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.8">Elastography</head><p>The differentiation between healthy and malignant prostate tissue is mostly determined on tissue stiffness, making this approach effective. Currently, two techniques are used: strain elastography and shear-wave elastography. Research has shown that using an elastography-focused method is more effective than sextant biopsy in detecting high-risk prostate cancer. Furthermore, it increases overall sensitivity when performing a combination biopsy, requires fewer cores to diagnose prostate cancer, and lowers imaging time <ref type="bibr" target="#b502">[503]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.1.9">Biomarkers Screening for Prostatic Cancer</head><p>Biomarkers facilitate the advancement of novel diagnostic and therapeutic methodologies by offering valuable information about the molecular processes involved.</p><p>MicroRNAs (miRNAs) have a significant impact on controlling gene expression in cancer cells <ref type="bibr" target="#b503">[504]</ref>. Detection of miRNAs is feasible in both blood and urine samples. Aberrant miRNAs produced by prostatic cancer can potentially be used as biomarkers to identify risk groups and determine the need for prostatic biopsy. Additionally, they can assist in the creation of treatments based on molecules <ref type="bibr" target="#b504">[505]</ref>. Application of miRNAs 141 is promising <ref type="bibr" target="#b503">[504]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.2">Limitations of Tradition Diagnostic Method in prostate Cancer</head><p>Prostate cancer affects a significant proportion of men worldwide, and timely detection is crucial in combating this prevalent health problem. Medical practitioners have developed standardized techniques for identifying the disease however they are not completely optimal. Table <ref type="table" target="#tab_27">27</ref> outlines the constraints of conventional approaches. [506]</p><p>The Prostate-Specific Antigen (PSA) Test Elevated Prostate Specific Antigen (PSA) levels alone do not definitively diagnose prostate cancer. This can lead to unnecessary testing and treatments, especially in cases where prostatitis or benign prostatic hyperplasia (BPH) are present.</p><p>[507]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Prostate Cancer Antigen 3 (PCA3)</head><p>Variable sensitivity and high specificity may result in the omission of therapeutically relevant prostate cancer detection due to the heterogeneous tumor manifestations. <ref type="bibr" target="#b507">[508]</ref> OPKO 4K Test Despite its notable predictive accuracy, this method may not substantially diminish the necessity for prostate biopsies due to its inability to differentiate between dormant and aggressive malignancies with specificity.</p><p>[509]</p><p>Multiparametric MRI Its application is restricted by accessibility, expense, and interpretation variability; as tumor size and Gleason score increase, so does sensitivity, which may result in the omission of small or exceptionally distinct lesions.</p><p>[510] PIRADS A greater incidence of false negatives for clinically significant prostate cancer, particularly in the transition zone, is attributable to interpretation variability and limited accuracy in specific instances.</p><p>[511]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HistoScanning</head><p>The diagnostic value and reproducibility of its results in detecting and defining prostatic lesions have been raised by inconsistent results throughout future investigations.</p><p>[512] Elastography Differentiating prostatitis from prostate cancer still requires further validation procedures, although such diagnostic approach can be applied just in limited conditions, once shown to have the potential to increase the accuracy of this procedure.</p><p>[513]</p><p>Biomarkers Screening for Prostatic Cancer</p><p>The new biomarkers present a bright functionality, triable they are standardized and proved their effectiveness. In spite of this, it remains challenging to identify the highly aggressive prostate tumors from their less damaging counterparts.</p><p>[514]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.3">Role of AI in Prostate Cancer</head><p>ML and AI are innovative technologies that can greatly improve the early identification of prostate cancer and reduce unneeded therapies. This has the potential to completely transform current medical procedures. Although the existing system for identifying PC has some shortcomings, AI shows great potential as a convincing alternative. By integrating imaging, physical findings, and genetic markers, AI will enhance the accuracy and thoroughness of prostate cancer detection. This is because AI is essential in the realm of big data, especially when considering its use in medical diagnostics.</p><p>. Figure <ref type="figure" target="#fig_13">13</ref> shows that AI has become a potent tool in the treatment of prostate cancer. AI carefully examines genetic and cellular data to improve our knowledge of the condition and interprets intricate details that a human analyst could ignore. AI actively contributes to the development of customized treatment plans, guaranteeing a one-of-a-kind approach for every patient, and enhances radiation accuracy by means of virtual imaging and ideal placement AI will influence several phases of diagnosis, such as risk and prognosis evaluation, by developing computer-based imaging and identifying markers that indicate the possibility of cancer development and medication response.</p><p>. The field of prostate cancer research is undergoing a significant transformation with the use of AI in the domain of medical imaging. AI accurately assesses radiological pictures with a high degree of precision. This technology advancement enhances the diagnostic process by optimizing assistance and reducing the likelihood of errors through improved accuracy, reduced variability, and strong clinical decision-making <ref type="bibr" target="#b514">[515]</ref>.</p><p>A programmer capable of using AI to detect prostate cancer was developed by scanning core biopsy needles. An investigation analyzed the more extensive matter. An AI system that was put into action demonstrated a degree of accuracy in identifying cancer that was comparable to that of a highly skilled human pathologist <ref type="bibr" target="#b515">[516]</ref>.</p><p>The forthcoming effort will concentrate on developing and evaluating a DL system optimization to enhance the accuracy of classifying prostate MRI abnormalities. This study used PI-RADS for the purpose of resolving the issue of lesion categorization. The dataset utilised was sufficiently extensive to allow for several iterations of a ML algorithm, thereby identifying the constraints that would result in AI surpassing human doctors in real-world scenarios. This work is a positive step in exploring the potential of AI to enhance healthcare design, namely in its ability to assist clinicians in analyzing MRI data <ref type="bibr" target="#b516">[517]</ref>.</p><p>Several academics have explored the possibilities of AI technology in analyzing prostate cancer histopathology. Their goal is to improve clinical procedures by increasing accuracy, streamlining workflow, and reducing patient wait times. The deployment of Paige Prostate, an AI-driven automated system for prostate cancer detection, involves the utilizations of distinct datasets. The study showcases the potential of AI in enhancing patient care by its capacity to accurately identify situations requiring further examination and minimizing diagnostic inconsistencies.</p><p>AI exhibits a high level of sensitivity and specificity. The integration of AI in histopathology analysis is a promising advancement for the future of healthcare as it signifies a significant progress in introducing intelligent technology into the diagnostic process <ref type="bibr" target="#b517">[518]</ref>. The major objective of the research was to detect prostate tumors using PET-CT scans. Thus, the potential of a completely automated AI approach was also taken into consideration. Translate that AI exhibits comparable, if not superior, proficiency to that of trained radiologists.</p><p>The efforts to incorporate AI capabilities in the analysis of PET-CT images demonstrate the inclination towards complexity and unpredictability of technology, which in turn has the potential to result in substantial advancements and novel methods to diagnosis <ref type="bibr" target="#b518">[519]</ref>.</p><p>A recent study examined the effects of two distinct artery input functions on distinguishing between intra-prostatic peripheral zone tumors and non-euplastic prostate tissue in DCE-MRI analysis.</p><p>The study showcases the use of high precision pharmacy-kinetic modelling to demonstrate how AI may be applied to analyze data from DCE-MRI <ref type="bibr" target="#b519">[520]</ref>. The work highlights the need of accurate predictive modelling in identifying prostate cancer using MRI, which improves the performance and effectiveness of AI in diagnostic imaging.</p><p>AI intelligence has made significant advancements in the field of prostate biopsies, assisting doctors in more precise and efficient diagnosis, grading, and prognosis of prostate malignancies compared to traditional procedures. DL algorithms integrated into AI models are utilized to extract prostate cancer data from a substantial quantity of biopsy samples, so introducing a novel field in the realm of prostate cancer diagnosis.</p><p>This AI software provides pathologists with a comprehensive list of indicators that suggest the presence or absence of cancer in a patient, including the Gleason score (GS) and perineural invasion (PNI). These factors are intended to assist pathologists in making accurate decisions and, ultimately, to enhance patient outcomes <ref type="bibr" target="#b515">[516]</ref>.</p><p>A significant study focused on the utilisation of AI to develop a model that can differentiate prostate cancer from a visually identical condition using transrectal ultrasonography (TRUS) images of biopsy needle tract tissue. The algorithm is trained using a large dataset of thousands of TRUS pictures and has demonstrated superior accuracy compared to expert radiologists <ref type="bibr" target="#b520">[521]</ref>. Furthermore, the attainment of this notable accomplishment demonstrates the capacity of AI to enhance the analysis of prostate cancer using imaging data. This, in turn, represents a new and innovative approach in utilizing AI for the diagnosis and evaluation of a prostate biopsy. These investigations clearly showcase the advanced level of AI in its application to prostate biopsy tests. Our accuracy, evaluation, scoring, and treatment planning capabilities are more than adequate. The advancements made in the field of AI in prostate cancer treatment can be recognized by studying its complexity.</p><p>Table <ref type="table" target="#tab_28">28</ref> serves as a sparse collection of data points, but more importantly, it captures a comprehensive representation of competence. Within the artwork, AI models serve as the brushstrokes that enhance our comprehension and approach in combatting prostate cancer. These models, which incorporate various forms of diversification by utilizing inputs from different data sources such as histopathology slides, magnetic resonance imaging, and integrated clinical databases, play a crucial role in driving innovations in cancer care. They collectively contribute to the ongoing narrative of how cancer is currently being treated. These AI possess remarkable capabilities that are noteworthy.</p><p>The advent of cancer technologies has transformed the landscape of cancer care. These technologies have the power to unveil the evolution of the disease, enhance the grading of different stages, and enable more personalized treatment approaches. The following paragraph exemplifies AI's dedication to revolutionizing our response to a significant healthcare concern of our era, in conjunction with the strength and intensity of AI. The unparalleled ability of AI to analyses various data sources, such as tiny tissue images, MRI scans, and patient files, has enabled it to outperform the current diagnostic tools, which were originally created to assist doctors and pathologists <ref type="bibr" target="#b528">[529]</ref>. The research demonstrates the longterm potential of AI in enhancing the diagnosis of prostate cancer by implementing extremely precise techniques and advancing personalized therapy alternatives.</p><p>Nevertheless, there are still several unresolved aspects related to the discussed topic, such as the need for comprehensive validation efforts, the integration of widely accepted models into medical processes, and ensuring consistency in interpretations. Despite the hurdles, the advancement of diagnostic techniques utilizing AI is the most promising approach to enhance the effectiveness of prostate cancer therapy and other diseases in a more personalized and effective manner. This development holds the key to success for both patients and the medical community.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="11.">Skin Cancer and AI</head><p>Skin cancer is a widespread form of cancer that constitutes over one-third of all documented cancer cases globally. The occurrence of this phenomenon is steadily rising annually <ref type="bibr" target="#b529">[530]</ref>. Over 9500 people are thought to be detected with skin cancer every day in the United States only <ref type="bibr" target="#b530">[531]</ref>. Timely identification and proper diagnosis of skin cancer are crucial for achieving excellent treatment outcomes and enhancing patient survival rates, despite the disease being often curable <ref type="bibr" target="#b531">[532]</ref><ref type="bibr" target="#b532">[533]</ref><ref type="bibr" target="#b533">[534]</ref>. Skin cancer is the predominant form of cancer in the United States, with around 5.4 million instances identified each year <ref type="bibr" target="#b534">[535]</ref>. The treatment of skin cancer is possible, but its effectiveness relies on the timely identification of the disease. Postponing the identification and medical intervention of an infection can result in unfavorable outcomes, including higher rates of metastasis, morbidity, and death. Traditional approaches to detecting skin cancer, such as visually examining the skin and performing a biopsy, are subjective, lengthy, and prone to considerable variations in interpretation <ref type="bibr" target="#b535">[536]</ref>. There has been a growing interest in using ML technologies, particularly DL approaches, to improve the effectiveness and accuracy of skin cancer diagnosis <ref type="bibr" target="#b536">[537]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="11.1">Evaluating Tradition Detection Method and AI Innovation in Skin Cancer</head><p>There is an increasing interest in utilizing ML technologies, DL methods, to enhance the efficiency and precision of skin cancer diagnostics. Skin cancer is characterized by the excessive growth of abnormal cells in the skin. Melanoma, squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma are the most common types of skin cancer <ref type="bibr" target="#b530">[531]</ref>. The primary cause of DNA damage resulting in non-melanoma skin cancer is exposure to ultraviolet light <ref type="bibr" target="#b537">[538]</ref>. Timely identification and proper diagnosis of skin cancer are crucial for achieving excellent treatment outcomes and enhancing patient survival rates, despite the disease being often curable <ref type="bibr" target="#b531">[532]</ref><ref type="bibr" target="#b532">[533]</ref><ref type="bibr" target="#b533">[534]</ref>.</p><p>In the past, skin cancer detection has relied on a combination of histological investigation and visual inspection. However, both methods have had notable limits in terms of accuracy and scalability. Nevertheless, the traditional approaches for detecting skin cancer, such as visually examining and studying tissue samples, are time-consuming, subjective, and exhibit significant variability among different observers. Over the past few years, numerous non-invasive imaging methods <ref type="bibr" target="#b538">[539]</ref> have been developed to aid in the detection and monitoring of skin cancer. One well-known example is the use of multi-spectral sensors to detect changes in the refraction index in millimeter-wave to terahertz photonic near-field imaging <ref type="bibr" target="#b539">[540]</ref>. The application of novel AI-based methodologies for skin cancer detection is presented in Table <ref type="table" target="#tab_29">29</ref>. Advancements in several aspects of AI have had significant and wide-ranging impacts across multiple fields. AI has the capacity to. Significantly improve cancer diagnoses.</p><p>Recent advancements in DL algorithms have greatly contributed to the field of medical diagnostics. Cutting-edge models like Xception, ResNet50V2, and InceptionResNetV2 are being utilised to enhance the accuracy and efficiency of medical diagnoses <ref type="bibr" target="#b540">[541,</ref><ref type="bibr" target="#b541">542]</ref>. The achievement of consistent and accurate diagnoses in skin cancer detection is challenging due to the limitations of current diagnostic technologies and the extensive range of abnormalities. Furthermore, transfer learning has resulted in enhancements in the precision of classification <ref type="bibr" target="#b542">[543,</ref><ref type="bibr" target="#b543">544]</ref>. Several techniques involve utilizing pre-trained CNN models to extract characteristics from medical images. The application of DL techniques for the identification and classification of skin cancer has emerged as a rapidly growing area of research in recent years.</p><p>Multiple studies have demonstrated that CNN model has the ability to accurately identify and classify skin cancer from medical images. Additionally, the utilization of transfer learning can further improve the accuracy of classification <ref type="bibr" target="#b544">[545,</ref><ref type="bibr" target="#b545">546]</ref>.</p><p>By employing AI algorithms for image analysis and skin cancer diagnosis, it is possible to mitigate healthcare inequities by eliminating inadvertent doctor bias and improving accessibility and costeffectiveness <ref type="bibr" target="#b531">[532]</ref>. An AI technique is employed for the identification of skin cancer, as depicted in Figure <ref type="figure" target="#fig_13">13</ref>. AI systems have demonstrated similar levels of performance <ref type="bibr" target="#b546">[547,</ref><ref type="bibr" target="#b547">548]</ref> as well as, in some cases, superior performance compared to dermatologists in accurately categorizing skin lesions <ref type="bibr" target="#b548">[549]</ref>. The potential for collaboration between humans and computers to greatly boost diagnostic accuracy is substantial <ref type="bibr" target="#b549">[550]</ref>. Most AI developments have primarily used homogeneous datasets <ref type="bibr" target="#b565">[566,</ref><ref type="bibr" target="#b566">567]</ref> collected from countries with predominantly European ancestry <ref type="bibr" target="#b567">[568]</ref>. The omission of the skin of color from training datasets increases the likelihood of inaccurate diagnoses or the complete omission of skin malignancies <ref type="bibr" target="#b546">[547]</ref>. Moreover, it increases the already existing racial disparities in the field of dermatology <ref type="bibr" target="#b568">[569]</ref>. types, each of which has particular examples such as nevi and keratoses. On the other hand, malignant conditions focus on several forms of skin cancer, including cutaneous lymphoma, melanoma, squamous cell carcinoma, and basal cell carcinoma. The main focus is on the possible application of AI in the diagnosis and differentiation of various skin conditions, which can range from benign to malignant. This is compatible with the growing contribution of AI to dermatology's prognosis evaluations, treatment planning, and diagnosis precision.</p><p>While numerous studies have assessed the effectiveness of AI-driven models in identifying skin cancer <ref type="bibr" target="#b569">[570,</ref><ref type="bibr" target="#b570">571]</ref>, there is currently no research investigating the utilization of AI in populations with darker skin tones. AI algorithms are capable of categorizing photos of pigmented skin lesions in populations with darker skin tones. Integrating AI algorithms into the diagnosis of pigmented lesions and screening for skin cancer has the potential to greatly improve patient outcomes and streamline operations in the area of dermatology. The efficacy and reliability of an AI algorithm that analyses photos are significantly impacted by the caliber of the data utilized for training and evaluation. If AI models utilized in clinical practice do not incorporate photos from diverse racial groups, they may fail to detect or experience delays in identifying tumors in individuals of color. This would further complicate health consequences <ref type="bibr" target="#b571">[572,</ref><ref type="bibr" target="#b572">573]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="12.">Discussion</head><p>AI applications in oncology are an important milestone towards customized cancer care. The development will involve a variety of aspects, including improved accuracy in detecting earlystage cancer and the administration of personalized treatments to specific patients. AI is used to treat various types of cancer, including lung and skin cancer, among others. This research revealed the detailed and intricate role that AI can play in cancer diagnosis, treatment planning, and outcome prediction.</p><p>AI has the potential to improve patient outcomes and reduce the overall cost of cancer care by analyzing vast datasets, identifying complex patterns, and even predicting clinical outcomes more accurately than humans. DL algorithms supported by AI have a higher reputation for identifying lung and breast cancer in the early stages with greater precision. It has been shown that using AI to look at imaging and genomic data can help find disease biomarkers and create personalized treatment plans for colorectal and liver cancers. AI technology improves endoscopic imaging and histological evaluations, making it critical in the diagnosis of stomach and esophageal malignancies. This allows for early detection and precise staging of these tumors. Including cervical, thyroid, and prostate cancers in our study shows that AI improves the accuracy of screenings and biopsies, which leads to finding cancers earlier and figuring out how bad they are. AI algorithms have demonstrated outstanding performance in classifying various types of skin lesions in patients with skin cancer, which could reduce the burden on dermatologists and enhance diagnostic precision. Nevertheless, the integration of AI into everyday healthcare environments brings some challenges. The data requirements include addressing any discrepancy that may arise from non-representative data training, guaranteeing the transparency and understanding of the algorithms, and making significant use of labeled training datasets to strengthen the models.</p><p>Furthermore, more academic research and regulatory development are required to address ethical concerns regarding patient confidentiality in the context of using AI as a tool in the medical sector.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="13.">Conclusion</head><p>The integration of AI into the field of oncology represents a groundbreaking change in the approach to combating cancer. The novel approach to treating cancer, which involves early identification, diagnosis, personalized therapy, and prognosis prediction, has emerged as a result of this significant transformation. This study on the utilizations of AI in tackling 10 cancers has showcased its capacity to expedite the clinical decision-making process, enhance the precision of diagnoses, and adapt treatment strategies to cater to the unique needs of individual patients. The enhanced powers of AI allow it to manipulate complicated data and recognize patterns beyond the capacity of the human brain. This has the potential to drive advancements in identifying new biomarkers, improving risk analysis, and enabling early detection of cancer. However, there are constraints to fully utilizing the potential of AI in cancer. These limitations consist of the necessity to bridge the technological gap, offer an extensive variety of data, be transparent in algorithms, and maintain ethical integrity to guarantee that AI breakthroughs are available to a large audience.</p><p>The effective implementation of AI in cancer treatment needs a collaborative effort that brings together individuals from the fields of computation and healthcare, including patients and legislators. AI is not the only possible remedy, but it is a powerful tool that offers the potential to enable clinicians to deliver superior, more precise, and individualized cancer treatment. In order to ensure that AI improves rather than replaces the essential human qualities of empathy and competence in helping others, cooperation is necessary to tackle the ethical, technological, and therapeutic issues associated with the combination of AI in the future. Our common goal as we move through this transitional time is still to effectively employ AI to revolutionize cancer treatment, improve patient outcomes globally, and lead the way in precision-based oncology.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="13.1">Future Directions</head><p>The incorporation of AI in the treatment of cancer is now in a promising stage, with significant advancements on the horizon that might potentially revolutionize the area of oncology. The incorporation of AI with genetics, imaging, and clinical data is anticipated to become more widespread, providing a comprehensive viewpoint on patient therapy. The progress of sophisticated algorithms capable of combining multiple types of data will enable the creation of more accurate and tailored treatments. Furthermore, advancements in the comprehensibility and clarity of AI will enhance trust and approval among professionals. The availability of AI tools through open-source platforms has the potential to accelerate research and improve accessibility, enabling resource-limited situations to reap the advantages of emerging technologies. In addition, there will probably be a shift in focus towards preventive oncology, utilizing AI to identify risk factors and intervene before the onset of cancer.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 :</head><label>2</label><figDesc>Figure 2: Applications of AI, ML, and DL in oncology and digital health care can predict the best line of treatment and cure health issues.</figDesc><graphic coords="6,72.00,260.66,467.99,263.30" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 :</head><label>3</label><figDesc>Figure 3:The image shows AI-based machine for analyzing multi-omics cancer patients' and healthy donors' data to improve cancer diagnosis and treatment. By integrating genomics, transcriptomics, and proteomics data, the AI algorithm achieves several key outcomes: meeting new challenges related to identification of cancers subtypes, predicting diseases progression and survival probabilities and discovering new drug targets. This multifaceted approach integrates these advanced mathematical methods to improve the comprehension of the cancer exhaustion as well as to create the individually-targeted therapies.</figDesc><graphic coords="7,240.40,338.06,167.20,262.03" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 4 :</head><label>4</label><figDesc>Figure 4: illustrates an advanced CNN system integrating CT and histology images, employing three CNN modules and ASPP for multi-scale contextual feature extraction. After global average pooling, the unified vector is fed into a pre-trained Dense Net and classification block to detect cancer, exemplifying how state-of-the-art ML techniques enhance diagnostic accuracy AI, especially DL, has made significant strides in cancer clinical research thanks to the increasing amount of contemporary biological data. AI-based technologies are increasingly being employed to improve accuracy and efficiency in a variety of cancer clinical research applications. These include the detection of cancer by imaging, the analysis of genetic data, the extraction of important information from medical records, the development of new drugs, and the utilization of biological literature. Furthermore, we will analyze the limitations of traditional methods and the importance of AI in the context of the ten most prevalent types of cancer worldwide.</figDesc><graphic coords="9,72.00,188.31,468.00,214.85" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 5 :</head><label>5</label><figDesc>Figure 5: AI significantly enhances lung cancer management by improving early detection, diagnosis, and personalized treatment plans. It aids in survival prediction and optimizes immunotherapy by analyzing patientspecific data and immune responses.</figDesc><graphic coords="13,181.63,72.00,248.75,283.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 6 :</head><label>6</label><figDesc>Figure 6: The diagram shows how AI and machine learning methods spanning supervised, unsupervised, semisupervised, and deep learning enhance breast cancer management through early detection, precise diagnosis, personalized treatment, and improved survival outcomes.</figDesc><graphic coords="18,187.38,291.34,237.25,283.45" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 7 :</head><label>7</label><figDesc>Figure 7: This diagram illustrates the integration of AI into colorectal cancer analysis. It synthesizes data from six sources: pathology, radiography, endoscopy, clinical data, omics data, and AI algorithms. Together, these components facilitate a comprehensive approach to the diagnosis and management of colorectal cancer.</figDesc><graphic coords="25,206.25,191.02,198.85,226.80" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 8 :</head><label>8</label><figDesc>Figure 8: Multifaceted AI-Driven Approach in the Clinical Diagnosis of Liver Cancer.</figDesc><graphic coords="35,90.75,87.87,429.80,287.97" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 9 :</head><label>9</label><figDesc>Figure 9: This image illustrates the role of AI in gastric cancer management, highlighting its applications in diagnostic imaging, personalized treatment, and targeted drug delivery. AI aids in analyzing tumor characteristics, optimizing treatment plans, and enhancing medication effectiveness for improved patient outcomes</figDesc><graphic coords="42,121.50,256.37,368.37,256.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 10 :</head><label>10</label><figDesc>Figure 10: The diagram shows how to use CNNs, to identify ESCC from endoscopic images. In order to get set up for examination, the incoming data first undergoes preprocessing, which includes normalization. After that, the data is processed through two different CNN modules, each of whose is intended to improve and refine the extraction of ESCC characteristics over time. The presented images highlight how AI technology can greatly increase diagnosis accuracy in medical imaging by illustrating certain ESCC properties.</figDesc><graphic coords="46,108.00,422.71,421.20,201.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Figure 11 :</head><label>11</label><figDesc>Figure 11: Artificial Intelligence Workflow in Prostate Cancer Diagnosis and Management</figDesc><graphic coords="54,173.10,72.00,265.80,168.87" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>Figure 12 :</head><label>12</label><figDesc>Figure 12: The image delivers a detailed and complete structure for the detection and classification of thyroid cancer employing AI, explaining each step from image acquisition to diagnosis. It emphasizes the use of radiological imaging modalities, pre-processing, and deep learning methods for improving the diagnostic accuracy.</figDesc><graphic coords="56,164.23,72.00,283.54,206.65" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><figDesc>. The research emphasizes the increasing importance of Deep Neural Networks (DNNs) in detecting thyroid cancer due to their outstanding accuracy.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head>10. 1</head><label>1</label><figDesc>Traditional Methods Used for the Prognosis of Prostate Cancer 10.1.1 Digital Rectal Examination (DRE)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_14"><head>Figure 14 :</head><label>14</label><figDesc>Figure 14: This figure, emphasizing on the use of AI in the detection and treatment of skin cancer, divides different skin disorders into three categories: benign, malignant, and non-neoplastic. Inflammatory and blistering diseases are examples of non-neoplastic disorders; benign conditions are further classified into dermal, melanocytic, and epidermal</figDesc><graphic coords="69,72.00,399.12,468.00,263.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="5,158.25,72.00,295.50,286.93" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="64,66.33,93.48,471.39,264.72" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 :</head><label>1</label><figDesc>ML for imaging-based early diagnosis and examination.</figDesc><table><row><cell>Input</cell><cell>Sample</cell><cell cols="2">Performance</cell><cell cols="2">Advantages</cell><cell>References</cell></row><row><cell></cell><cell>Type/Images</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Clinical risk factors + nodule</cell><cell>CT images/</cell><cell>AUC</cell><cell>(0.907-</cell><cell cols="3">High AUC in small nodules (&lt;</cell><cell>[95]</cell></row><row><cell></cell><cell>2961</cell><cell>0.960)</cell><cell></cell><cell>10 mm)</cell><cell></cell></row><row><cell>Clinical factors + nodule</cell><cell>CT images/300</cell><cell>AUC</cell><cell>(0.706-</cell><cell cols="3">Comparable performance to</cell><cell>[62]</cell></row><row><cell></cell><cell></cell><cell>0.932)</cell><cell></cell><cell cols="2">human observers</cell></row><row><cell>Mass spectra from ROIs of</cell><cell>MALDI/326</cell><cell cols="5">Accuracy (0.991) High accuracy on FFPE</cell><cell>[63]</cell></row><row><cell>MALDI image</cell><cell></cell><cell></cell><cell></cell><cell>biopsies</cell><cell></cell></row><row><cell>CT imaging patches +</cell><cell cols="3">CT images/1018 Accuracy (0.793-</cell><cell cols="3">Higher predictive accuracy by</cell><cell>[96]</cell></row><row><cell>radiologists' binary nodule</cell><cell></cell><cell>0.824)</cell><cell></cell><cell>integrating</cell><cell>shape</cell><cell>and</cell></row><row><cell>segmentations</cell><cell></cell><cell></cell><cell></cell><cell cols="2">appearance features</cell></row><row><cell>3D CT volume feature</cell><cell cols="2">CT images/1018 Accuracy</cell><cell></cell><cell>Higher</cell><cell>accuracy</cell><cell>than</cell><cell>[97]</cell></row><row><cell></cell><cell></cell><cell>(0.9126)</cell><cell></cell><cell cols="2">benchmarked models</cell></row><row><cell>3D CT volume feature</cell><cell cols="2">CT images/6960 DSC</cell><cell>(0.91);</cell><cell cols="3">Integration of clustering and</cell><cell>[98]</cell></row><row><cell></cell><cell></cell><cell cols="2">classification</cell><cell cols="3">scarification algorithms for</cell></row><row><cell></cell><cell></cell><cell cols="2">accuracy (0.97)</cell><cell cols="2">accurate extraction</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 :</head><label>2</label><figDesc>Machine learning applied for the analysis of sequencing data to enable early detection and classification.</figDesc><table><row><cell cols="3">Model Type Sample</cell><cell>Performanc</cell><cell cols="3">Feature Selection</cell><cell cols="2">Advantages</cell><cell>Reference</cell></row><row><cell></cell><cell></cell><cell>type/Image</cell><cell>e</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>LR</cell><cell>with</cell><cell>cfDNA</cell><cell>AUC (0.98)</cell><cell cols="3">cfDNA features +</cell><cell cols="2">Combines cfDNA with</cell><cell>[104]</cell></row><row><cell>LASSO</cell><cell></cell><cell>fragments/79</cell><cell></cell><cell cols="3">clinical + CT imaging</cell><cell cols="2">other markers for lung</cell></row><row><cell>penalty</cell><cell></cell><cell>9</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">cancer detection</cell></row><row><cell>5-NN,</cell><cell>3-</cell><cell>cfDNA/160</cell><cell>AUC (0.69-</cell><cell cols="4">SNV + CNV features Early</cell><cell>lung</cell><cell>cancer</cell><cell>[105]</cell></row><row><cell>NN,</cell><cell>NB,</cell><cell></cell><cell>0.98)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">detection using cfDNA</cell></row><row><cell>LR, DT</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>LR</cell><cell></cell><cell>ctDNA/296</cell><cell cols="4">AUC (0.816) 9 DNA methylation</cell><cell>Early</cell><cell>lung</cell><cell>cancer</cell><cell>[106]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>markers</cell><cell></cell><cell></cell><cell cols="2">detection using DNA</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">methylation</cell></row><row><cell cols="2">RF, SVM,</cell><cell>cfDNA/843</cell><cell>mAUC</cell><cell cols="5">Copy number profiles Biomarker framework</cell><cell>[107]</cell></row><row><cell>LR</cell><cell>with</cell><cell></cell><cell>(0.896-</cell><cell></cell><cell></cell><cell></cell><cell>for</cell><cell>lung</cell><cell>cancer</cell></row><row><cell cols="2">ridge/elastic</cell><cell></cell><cell>0.936)</cell><cell></cell><cell></cell><cell></cell><cell cols="2">detection using cfDNA</cell></row><row><cell cols="2">net/LASSO</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">copy number profiling</cell></row><row><cell>Diet</cell><cell></cell><cell>Somatic</cell><cell>Accuracy</cell><cell>SNVs,</cell><cell></cell><cell>insertions,</cell><cell cols="2">EIS stabilizes Diet</cell><cell>[108]</cell></row><row><cell cols="2">Networks</cell><cell>mutations/95</cell><cell>(0.8)</cell><cell cols="3">deletions across 1796</cell><cell cols="2">Network training</cell></row><row><cell cols="2">with EIS</cell><cell>4</cell><cell></cell><cell>genes</cell><cell></cell><cell></cell><cell></cell></row><row><cell>LR</cell><cell></cell><cell>RNA-seq of</cell><cell>AUC (0.81)</cell><cell>Lung</cell><cell></cell><cell>cancer-</cell><cell cols="2">Maintains sensitivity for</cell><cell>[109]</cell></row><row><cell></cell><cell></cell><cell>BECs/299</cell><cell></cell><cell cols="3">associated &amp; clinical</cell><cell cols="2">small/peripheral lesions</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>covariate</cell><cell></cell><cell>RNA</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>markers</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">KNN, NB,</cell><cell cols="2">RNA-seq/529 AUC (0.91)</cell><cell cols="3">Hold-out RNA-seq</cell><cell cols="2">Systematically</cell><cell>[110]</cell></row><row><cell cols="2">SVM, C4.5</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">compares models for</cell></row><row><cell>DT</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">lung cancer subtype</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">classification</cell></row><row><cell cols="2">Ensemble</cell><cell>RNA-seq of</cell><cell>AUC (0.74)</cell><cell cols="3">RNA-seq of 1232</cell><cell cols="2">Integrates RNA-seq and</cell><cell>[111]</cell></row><row><cell cols="2">model with</cell><cell>bronchial</cell><cell></cell><cell>genes</cell><cell>+</cell><cell>clinical</cell><cell>clinical</cell><cell>info</cell><cell>for</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">covariates</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 :</head><label>3</label><figDesc>Issues and Challenges</figDesc><table><row><cell>Technique</cell><cell>Issues</cell><cell cols="2">Challenges</cell></row><row><cell>Mammography</cell><cell> Not effective for women</cell><cell cols="2"> Limited dynamic range, low</cell></row><row><cell></cell><cell>under 40.</cell><cell></cell><cell>contrast, and grainy images</cell></row><row><cell></cell><cell> Difficulty detecting lesions</cell><cell cols="2"> Breast density affects sensitivity and</cell></row><row><cell></cell><cell>in dense breasts and in those</cell><cell></cell><cell>specificity</cell></row><row><cell></cell><cell>with surgical implants.</cell><cell></cell><cell>Age factor, rupture risk, and</cell></row><row><cell></cell><cell> Radiation exposure</cell><cell></cell><cell>BRCA1/2 mutations</cell></row><row><cell>Breast MRI</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell cols="2"> Low specificity</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Slow imaging time</cell></row><row><cell></cell><cell> Not standardized</cell><cell></cell><cell>Not recommended for patients with</cell></row><row><cell></cell><cell> Expensive</cell><cell></cell><cell>metallic devices</cell></row><row><cell></cell><cell> Non-portable device</cell><cell cols="2"> Recommended only for high-risk</cell></row><row><cell></cell><cell> Further biopsies needed</cell><cell></cell><cell>women</cell></row><row><cell>Breast</cell><cell></cell><cell></cell></row><row><cell>Ultrasound</cell><cell></cell><cell></cell></row><row><cell></cell><cell> Difficulty covering the entire</cell><cell></cell></row><row><cell></cell><cell>breast surface due to probe</cell><cell></cell></row><row><cell></cell><cell>size</cell><cell></cell></row><row><cell></cell><cell> Depends on the quality of the transducer and the physician's expertise in</cell><cell> </cell><cell>Poor resolution Low-contrast images</cell></row><row><cell></cell><cell>scanning and interpretation</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 :</head><label>4</label><figDesc>Some latest Breast cancer classification, detection and segmentation models.</figDesc><table><row><cell>Model</cell><cell cols="2">Diagnostic method Dataset</cell><cell>Performance</cell><cell>Ref.</cell></row><row><cell>ROI, ANN</cell><cell>thermography</cell><cell>Mastology Research</cell><cell>Accuracy is 90.2% Sn value is 89.34% Sp</cell><cell>[169]</cell></row><row><cell></cell><cell>images</cell><cell></cell><cell>value is 91%</cell><cell></cell></row><row><cell>CNN</cell><cell>thermography</cell><cell>Mastology Research</cell><cell>Accuracy is 98.95%</cell><cell>[161]</cell></row><row><cell></cell><cell>images</cell><cell></cell><cell></cell><cell></cell></row><row><cell>DWAN</cell><cell>thermography</cell><cell>Mastology Research</cell><cell>Sn value: 0.95</cell><cell>[170]</cell></row><row><cell></cell><cell>images</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CNN based on</cell><cell>Ultrasound</cell><cell>Private images 882</cell><cell>Acc value is 88.7% TP value is 84.8% TN</cell><cell>[163]</cell></row><row><cell>VGG19</cell><cell></cell><cell></cell><cell>value is 89.7% AUC value is 93.6%</cell><cell></cell></row><row><cell>DT, KNN, RF</cell><cell>Ultrasound</cell><cell>283 owned cases</cell><cell>SVM accuracy is 77.7% AUC Value is 0.84</cell><cell>[164]</cell></row><row><cell>SVM</cell><cell></cell><cell></cell><cell>RF accuracy is 78.5% AUC value is 0.83</cell><cell></cell></row><row><cell>Fuzzy C-Means</cell><cell>mammogram</cell><cell>DDSM</cell><cell>Accuracy is 87% Sn value is 90 to 47% Sp</cell><cell>[167]</cell></row><row><cell>(FCM)</cell><cell>images</cell><cell></cell><cell>value is 84 to 84%</cell><cell></cell></row><row><cell>CNN</cell><cell>mammogram</cell><cell>MIAS</cell><cell>Acc 92.1</cell><cell>[171]</cell></row><row><cell></cell><cell>images</cell><cell></cell><cell>AUC 95.0%</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 5 :</head><label>5</label><figDesc>Traditional Methods for the Detection of CRC.</figDesc><table><row><cell cols="2">Traditional</cell><cell>Application</cell><cell cols="2">Limitations</cell><cell></cell><cell></cell><cell>Ref.</cell></row><row><cell>Method</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Digital Rectal</cell><cell>Recommended for individuals over</cell><cell>Limited</cell><cell>reach,</cell><cell>depends</cell><cell>on</cell><cell>[177]</cell></row><row><cell cols="2">Examination</cell><cell>50 years old or with clinical</cell><cell cols="4">examiner's expertise, more valuable</cell></row><row><cell>(DRE)</cell><cell></cell><cell>symptoms. Assesses abnormalities in</cell><cell cols="4">for locally advanced tumors than</cell></row><row><cell></cell><cell></cell><cell>the perianal area, distal rectum, and</cell><cell cols="2">early-stage tumors.</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>evaluates tumor size, mobility, and</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>extension for surgical planning.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Fecal</cell><cell>Occult</cell><cell>Early detection tool identifying</cell><cell cols="4">gFOBT prone to false positives and</cell><cell>[180]</cell></row><row><cell>Blood</cell><cell>Tests</cell><cell>unseen blood in feces. Includes</cell><cell cols="4">requires dietary restrictions. TMB</cell></row><row><cell>(FOBTs)</cell><cell></cell><cell>chemical, immunochromatography,</cell><cell cols="4">test limited by interpretative errors</cell></row><row><cell></cell><cell></cell><cell>and DNA-based tests.</cell><cell cols="4">and only detects blood in stool's</cell></row><row><cell></cell><cell></cell><cell></cell><cell>outer layer.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Endoscopic</cell><cell>Direct visualization of the colon and</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Methods</cell><cell></cell><cell>rectum's mucosal lining. Colonoscopy</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>is linked to significant reductions in</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>CRC risk and mortality.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 6 :</head><label>6</label><figDesc>Comparative Analysis of Computer-Aided Detection Systems in Colonoscopy.</figDesc><table><row><cell cols="2">CADe System Control</cell><cell cols="3">Patients (n) ADR (AI vs. Control) Advanced ADR</cell><cell>Ref.</cell></row><row><cell>CAD EYE</cell><cell>HD-WLI</cell><cell>415</cell><cell>59.4% vs. 47.6% (p =</cell><cell>7.2% vs. 7.7% (p = 1)</cell><cell>[203]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.018)</cell><cell></cell><cell></cell></row><row><cell>Eagle-Eye</cell><cell>HD-WLI</cell><cell>3059</cell><cell>39.4% vs. 32.4% (p &lt;</cell><cell>6.6% vs. 4.9% (p = 0.041)</cell><cell>[204]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.001)</cell><cell></cell><cell></cell></row><row><cell>Endo Screener</cell><cell>HD-WLI</cell><cell>1261</cell><cell>25.8% vs. 24.0% (p =</cell><cell>0.314% vs. 0.39% (p = 0.562)</cell><cell>[205]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.464)</cell><cell></cell><cell></cell></row><row><cell>Endo Vigilant</cell><cell>HD-WLI</cell><cell>769</cell><cell>37.2% vs. 35.9% (p =</cell><cell>N/A</cell><cell>[206]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.774)</cell><cell></cell><cell></cell></row><row><cell>GI Genius</cell><cell>HD-WLI</cell><cell>658</cell><cell>71.4% vs. 65.4% (p =</cell><cell>N/A</cell><cell>[207]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.09)</cell><cell></cell><cell></cell></row><row><cell>ENDO-AID</cell><cell>HD-WLI</cell><cell>370</cell><cell>55.1% vs. 43.8% (p =</cell><cell>11.6% vs. 12.1% (p = 0.89)</cell><cell>[208]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.029)</cell><cell></cell><cell></cell></row><row><cell>GI Genius</cell><cell>HD-WLI</cell><cell>660</cell><cell>53.3% vs. 44.5% (p &lt;</cell><cell>12.7% vs. 12.7% (p = 0.956)</cell><cell>[209]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.02)</cell><cell></cell><cell></cell></row><row><cell>CAD EYE</cell><cell>HD-WLI</cell><cell>800</cell><cell>53.6% vs. 45.3% (RR</cell><cell>15.9% vs. 15.8% (RR 1.03, 95%</cell><cell>[210]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>1.18, 95% CI 1.03-</cell><cell>CI 0.96-1.09)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>1.36)</cell><cell></cell><cell></cell></row><row><cell>SKOUT</cell><cell>HD-WLI</cell><cell>1359</cell><cell>47.8% vs. 43.9% (p =</cell><cell>N/A</cell><cell>[211]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.065)</cell><cell></cell><cell></cell></row><row><cell>Xiamen</cell><cell>HD-WLI</cell><cell>150</cell><cell>PDR 38.7% vs. 34.0%</cell><cell>N/A</cell><cell>[212]</cell></row><row><cell>Innovation</cell><cell></cell><cell></cell><cell>(p &lt; 0.001)</cell><cell></cell><cell></cell></row><row><cell>N/A</cell><cell>HD-WLI</cell><cell>2352</cell><cell>PDR 38.8% vs. 36.2%</cell><cell>N/A</cell><cell>[213]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(p = 0.183)</cell><cell></cell><cell></cell></row><row><cell>Endo Screener</cell><cell>HD-WLI</cell><cell>790</cell><cell>29.0% vs. 20.91% (p =</cell><cell>1.43% vs. 3.92% (p = 0.607)</cell><cell>[214]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.009)</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 7 :</head><label>7</label><figDesc>CAD System Development Techniques for Endoscopic Image Analysis</figDesc><table><row><cell>Objective</cell><cell cols="2">Methods Used</cell><cell></cell><cell>Image Type</cell><cell>Maximum Results</cell><cell>Ref.</cell></row><row><cell>To develop CAD systems for</cell><cell cols="2">Texture analysis, k-NN</cell><cell></cell><cell>Endoscopic</cell><cell>Sensitivity = 98.2%,</cell><cell>[210]</cell></row><row><cell>the classification of colorectal</cell><cell></cell><cell></cell><cell></cell><cell>images</cell><cell>Specificity = 87.5%</cell><cell></cell></row><row><cell>polyps.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Automated and fully developed</cell><cell cols="3">SVM, texture analysis, shape</cell><cell>Endoscopic</cell><cell>Sensitivity = 98.2%,</cell><cell>[211]</cell></row><row><cell>system for the classification of</cell><cell cols="2">classification</cell><cell></cell><cell>images</cell><cell>Specificity = 87.5%</cell><cell></cell></row><row><cell>colorectal polyps and mucosal</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>abnormalities.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>To develop an objective</cell><cell>CNN</cell><cell>extraction,</cell><cell>gray-scale</cell><cell>Endoscopic</cell><cell>Accuracy = 93.5%</cell><cell>[215]</cell></row><row><cell>classifier of colorectal polyps to</cell><cell cols="3">conversion, feature extraction</cell><cell>images</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 8 :</head><label>8</label><figDesc>Limits of Current Detection Techniques for Hepatocellular Carcinoma (HCC).</figDesc><table><row><cell>Detection Technique</cell><cell>Limitation</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>Table 9 :</head><label>9</label><figDesc>Applications of AI in Liver Cancer Management and Diagnosis.</figDesc><table><row><cell>AI Application</cell><cell>Function</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>Table 10 :</head><label>10</label><figDesc>Advancements in AI for the Detection and Stratification of Liver Cancers</figDesc><table><row><cell>AI Application</cell><cell>Function</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_10"><head>Table 11 :</head><label>11</label><figDesc>Innovative Methods for Liver Cancer Biomarker Detection.</figDesc><table><row><cell>Method Name</cell><cell>Function</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_11"><head>Table 12 :</head><label>12</label><figDesc>Performance Metrics of AI Applications in Various Liver Disease Diagnostics.</figDesc><table><row><cell cols="2">AI Application</cell><cell cols="2">Data Type</cell><cell></cell><cell></cell><cell>Efficacy</cell><cell>Ref.</cell></row><row><cell cols="2">Various AI models</cell><cell>B-mode</cell><cell cols="3">ultrasonography,</cell><cell>Exceeds the diagnostic acumen of</cell><cell>[275]</cell></row><row><cell></cell><cell></cell><cell cols="2">medical imaging</cell><cell></cell><cell></cell><cell>human experts</cell></row><row><cell cols="2">AI in medical imaging</cell><cell>Medical</cell><cell cols="2">imaging,</cell><cell>virtual</cell><cell>Enhances risk assessments and</cell><cell>[252]</cell></row><row><cell>diagnosis</cell><cell></cell><cell>assistants</cell><cell></cell><cell></cell><cell></cell><cell>treatment response predictions</cell></row><row><cell cols="4">Six different AI models Histopathology</cell><cell></cell><cell></cell><cell>Sets new benchmarks for sensitivity,</cell><cell>[262]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>specificity, and predictive values</cell></row><row><cell>Hybrid</cell><cell>pre-trained</cell><cell cols="3">CT scans, histology</cell><cell></cell><cell>Showcases exceptional levels of</cell><cell>[276]</cell></row><row><cell>models</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>accuracy, precision, and recall</cell></row><row><cell cols="2">AI and machine ML</cell><cell cols="2">Surveillance</cell><cell cols="2">Epidemiology</cell><cell>Significant leap in sensitivity,</cell><cell>[250]</cell></row><row><cell></cell><cell></cell><cell cols="4">and End Results database</cell><cell>specificity, and AUC</cell></row><row><cell cols="2">AI model based on CT</cell><cell cols="3">CT data, clinical factors</cell><cell></cell><cell>Enhanced capability to predict liver</cell><cell>[277]</cell></row><row><cell>data</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>metastasis with greater accuracy</cell></row><row><cell cols="2">Deep learning assistant</cell><cell cols="4">Whole-slide images (WSI)</cell><cell>Improves diagnostic accuracy for</cell><cell>[263]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>liver cancer subtypes</cell></row><row><cell cols="2">AI for segmentation and</cell><cell>Medical</cell><cell cols="2">imaging</cell><cell>from</cell><cell>High Dice similarity coefficients for</cell><cell>[278]</cell></row><row><cell>classification</cell><cell></cell><cell cols="4">MICCAI 2027 LITS database</cell><cell>accurate tumor identification and</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>segmentation</cell></row><row><cell cols="2">AI in HCC treatment</cell><cell cols="4">Various, including ANN and</cell><cell>Enhanced accuracy over traditional</cell><cell>[279]</cell></row><row><cell cols="2">and prognosis</cell><cell>radiomics</cell><cell></cell><cell></cell><cell></cell><cell>analysis for treatment and prognosis</cell></row><row><cell cols="2">AI for liver tumor</cell><cell cols="5">CT scans with synthetic tumors Accurate segmentation without</cell><cell>[280]</cell></row><row><cell cols="2">segmentation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>manual annotation, reducing time</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and resources for training</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_12"><head>Table 13 :</head><label>13</label><figDesc>Emerging Diagnostic Technologies for Gastric Cancer: Functions and Limitation.</figDesc><table><row><cell cols="2">Diagnostic Type</cell><cell>Function</cell><cell></cell><cell></cell><cell>Limitations</cell><cell>Ref.</cell></row><row><cell cols="2">Second-generation</cell><cell cols="3">Enhances visualization of</cell><cell>Limited by the sensitivity of WLI</cell><cell>[284]</cell></row><row><cell cols="2">narrow band imaging</cell><cell cols="3">surface structures and blood</cell><cell>and requires further studies to</cell></row><row><cell>(2G-NBI)</cell><cell></cell><cell cols="3">vessels for better detection of</cell><cell>confirm its efficacy in detecting</cell></row><row><cell></cell><cell></cell><cell cols="3">EGC compared to WLI.</cell><cell>EGC.</cell></row><row><cell>Serum</cell><cell>Screening</cell><cell cols="3">Uses serum anti-HP antibody</cell><cell>Some gastric cancer patients fall</cell><cell>[287]</cell></row><row><cell>System</cell><cell></cell><cell cols="3">titers and PG levels for a</cell><cell>into the HP (-)/PG (-) category,</cell></row><row><cell></cell><cell></cell><cell cols="3">stratified risk assessment of</cell><cell>indicating a need for further</cell></row><row><cell></cell><cell></cell><cell cols="2">gastric cancer.</cell><cell></cell><cell>validation.</cell></row><row><cell>Liquid</cell><cell>Biopsy</cell><cell cols="3">Utilizes circulating biomarkers</cell></row><row><cell>Signature</cell><cell></cell><cell cols="3">like EVs for non-invasive</cell></row><row><cell></cell><cell></cell><cell>diagnosis</cell><cell>and</cell><cell>real-time</cell></row><row><cell></cell><cell></cell><cell cols="3">surveillance of malignancies.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_13"><head>Table 14 :</head><label>14</label><figDesc>Therapeutic use of deep learning technology trained on CT data.</figDesc><table><row><cell cols="2">Lesion Type</cell><cell>Diagnostic</cell><cell>Dataset</cell><cell>AI Method</cell><cell>Efficacy</cell><cell></cell><cell>Ref.</cell></row><row><cell></cell><cell></cell><cell>Method</cell><cell>Capacity</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Lymph node</cell><cell>CT</cell><cell>Patient: 730</cell><cell>DL</cell><cell>C-index</cell><cell cols="2">Outperformed</cell><cell>[308]</cell></row><row><cell cols="2">metastasis</cell><cell></cell><cell></cell><cell>(Multivariable</cell><cell cols="3">External validation: 0.797</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>linear</cell><cell cols="3">International validation:</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>regression</cell><cell>0.822</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>analysis)</cell><cell></cell><cell></cell></row><row><cell cols="2">Lymph node</cell><cell>CT</cell><cell>Patient: 204</cell><cell>DCNN</cell><cell cols="3">AUC: 0.82 Outperformed [309]</cell></row><row><cell cols="2">metastasis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Lymph node</cell><cell>CT</cell><cell>Patient: 1,699</cell><cell>ResNet-18</cell><cell cols="3">Extranational validation</cell><cell>[310]</cell></row><row><cell cols="2">metastasis</cell><cell></cell><cell></cell><cell></cell><cell>median</cell><cell>AUC:</cell><cell>0.876</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="3">Accuracy: nearly 90%</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Sensitivity:</cell><cell>0.743</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Specificity: 0.936</cell></row><row><cell cols="2">Risk prediction</cell><cell>CT</cell><cell>Patient: 640</cell><cell>ResNet</cell><cell>C-index</cell><cell cols="2">Outperformed</cell><cell>[311]</cell></row><row><cell>of</cell><cell>overall</cell><cell></cell><cell></cell><cell></cell><cell cols="3">than DL (internal) vs</cell></row><row><cell>survival</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Clinical(external)</cell><cell>vs</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>clinical</cell><cell cols="2">radiomics</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Radiomics</cell><cell></cell></row><row><cell>Predict</cell><cell></cell><cell>CT</cell><cell>Patient: 1,615</cell><cell>S-Net</cell><cell cols="3">Extranational validation</cell><cell>[312]</cell></row><row><cell cols="2">prognosis</cell><cell></cell><cell></cell><cell></cell><cell cols="3">Useful than TNM C-index</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">staging system</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_14"><head>Table 15 :</head><label>15</label><figDesc>AI-Based Diagnostic Technologies for Early Gastric Cancer Detection: Efficacy and Outcomes.</figDesc><table><row><cell>Lesion</cell><cell>Diagnostic</cell><cell>Dataset</cell><cell></cell><cell>AI</cell><cell cols="2">Summarized Outcomes</cell><cell></cell><cell>Ref.</cell></row><row><cell></cell><cell>Method</cell><cell cols="2">Capacity</cell><cell>Technology</cell><cell></cell><cell></cell><cell></cell></row><row><cell>EGC</cell><cell>BLI-ME</cell><cell cols="2">Patients: 95</cell><cell>SVM</cell><cell cols="3">Validated with SVM, notable</cell><cell>[318]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">cancer detection rate</cell><cell></cell></row><row><cell>Classification</cell><cell>WLE</cell><cell cols="2">Images: 5,017;</cell><cell>Inception-</cell><cell cols="3">High AUC values in both</cell><cell>[319]</cell></row><row><cell>of lesion</cell><cell></cell><cell cols="2">Patients: 1,269;</cell><cell>ResNet-v2</cell><cell cols="3">retrospective and prospective</cell></row><row><cell></cell><cell></cell><cell>Images:</cell><cell>200;</cell><cell></cell><cell cols="3">validations, good average</cell></row><row><cell></cell><cell></cell><cell cols="2">Patients: 200</cell><cell></cell><cell>accuracy</cell><cell></cell><cell></cell></row><row><cell cols="2">Gastric lesions NBI</cell><cell>NBI</cell><cell>images:</cell><cell>ResNet</cell><cell>Excellent</cell><cell>AUC,</cell><cell>high</cell><cell>[320]</cell></row><row><cell></cell><cell></cell><cell>2,000</cell><cell></cell><cell></cell><cell cols="3">accuracy, sensitivity, and</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">good specificity</cell><cell></cell></row><row><cell>EGC</cell><cell>WLE, NBI</cell><cell>GC:</cell><cell>2,639;</cell><cell>SSD</cell><cell cols="3">Validated with CHN and</cell><cell>[321]</cell></row><row><cell></cell><cell></cell><cell cols="2">Images: 13,584</cell><cell></cell><cell cols="3">expert comparisons, mixed</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>sensitivity</cell><cell>and</cell><cell>high</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>specificity</cell><cell></cell><cell></cell></row><row><cell>EGC</cell><cell>WLE</cell><cell cols="2">Neoplastic: 150;</cell><cell>Tango</cell><cell cols="3">Validated with Tango/Expert,</cell><cell>[322]</cell></row><row><cell></cell><cell></cell><cell cols="2">non-neoplastic:</cell><cell></cell><cell cols="3">reasonable accuracy and</cell></row><row><cell></cell><cell></cell><cell>165</cell><cell></cell><cell></cell><cell>sensitivity</cell><cell></cell><cell></cell></row></table><note><p>Tables15 and 16</p><p>provide a concise overview of how AI is used in the diagnosis of stomach cancer lesions. SVM and Inception-ResNet-v2 exhibited higher AUC values in both prospective and retrospective trials, although ResNet for NBI pictures yielded the most favorable metrics in terms of accuracy, sensitivity, and specificity.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_15"><head>Table 16 :</head><label>16</label><figDesc>Transformative AI Applications in Gastrointestinal Diagnostic Methods.</figDesc><table><row><cell>Traditional</cell><cell>Diagnostic</cell><cell>Integration of AI</cell><cell>Improvements</cell><cell>Ref.</cell></row><row><cell>Techniques</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_16"><head>Table 17 :</head><label>17</label><figDesc>ESCC Detection Strategies: Advancements and Challenges.</figDesc><table><row><cell cols="2">Diagnostic Technique</cell><cell>Function</cell><cell>Limitation</cell><cell>Ref.</cell></row><row><cell>Upper</cell><cell>Gastrointestinal</cell><cell>The gold standard for</cell><cell></cell></row><row><cell>Endoscopy</cell><cell></cell><cell>diagnosis of ESCC.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_18"><head>Table 18 :</head><label>18</label><figDesc>AI-Based Model in the Detection of ESCC</figDesc><table><row><cell>Study Objective</cell><cell>Image Type</cell><cell>Model</cell><cell>Test Set</cell><cell>Reference</cell></row><row><cell>Differentiation of abnormal</cell><cell>ME-NBI</cell><cell>CNN</cell><cell>17 (10 ESCCs), 7046 images</cell><cell>[348]</cell></row><row><cell>IPCL from normal</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Detection of ESCC</cell><cell>ME-NBI</cell><cell>CNN-SVM</cell><cell cols="2">219 (165 ESCCs), 1383 images [349]</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_19"><head>Table 19 :</head><label>19</label><figDesc>Comparative Overview of Traditional Cervical Cancer Screening Methods and Their Limitations</figDesc><table><row><cell>Traditional</cell><cell>Application</cell><cell>Limitation Summary</cell><cell>Ref.</cell></row><row><cell>Method</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_20"><head>Table 20 :</head><label>20</label><figDesc>From Traditional Screening to AI: The Changing Landscape of Cervical Cancer Diagnostics</figDesc><table><row><cell>Advancement</cell><cell>Summary</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_21"><head>Table 21 :</head><label>21</label><figDesc>Artificial Intelligence in Cervical Cancer: Detection to Treatment</figDesc><table><row><cell cols="2">AI Application</cell><cell cols="2">Application</cell><cell></cell><cell></cell><cell>Advantage</cell><cell></cell><cell>Ref.</cell></row><row><cell>Detection</cell><cell>and</cell><cell cols="4">AI algorithms identify HSIL</cell><cell>Improved</cell><cell cols="2">diagnostic</cell><cell>[372]</cell></row><row><cell>Diagnosis</cell><cell></cell><cell cols="4">and cervical cancer considering the</cell><cell cols="2">accuracy with DL techniques.</cell></row><row><cell></cell><cell></cell><cell cols="4">impact of HPV on protein expression.</cell><cell></cell><cell></cell></row><row><cell>Treatment</cell><cell></cell><cell cols="4">AI enables understanding of</cell><cell cols="3">Aids in evaluating the</cell><cell>[371]</cell></row><row><cell cols="2">Individualization</cell><cell>cervical</cell><cell>cancer's</cell><cell cols="2">pathogenesis,</cell><cell cols="3">effectiveness of surgical and drug</cell></row><row><cell></cell><cell></cell><cell cols="4">allowing for personalized treatments.</cell><cell>treatments.</cell><cell></cell></row><row><cell>Screening</cell><cell></cell><cell cols="4">AI models, using techniques</cell><cell cols="3">High diagnostic accuracy in</cell><cell>[373]</cell></row><row><cell>Improvement</cell><cell></cell><cell cols="4">like SVM and deep learning, analyze</cell><cell>screening processes.</cell><cell></cell></row><row><cell></cell><cell></cell><cell cols="2">screening images.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Clinical</cell><cell></cell><cell cols="4">ML and DL categorize</cell><cell cols="3">Automates segmentation</cell><cell>[374]</cell></row><row><cell>Decision</cell><cell></cell><cell cols="4">cervical cytology and colposcopy</cell><cell cols="3">and aids in clinical decision-making.</cell></row><row><cell>Support</cell><cell></cell><cell cols="2">images for clinicians.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Prevention</cell><cell></cell><cell cols="4">AI detects precancerous</cell><cell cols="3">Enhances early detection</cell><cell>[375]</cell></row><row><cell>Strategies</cell><cell></cell><cell cols="4">lesions and assists in treatment</cell><cell cols="2">and prevention efforts.</cell></row><row><cell></cell><cell></cell><cell>decisions.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Reproducible</cell><cell></cell><cell>AI</cell><cell cols="2">pipelines</cell><cell>diagnose</cell><cell>Provides</cell><cell>robust</cell><cell>and</cell><cell>[402]</cell></row><row><cell>Screening</cell><cell></cell><cell cols="4">treatable precancerous lesions.</cell><cell cols="3">clinically translatable screening</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>tools.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_23"><head>Table 23 :</head><label>23</label><figDesc>Public and Private Thyroid Cancer Database used in thyroid cancer detection.</figDesc><table><row><cell>TCD</cell><cell>Image Type</cell><cell>Data Type</cell><cell>Instance</cell><cell>Year/Ref</cell></row><row><cell>BMU</cell><cell>Sonographic</cell><cell>PNG</cell><cell>1077</cell><cell>[432]</cell></row><row><cell>TCCC</cell><cell>US</cell><cell>PNG</cell><cell>370</cell><cell>[433]</cell></row><row><cell>Clinical</cell><cell>US</cell><cell>JPEG</cell><cell>117</cell><cell>[434]</cell></row><row><cell>Hospital</cell><cell>US</cell><cell>JPEG</cell><cell>62</cell><cell>[435]</cell></row><row><cell>TIRADS</cell><cell>US</cell><cell>JPEG</cell><cell>5278</cell><cell>[436]</cell></row><row><cell>Peking Union</cell><cell>US</cell><cell>JPEG</cell><cell>4309</cell><cell>[437]</cell></row><row><cell cols="2">Medical Center US</cell><cell>PNG</cell><cell>1425</cell><cell>[438]</cell></row><row><cell>PubMed</cell><cell>CT scans</cell><cell>JPEG</cell><cell>2108</cell><cell>[439]</cell></row><row><cell>ACR</cell><cell>DICOM</cell><cell>DICOM</cell><cell>1629</cell><cell>[440]</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_24"><head>Table 24 :</head><label>24</label><figDesc>The advantages and disadvantages of artificial intelligence-based methods for the detection of thyroid cancer.</figDesc><table><row><cell>AI Method</cell><cell>Acc. (%)</cell><cell cols="2">Advantages</cell><cell></cell><cell>Drawbacks</cell><cell></cell><cell></cell><cell>Ref.</cell></row><row><cell>DAE</cell><cell>92.9</cell><cell cols="7">No need for labeled data Insufficient training data, requires relevant</cell><cell>[441]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>data</cell><cell></cell><cell></cell></row><row><cell>CNN</cell><cell>85.0</cell><cell cols="3">High detection rate</cell><cell>Insufficient</cell><cell>labeled</cell><cell>data,</cell><cell>weak</cell><cell>[442]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interpretability</cell><cell></cell><cell></cell></row><row><cell>RNN</cell><cell>98.2</cell><cell cols="6">No need for labeled data Slow computation, complex training</cell><cell>[443]</cell></row><row><cell>MLP</cell><cell>95.0</cell><cell cols="2">Adaptive learning</cell><cell></cell><cell>Limited results</cell><cell></cell><cell></cell><cell>[444]</cell></row><row><cell>KNN</cell><cell>93.0</cell><cell cols="2">High sensitivity</cell><cell></cell><cell cols="2">Insufficient labeled data</cell><cell></cell><cell>[445]</cell></row><row><cell>SVM</cell><cell>97.0</cell><cell cols="2">High sensitivity</cell><cell></cell><cell cols="4">Weak interpretability, long training time</cell><cell>[446]</cell></row><row><cell>DT</cell><cell>73.10</cell><cell>No.</cell><cell>of</cell><cell>scaling</cell><cell>Unstable</cell><cell></cell><cell></cell><cell>[447]</cell></row><row><cell></cell><cell></cell><cell cols="3">normalization needed</cell><cell></cell><cell></cell><cell></cell></row><row><cell>LR</cell><cell>-</cell><cell cols="3">Low-cost training, easy</cell><cell cols="2">Difficulty labeling data</cell><cell></cell><cell>[448]</cell></row><row><cell></cell><cell></cell><cell cols="2">implementation</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>B</cell><cell>94.88</cell><cell cols="3">High detection rate</cell><cell cols="4">Loss of interpretability, high computational</cell><cell>[449]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>cost</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_25"><head>Table 25 :</head><label>25</label><figDesc>Selection and Extraction methods based on DL conducted in the diagnosis of thyroid cancer.</figDesc><table><row><cell cols="2">Classifier Feature</cell><cell>Feature Engineering</cell><cell cols="2">Contributions</cell><cell></cell><cell></cell><cell>Ref.</cell></row><row><cell>KNN</cell><cell>FC/IG</cell><cell>ANFIS</cell><cell>Reduced</cell><cell>data</cell><cell cols="2">redundancy,</cell><cell>[450]</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="3">handling missing data</cell><cell></cell></row><row><cell>SVM</cell><cell>FC/CFS</cell><cell>Kernel-based feature extraction</cell><cell cols="4">Geometric and moment feature</cell><cell>[451]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>extraction</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CNN</cell><cell>FC/R</cell><cell>Combined ML and feature selection</cell><cell cols="4">Analyzed SEER database using</cell><cell>[452]</cell></row><row><cell></cell><cell></cell><cell>algorithms</cell><cell cols="2">various algorithms</cell><cell></cell><cell></cell></row><row><cell>CNN</cell><cell>FE/PCA-</cell><cell>Oversampling and PCA for dimension</cell><cell>Improved</cell><cell cols="2">accuracy</cell><cell>with</cell><cell>[453]</cell></row><row><cell></cell><cell></cell><cell>reduction</cell><cell cols="2">unbalanced data</cell><cell></cell><cell></cell></row><row><cell>O</cell><cell>FE/TD</cell><cell cols="2">CAD, DWT, and texture feature extraction Combined</cell><cell>CAD,</cell><cell></cell><cell>wavelet</cell><cell>[454]</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="4">transform, and texture features</cell></row><row><cell>CNN</cell><cell>FE/AC-</cell><cell>Image enhancement, segmentation, multi-</cell><cell cols="4">Enhanced images, extracted</cell><cell>[455]</cell></row><row><cell></cell><cell></cell><cell>feature extraction</cell><cell cols="3">multi-feature information</cell><cell></cell></row><row><cell>SVM</cell><cell>FE/LBP-</cell><cell>CNN deep features fused with HOG and</cell><cell cols="4">Combined handcrafted and deep</cell><cell>[436]</cell></row><row><cell></cell><cell></cell><cell>SIFT</cell><cell cols="4">features for improved accuracy</cell></row><row><cell>SVM</cell><cell cols="2">FE/GLCM Median filter, contour delineation, GLCM</cell><cell>Noise</cell><cell>reduction,</cell><cell></cell><cell>feature</cell><cell>[456]</cell></row><row><cell></cell><cell></cell><cell>texture features</cell><cell cols="4">extraction, and multiple classifiers</cell></row><row><cell>SVM</cell><cell>FE/ICA</cell><cell>Multi-kernel-based SVM</cell><cell cols="4">Improved classification accuracy</cell><cell>[457]</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">with ICA features</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_26"><head>Table 26 :</head><label>26</label><figDesc>Percentage-based performance evaluations of several frameworks for thyroid cancer.</figDesc><table><row><cell>AI Model</cell><cell>Dataset</cell><cell>ACC (%)</cell><cell>SPE (%)</cell><cell>SEN (%)</cell><cell>Ref.</cell></row><row><cell>CNN</cell><cell>PD</cell><cell>88.00</cell><cell>79.10</cell><cell>98.10</cell><cell>[458]</cell></row><row><cell>ELM</cell><cell>PD</cell><cell>87.72</cell><cell>94.55</cell><cell>78.89</cell><cell>[459]</cell></row><row><cell>MLP</cell><cell>PD</cell><cell>87.16</cell><cell>87.05</cell><cell>91.18</cell><cell>[452]</cell></row><row><cell>SVM</cell><cell>PD</cell><cell>63.27</cell><cell>71.85</cell><cell>38.46</cell><cell>[460]</cell></row><row><cell>RF</cell><cell>PD</cell><cell>86.80</cell><cell>87.90</cell><cell>85.20</cell><cell>[461]</cell></row><row><cell>LR</cell><cell>PD</cell><cell>77.80</cell><cell>79.80</cell><cell>70.60</cell><cell>[462]</cell></row><row><cell>B</cell><cell>PD</cell><cell>84.69</cell><cell>86.96</cell><cell>82.69</cell><cell>[456]</cell></row><row><cell>Ensemble DL</cell><cell>Cytological images</cell><cell>99.71</cell><cell>-</cell><cell>-</cell><cell>[463]</cell></row><row><cell>VGG-16</cell><cell>Cytological images</cell><cell>97.66</cell><cell>-</cell><cell>-</cell><cell>[464]</cell></row><row><cell>VGG-16</cell><cell>-</cell><cell>99.00</cell><cell>86.00</cell><cell>94.00</cell><cell>[465]</cell></row><row><cell>RF</cell><cell>Ultrasound</cell><cell>-</cell><cell>-</cell><cell>94.00</cell><cell>[466]</cell></row><row><cell>k-SVM</cell><cell>Ultrasound</cell><cell>-</cell><cell>-</cell><cell>95.00</cell><cell>[434]</cell></row><row><cell>ANN</cell><cell>Ultrasound</cell><cell>-</cell><cell>-</cell><cell>69.00</cell><cell>[467]</cell></row><row><cell>SVM RF</cell><cell>Ultrasound</cell><cell>-</cell><cell>-</cell><cell>95.10</cell><cell>[468]</cell></row><row><cell>ANN SVM</cell><cell>Ultrasound</cell><cell>96.00</cell><cell>-</cell><cell>-</cell><cell>[469]</cell></row><row><cell>RF</cell><cell>Ultrasound</cell><cell>-</cell><cell>-</cell><cell>75.00</cell><cell>[470]</cell></row><row><cell>CNN</cell><cell>DICOM</cell><cell>83.00</cell><cell>85.00</cell><cell>82.40</cell><cell>[471]</cell></row><row><cell>CNN</cell><cell>DICOM</cell><cell>-</cell><cell>91.50</cell><cell>-</cell><cell>[472]</cell></row><row><cell>Fine-tuned DCNN</cell><cell>PD</cell><cell>99.10</cell><cell>-</cell><cell>-</cell><cell>[473]</cell></row><row><cell>ResNet18-based network</cell><cell>PD</cell><cell>93.80</cell><cell>-</cell><cell>-</cell><cell>[474]</cell></row><row><cell>Multiple-scale CNN</cell><cell>PD</cell><cell>82.20</cell><cell>-</cell><cell>-</cell><cell>[475]</cell></row><row><cell>ThyNet</cell><cell>PD</cell><cell>-</cell><cell>-</cell><cell>92.10</cell><cell>[476]</cell></row><row><cell>AlexNet CNN</cell><cell>PD</cell><cell>86.00</cell><cell>-</cell><cell>-</cell><cell>[477]</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_27"><head>Table 27 :</head><label>27</label><figDesc>Comparative Limitations of Prostate Cancer Diagnostic Methods</figDesc><table><row><cell>Detection Method</cell><cell>Limitation</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_28"><head>Table 28 :</head><label>28</label><figDesc>Efficacy of AI Models in Prostate Cancer Diagnosis.</figDesc><table><row><cell>AI-based Model</cell><cell>Data Type</cell><cell>Efficacy</cell><cell></cell><cell></cell><cell></cell><cell>Ref.</cell></row><row><cell>Model DEEP NET using deep</cell><cell>Histopathological</cell><cell cols="4">High accuracy in detecting and scoring,</cell><cell>[522]</cell></row><row><cell>learning for biopsies DEEP</cell><cell>Data</cell><cell cols="4">prognostic for detrimental organizing and</cell><cell></cell></row><row><cell>NET</cell><cell></cell><cell>resurgence.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ResNet50 model based on</cell><cell>MR Image</cell><cell cols="4">Enhanced diagnostic accuracy, increased</cell><cell>[523]</cell></row><row><cell>TRUS images</cell><cell></cell><cell cols="3">sensitivity, and specificity</cell><cell></cell><cell></cell></row><row><cell>A motel YOLO3 propelled by</cell><cell>Histopathological</cell><cell>Forecasts</cell><cell>early</cell><cell>recurrence</cell><cell>following</cell><cell>[524]</cell></row><row><cell>AI for the early prediction of</cell><cell>Data</cell><cell cols="4">prostatectomy and pinpoints driving regions.</cell><cell></cell></row><row><cell>recurrence</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>AI for prostate treatment</cell><cell>MR Image</cell><cell cols="4">Prostate and OARs outlines have a high level</cell><cell>[525]</cell></row><row><cell>planning automation</cell><cell></cell><cell cols="2">of clinical acceptance.</cell><cell></cell><cell></cell><cell></cell></row><row><cell>"Dr. Answer" AI for clinical</cell><cell>Clinical Data</cell><cell cols="4">Precise forecasting of clinical results after</cell><cell>[526]</cell></row><row><cell>outcome prediction</cell><cell></cell><cell cols="2">radical prostatectomy</cell><cell></cell><cell></cell><cell></cell></row><row><cell>A review of the use of AI to</cell><cell>MRI,</cell><cell cols="4">Describes the pros and cons of clinical</cell><cell>[515]</cell></row><row><cell>detect prostate cancer</cell><cell>Histopathological,</cell><cell cols="2">workflow aid</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Video</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>AI to help doctors diagnose</cell><cell>MR Image, Clinical</cell><cell cols="4">Potentially extensive applicability in terms of</cell><cell>[527]</cell></row><row><cell>and treat patients</cell><cell>Data</cell><cell cols="3">treatment and diagnosis efficacy</cell><cell></cell><cell></cell></row><row><cell>An AI algorithm for the</cell><cell>Histopathological</cell><cell cols="4">Cancer detection, grading, and clinically</cell><cell>[516]</cell></row><row><cell>diagnosis of prostate cancer in</cell><cell>Data</cell><cell cols="4">significant findings with exceptional precision</cell><cell></cell></row><row><cell>CNBs</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Utilization of AI in imaging</cell><cell>MR Image</cell><cell cols="4">Possibility to direct treatment, reduce</cell><cell>[528]</cell></row><row><cell>prostate cancer</cell><cell></cell><cell cols="3">variability, and enhance diagnosis</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_29"><head>Table 29 :</head><label>29</label><figDesc>Recently researched various skin cancer datasets and AI Models</figDesc><table><row><cell>Model</cell><cell>Datasets</cell><cell></cell><cell>Performance</cell><cell>Reference</cell></row><row><cell>AlexNet, VGG16, VGG19</cell><cell cols="2">ISIC 2016, 2017,</cell><cell cols="2">Accuracy = 98.33%, F1 score = 96% [551]</cell></row><row><cell></cell><cell cols="2">PH2, HAM10000</cell><cell></cell><cell></cell></row><row><cell>Deep Residual Network</cell><cell>ISIC</cell><cell>2017,</cell><cell>Accuracy = 96.97%</cell><cell>[552]</cell></row><row><cell></cell><cell>HAM10000</cell><cell></cell><cell></cell><cell></cell></row><row><cell>CNN</cell><cell cols="2">Xiangya-Derm</cell><cell>AUC = 0.87</cell><cell>[553]</cell></row><row><cell>CNN, ResNet50</cell><cell>HAM10000</cell><cell></cell><cell>F1-score = 0.859 (CNN), 0.852</cell><cell>[554]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(ResNet50)</cell><cell></cell></row><row><cell>ResNet-101 and SVM</cell><cell cols="2">ISIC 2019, 2020</cell><cell>Accuracy = 96.15% (ISIC19),</cell><cell>[555]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>97.15% (ISIC20)</cell><cell></cell></row><row><cell>NASNet</cell><cell>ISIC 2020</cell><cell></cell><cell>Accuracy = 97.7%, F1-score =</cell><cell>[556]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.97%</cell><cell></cell></row><row><cell>ResNet15V2, MobileNetV2</cell><cell>ISIC 2019</cell><cell></cell><cell>Accuracy = 89%, F1-score = 0.91</cell><cell>[541]</cell></row></table></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">World Oncology Forum amplifies its appeal in global fight against cancer</title>
		<author>
			<persName><forename type="first">F</forename><surname>Cavalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mikkelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Weiderpass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jaffray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gospodarowicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Oncology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="170" to="174" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Artificial intelligence in radiation oncology</title>
		<author>
			<persName><forename type="first">E</forename><surname>Huynh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Clinical Oncology</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="771" to="781" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">CA: A</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Giaquinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Journal for Clinicians</title>
		<imprint>
			<date type="published" when="2024">2024. 2024</date>
		</imprint>
	</monogr>
	<note>Cancer statistics</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">ChemGenX: AI in the Chemistry Classroom</title>
		<author>
			<persName><forename type="first">T</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Javed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Raza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the 2024 International Symposium on Artificial Intelligence for Education</title>
		<meeting>the 2024 International Symposium on Artificial Intelligence for Education</meeting>
		<imprint>
			<date type="published" when="2024">2024</date>
			<biblScope unit="page" from="224" to="230" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Current State of Artificial Intelligence (AI) in Oncology: A Review</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Naeem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Anam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Ahmed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Trends in OMICS</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="17" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Biomarker Discovery and Validation for Gastrointestinal Tumors: A Comprehensive review of Colorectal, Gastric, and Liver Cancers</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Hakami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathology-Research and Practice</title>
		<imprint>
			<biblScope unit="page">155216</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Deep learning-based multi-omics integration robustly predicts survival in liver cancer</title>
		<author>
			<persName><forename type="first">K</forename><surname>Chaudhary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">B</forename><surname>Poirion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">X</forename><surname>Garmire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1248" to="1259" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification</title>
		<author>
			<persName><forename type="first">H</forename><surname>Froehlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Patjoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yeghiazaryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kehrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Golubnitschaja</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EPMA Journal</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="175" to="186" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Variational autoencoders for cancer data integration: design principles and computational practice</title>
		<author>
			<persName><forename type="first">N</forename><surname>Simidjievski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in genetics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">1205</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Deep learning-based multi-omics data integration reveals two prognostic subtypes in high-risk neuroblastoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in genetics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">477</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse</title>
		<author>
			<persName><forename type="first">S</forename><surname>Madhavan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in genetics</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">236</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">SALMON: survival analysis learning with multi-omics neural networks on breast cancer</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in genetics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">166</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Advancements in Human Action Recognition Through 5G/6G Technology for Smart Cities: Fuzzy Integral-Based Fusion</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Transactions on Consumer Electronics</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<author>
			<persName><forename type="first">B</forename><surname>Zhu</surname></persName>
		</author>
		<title level="m">Integrating clinical and multiple omics data for prognostic assessment across human cancers. Sci Rep</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Modelling liver cancer microenvironment using a novel 3D culture system</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Al Hrout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cervantes-Gracia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chahwan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Amin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific reports</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">8003</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective</title>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Seminars in Cancer Biology</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Artificial intelligence in pancreatic cancer: diagnosis, limitations, and the future prospects-a narrative review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Katta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K R</forename><surname>Kalluru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Bavishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hameed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Valisekka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Cancer Research and Clinical Oncology</title>
		<imprint>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Machine learning applications in cancer prognosis and prediction</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kourou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Exarchos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Exarchos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Karamouzis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Fotiadis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computational and structural biotechnology journal</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="8" to="17" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Artificial intelligence (AI) and big data in cancer and precision oncology</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Dlamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Z</forename><surname>Francies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Marima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computational and structural biotechnology journal</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="2300" to="2311" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer cell international</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Advances in artificial intelligence to predict cancer immunotherapy efficacy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Immunology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">1076883</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Liquid biopsies: the future of cancer early detection</title>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of translational medicine</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">118</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Narrowing the gap: imaging disparities in radiology</title>
		<author>
			<persName><forename type="first">S</forename><surname>Waite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Colombo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="35" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Clinically applicable deep learning for diagnosis and referral in retinal disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">De</forename><surname>Fauw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1342" to="1350" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Artificial intelligence in digital pathology-new tools for diagnosis and precision oncology</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Schalper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Rimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Velcheti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Madabhushi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews Clinical oncology</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="703" to="715" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main">Human Action Recognition (HAR) Using Skeleton-based Spatial Temporal Relative Transformer Network: ST-RTR</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Alzanin</surname></persName>
		</author>
		<idno type="arXiv">arXiv:2410.23806</idno>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note type="report_type">arXiv preprint</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Artificial intelligence of things for smarter healthcare: a survey of advancements, challenges, and opportunities</title>
		<author>
			<persName><forename type="first">S</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Communications Surveys &amp; Tutorials</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main">The Future of Prevention and Treatment of Breast Cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Russo</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2021">2021</date>
			<publisher>Springer</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Global perceptions of women on breast cancer and barriers to screening</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mascara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Constantinou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Oncology Reports</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A hybrid deep learning model for effective segmentation and classification of lung nodules from CT images</title>
		<author>
			<persName><forename type="first">M</forename><surname>Murugesan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kaliannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Balraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Singaram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kaliannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Albert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Intelligent &amp; Fuzzy Systems</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="2667" to="2679" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Prostate cancer classification from ultrasound and MRI images using deep learning based Explainable Artificial Intelligence</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hassan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Future Generation Computer Systems</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="462" to="472" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Application of machine learning in CT images and X-rays of COVID-19 pneumonia</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicine</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">36</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Digital pathology and computational image analysis in nephropathology</title>
		<author>
			<persName><forename type="first">L</forename><surname>Barisoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Lafata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Madabhushi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">G</forename><surname>Balis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Nephrology</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="669" to="685" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Next-generation sequencing: insights to advance clinical investigations of the microbiome</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Wensel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Pluznick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Salzberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Sears</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of clinical investigation</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="issue">7</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Harnessing multimodal data integration to advance precision oncology</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Boehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Khosravi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vanguri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Cancer</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="114" to="126" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care</title>
		<author>
			<persName><forename type="first">C</forename><surname>Corti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Treatment Reviews</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page">102498</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Artificial intelligence-based multi-omics analysis fuels cancer precision medicine</title>
		<author>
			<persName><forename type="first">X</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jing</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Seminars in Cancer Biology</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2023">2023</date>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="187" to="200" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">A machine learning model identifies patients in need of autoimmune disease testing using electronic health records</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Forrest</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Communications</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">2385</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Artificial intelligence in clinical research of cancers</title>
		<author>
			<persName><forename type="first">D</forename><surname>Shao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Briefings in Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Artificial Intelligence Failure at IBM&apos;Watson for Oncology</title>
		<author>
			<persName><forename type="first">H</forename><surname>Faheem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dutta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IUP Journal of Knowledge Management</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="47" to="75" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title level="m" type="main">Can Artificial Intelligence Help See Cancer in New Ways</title>
		<author>
			<persName><forename type="first">N</forename><surname>Jaber</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2022">2022</date>
			<publisher>National Cancer Institute</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment</title>
		<author>
			<persName><forename type="first">S</forename><surname>Khalighi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Midya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Pandav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Madabhushi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abedalthagafi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NPJ Precision Oncology</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">80</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Extended multistream temporal-attention module for skeleton-based human action recognition (HAR)</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Akbar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ullah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computers in Human Behavior</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page">108482</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">High-dimensional role of AI and machine learning in cancer research</title>
		<author>
			<persName><forename type="first">E</forename><surname>Capobianco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British journal of cancer</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="523" to="532" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Predicting cancer outcomes with radiomics and artificial intelligence in radiology</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Braman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Velcheti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Madabhushi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Clinical Oncology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="132" to="146" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Recent advances in machine-learning-based chemoinformatics: a comprehensive review</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Niazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Mariam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Sciences</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page">11488</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">European cancer mortality predictions for the year 2023 with focus on lung cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Malvezzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of Oncology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="410" to="419" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</title>
		<author>
			<persName><forename type="first">S</forename><surname>Novello</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of Oncology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1" to="27" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Seminars in Cancer Biology</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="13" to="19" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Radiomics: the bridge between medical imaging and personalized medicine</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lambin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews Clinical oncology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="749" to="762" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Cloud computing for genomic data analysis and collaboration</title>
		<author>
			<persName><forename type="first">B</forename><surname>Langmead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nellore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Genetics</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="208" to="219" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">A five-gene signature and clinical outcome in non-small-cell lung cancer</title>
		<author>
			<persName><forename type="first">H.-Y</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="20" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Comparative mass spectrometrybased metabolomics strategies for the investigation of microbial secondary metabolites</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Covington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">O</forename><surname>Bachmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Natural product reports</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="6" to="24" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Similarity network fusion for aggregating data types on a genomic scale</title>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature methods</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="333" to="337" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<title level="m" type="main">Extended Multi-Stream Adaptive Graph Convolutional Networks (EMS-AAGCN) for Skeleton-Based Human Action Recognition</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Albinali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Razzaq</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Overview and comparative study of dimensionality reduction techniques for high dimensional data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ayesha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Hanif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Talib</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Information Fusion</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="44" to="58" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Gut microbiome, big data and machine learning to promote precision medicine for cancer</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cammarota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews gastroenterology &amp; hepatology</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="635" to="648" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Applications of machine learning in drug discovery and development</title>
		<author>
			<persName><forename type="first">J</forename><surname>Vamathevan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews Drug discovery</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="463" to="477" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Lung cancer LDCT screening and mortality reduction-evidence, pitfalls and future perspectives</title>
		<author>
			<persName><forename type="first">M</forename><surname>Oudkerk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Heuvelmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Field</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews Clinical oncology</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="135" to="151" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Rampinelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">bmj</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">A systematic survey of computer-aided diagnosis in medicine: Past and present developments</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yanase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Triantaphyllou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Systems with Applications</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page">112821</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Van Riel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">11</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>p. e0185032</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Reliable entity subtyping in non-small cell lung cancer by matrixassisted laser desorption/ionization imaging mass spectrometry on formalin-fixed paraffinembedded tissue specimens</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kriegsmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular &amp; Cellular Proteomics</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3081" to="3089" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">A review of lung cancer screening and the role of computer-aided detection</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Al</forename><surname>Mohammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mello-Thoms</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical radiology</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="433" to="442" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Machine learning for lung cancer diagnosis, treatment, and prognosis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proteomics &amp; Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="850" to="866" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Genomics</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">COVID-MTL: Multitask learning with Shift3D and random-weighted loss for COVID-19 diagnosis and severity assessment</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pattern Recognition</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page">108499</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Eye tracking based deep learning analysis for the early detection of diabetic retinopathy: A pilot study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedical Signal Processing and Control</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page">104830</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">LCSCNet: A multi-level approach for lung cancer stage classification using 3D dense convolutional neural networks with concurrent squeeze-andexcitation module</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tyagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Talbar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedical Signal Processing and Control</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page">104391</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Solid waste image classification using deep convolutional neural network</title>
		<author>
			<persName><forename type="first">N</forename><surname>Nnamoko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Barrowclough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Procter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infrastructures</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">47</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Texture appearance model, a new model-based segmentation paradigm, application on the segmentation of lung nodule in the CT scan of the chest</title>
		<author>
			<persName><forename type="first">F</forename><surname>Shariaty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Orooji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Velichko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Zavjalov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computers in biology and medicine</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page">105086</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Computational conformal geometric methods for vision</title>
		<author>
			<persName><forename type="first">N</forename><surname>Lei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-T</forename><surname>Yau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Handbook of Mathematical Models and Algorithms in Computer Vision and Imaging: Mathematical Imaging and Vision</title>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2023">2023</date>
			<biblScope unit="page" from="1739" to="1790" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Image classification of root-trimmed garlic using multi-label and multi-class classification with deep convolutional neural network</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T Q</forename><surname>Anh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Q</forename><surname>Thuyet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kobayashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Postharvest Biology and Technology</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page">111956</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Prior CT improves deep learning for malignancy risk estimation of screening-detected pulmonary nodules</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Venkadesh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">308</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2023">223308. 2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Deep residual learning for image recognition: A survey</title>
		<author>
			<persName><forename type="first">M</forename><surname>Shafiq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Applied Sciences</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page">8972</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">A heterogeneous two-stream network for human action recognition</title>
		<author>
			<persName><forename type="first">S</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AI Communications</title>
		<imprint>
			<biblScope unit="page" from="1" to="15" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="report_type">Preprint</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Sybil: A validated deep learning model to predict future lung cancer risk from a single low-dose chest computed tomography</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Mikhael</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Oncology</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2191" to="2200" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">mask R-CNN models</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hassan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>El-Rashidy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Talaa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nile Journal of Communication and Computer Science</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="17" to="27" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Modified U-Net for cytological medical image segmentation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Benazzouz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Benomar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Moualek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Imaging Systems and Technology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1761" to="1773" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Few-shot out-of-distribution detection for automated screening in retinal OCT images using deep learning</title>
		<author>
			<persName><forename type="first">T</forename><surname>Arajo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Aresta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schmidt-Erfurth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bogunovi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">16231</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Geospatial immune variability illuminates differential evolution of lung adenocarcinoma</title>
		<author>
			<persName><forename type="first">K</forename><surname>Abduljabbar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1054" to="1062" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Endocrinology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Separated channel attention convolutional neural network (SC-CNNattention) to identify ADHD in multi-site rs-fMRI dataset</title>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Entropy</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">893</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Performance of Lung-RADS in different target populations: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Mao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Radiology</title>
		<imprint>
			<biblScope unit="page" from="1" to="16" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Lung cancer screening with low-dose computed tomography: current status in Germany</title>
		<author>
			<persName><forename type="first">M</forename><surname>Reck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dettmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-U</forename><surname>Kauczor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kaaks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Reinmuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vogel-Claussen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Deutsches rzteblatt International</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page">387</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<author>
			<persName><forename type="first">F.-J</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">frontiers Frontiers in Oncology ORIGINAL RESEARCH published: 08</title>
		<imprint>
			<date type="published" when="2022-06">June 2022. 2023</date>
			<biblScope unit="page">22</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Golpon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Borlak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Translational Research</title>
		<imprint>
			<biblScope unit="volume">230</biblScope>
			<biblScope unit="page" from="164" to="196" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dhahbi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific reports</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">13323</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning</title>
		<author>
			<persName><forename type="first">N</forename><surname>Coudray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1559" to="1567" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Classification of distribution power grid structures using inception v3 deep neural network</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Stefenon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-C</forename><surname>Yow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nied</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Meyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Electrical Engineering</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="4557" to="4569" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">New controlled and unmonitored learning methods pulmonary and cancer progression characterisation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Deepa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhagyalakshmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rajalakshmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ishwarya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">AIP Conference Proceedings</title>
		<imprint>
			<publisher>AIP Publishing</publisher>
			<date type="published" when="2022">2022</date>
			<biblScope unit="volume">2519</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">PANTHER: pathway augmented nonnegative tensor factorization for HighER-order feature learning</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the AAAI conference on artificial intelligence</title>
		<meeting>the AAAI conference on artificial intelligence</meeting>
		<imprint>
			<date type="published" when="2021">2021</date>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="371" to="380" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">ScanMap: supervised confounding aware non-negative matrix factorization for polygenic risk modeling</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Machine learning for healthcare conference</title>
		<imprint>
			<publisher>PMLR</publisher>
			<date type="published" when="2020">2020</date>
			<biblScope unit="page" from="27" to="45" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">47</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>E6496-E6505</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Pan-cancer analysis of whole-genome doubling and its association with patient prognosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Kikutake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC cancer</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">619</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Probability of cancer in pulmonary nodules detected on first screening CT</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mcwilliams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="910" to="919" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Characterization of lung nodule malignancy using hybrid shape and appearance features</title>
		<author>
			<persName><forename type="first">M</forename><surname>Buty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Bagci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Mollura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Medical Image Computing and Computer-Assisted Intervention-MICCAI 2016: 19th International Conference</title>
		<meeting><address><addrLine>Athens, Greece</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2016">October 17-21, 2016. 2016</date>
			<biblScope unit="page" from="662" to="670" />
		</imprint>
	</monogr>
	<note>Proceedings, Part I 19</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Risk stratification of lung nodules using 3D CNN-based multi-task learning</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hussein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Bagci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Information Processing in Medical Imaging: 25th International Conference</title>
		<meeting><address><addrLine>Boone, NC, USA</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2017-06-25">2017. June 25-30, 2017. 2017</date>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="249" to="260" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">A collaborative computer aided diagnosis (C-CAD) system with eye-tracking, sparse attentional model, and deep learning</title>
		<author>
			<persName><forename type="first">N</forename><surname>Khosravan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Celik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Turkbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Bagci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical image analysis</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="101" to="115" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Automatic classification of pulmonary peri-fissural nodules in computed tomography using an ensemble of 2D views and a convolutional neural network out-ofthe-box</title>
		<author>
			<persName><forename type="first">F</forename><surname>Ciompi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical image analysis</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="195" to="202" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Deep learning for malignancy risk estimation of pulmonary nodules detected at low-dose screening CT</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Venkadesh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="438" to="447" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ardila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="954" to="961" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Using generative adversarial networks and parameter optimization of convolutional neural networks for lung tumor classification</title>
		<author>
			<persName><forename type="first">C.-H</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-H</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Applied Sciences</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">480</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">A hybrid framework for lung cancer classification</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Electronics</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">1614</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Detection and characterization of lung cancer using cell-free DNA fragmentomes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mathios</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature communications</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">5060</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Integrating genomic features for non-invasive early lung cancer detection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Chabon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">580</biblScope>
			<biblScope unit="issue">7802</biblScope>
			<biblScope unit="page" from="245" to="251" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)</title>
		<author>
			<persName><forename type="first">W</forename><surname>Liang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Theranostics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">2056</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Raman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Medicine</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Fully-connected neural networks with reduced parameterization for predicting histological types of lung cancer from somatic mutations</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bolatkan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shiina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hamamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomolecules</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">1249</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Whitney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC medical genomics</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Evaluation of machine learning algorithm utilization for lung cancer classification based on gene expression levels</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Podolsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Barchuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">I</forename><surname>Kuznetcov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Gusarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Gaidukov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Tarakanov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Asian Pacific journal of cancer prevention</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="835" to="838" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Medical Genomics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1" to="15" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Machine Learning Models for Classification of Lung Cancer and Selection of Genomic Markers Using Array Gene Expression Data</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Aliferis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tsamardinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Massion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Statnikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fananapazir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Hardin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">FLAIRS conference</title>
		<imprint>
			<date type="published" when="2003">2003</date>
			<biblScope unit="page" from="67" to="71" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Machine learning models for lung cancer classification using array comparative genomic hybridization</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Aliferis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hardin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Massion</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the AMIA Symposium</title>
		<meeting>the AMIA Symposium</meeting>
		<imprint>
			<publisher>American Medical Informatics Association</publisher>
			<date type="published" when="2002">2002</date>
			<biblScope unit="page">7</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<monogr>
		<title level="m" type="main">Supervised classification of array cgh data with hmm-based feature selection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Daemen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gevaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Leunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Legius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Vergote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">De</forename><surname>Moor</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009. 2009</date>
			<publisher>World Scientific</publisher>
			<biblScope unit="page" from="468" to="479" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases</title>
		<author>
			<persName><forename type="first">P</forename><surname>Jurmeister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science Translational Medicine</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">509</biblScope>
			<biblScope unit="page">8513</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">PD-1/PD-L1 blockade therapy in advanced non-small-cell lung cancer: current status and future directions</title>
		<author>
			<persName><forename type="first">L</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The oncologist</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="31" to="S41" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Immunotherapy in non-small cell lung cancer: facts and hopes</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Doroshow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="4592" to="4602" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Immunotherapy for non-small cell lung cancer: current landscape and future perspectives</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immune Network</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Applying artificial intelligence for cancer immunotherapy</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Pharmaceutica Sinica B</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3393" to="3405" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Machine learning reveals a PD-L1-independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wiesweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="76" to="85" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers</title>
		<author>
			<persName><forename type="first">S</forename><surname>Trebeschi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of Oncology</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="998" to="1004" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Radiomic phenotype features predict pathological response in nonsmall cell lung cancer</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Coroller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiotherapy and oncology</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="480" to="486" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Pathology: Clinical Research</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="327" to="339" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Oncology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1180" to="1191" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images</title>
		<author>
			<persName><forename type="first">J</forename><surname>Saltz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell reports</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="181" to="193" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Tumour-infiltrating lymphocytes: From prognosis to treatment selection</title>
		<author>
			<persName><forename type="first">K</forename><surname>Brummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Eerkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Bruyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Nijman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="451" to="458" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">GGNpTCR: A Generative Graph Structure Neural Network for Predicting Immunogenic Peptides for T-cell Immune Response</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Chemical Information and Modeling</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="7557" to="7567" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Predicting Binding Affinity Between MHC-I Receptor and Peptides Based on Molecular Docking and Protein-peptide Interaction Interface Characteristics</title>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ding</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Letters in Drug Design &amp; Discovery</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1982" to="1993" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Evaluating NetMHCpan performance on non-European HLA alleles not present in training data</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Atkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Solanki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vasmatzis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cornette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Riedel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Immunology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Neoantigens: promising targets for cancer therapy</title>
		<author>
			<persName><forename type="first">N</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Signal Transduction and Targeted Therapy</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">9</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Neoantigen load as a prognostic and predictive marker for stage II/III nonsmall cell lung cancer in Chinese patients</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thoracic Cancer</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2170" to="2181" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Keskin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">565</biblScope>
			<biblScope unit="issue">7738</biblScope>
			<biblScope unit="page" from="234" to="239" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF 09b, in patients with metastatic melanoma</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Mrk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncoimmunology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">2023255</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Three dimensional agricultural land modeling using unmanned aerial system (UAS)</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mahmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Raza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Khan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Advanced Computer Science and Applications</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Human action recognition of spatiotemporal parameters for skeleton sequences using MTLN feature learning framework</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Akbar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Alsanad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Electronics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page">2708</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Automatically human action recognition (HAR) with view variation from skeleton means of adaptive transformer network</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Akbar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Soft Computing</title>
		<imprint>
			<date type="published" when="2023">2023</date>
			<biblScope unit="page" from="1" to="20" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Learning the language of viral evolution and escape</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bryson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="issue">6526</biblScope>
			<biblScope unit="page" from="284" to="288" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">SubOmiEmbed: self-supervised representation learning of multi-omics data for cancer type classification</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hashim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nandakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yaqub</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">2022 10th International Conference on Bioinformatics and Computational Biology (ICBCB)</title>
		<imprint>
			<publisher>IEEE</publisher>
			<date type="published" when="2022">2022</date>
			<biblScope unit="page" from="66" to="72" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Exploring tissue architecture using spatial transcriptomics</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Barkley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Frana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Yanai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">596</biblScope>
			<biblScope unit="issue">7871</biblScope>
			<biblScope unit="page" from="211" to="220" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Using an unsupervised clustering model to detect the early spread of SARS-CoV-2 worldwide</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">648</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Molecular portraits of human breast tumours</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Perou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">nature</title>
		<imprint>
			<biblScope unit="volume">406</biblScope>
			<biblScope unit="issue">6797</biblScope>
			<biblScope unit="page" from="747" to="752" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Wagle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer statistics</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="17" to="48" />
			<date type="published" when="2023">2023. 2023</date>
		</imprint>
	</monogr>
	<note>Ca Cancer J Clin</note>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G O H F I B</forename><surname>Cancer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="issue">9328</biblScope>
			<biblScope unit="page" from="187" to="195" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Survival after breast cancer according to participation in organised or opportunistic screening and deprivation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Poiseuil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiology</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page">102312</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Contrast-enhanced breast imaging: Current status and future challenges</title>
		<author>
			<persName><forename type="first">T</forename><surname>Van Nijnatten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Radiology</title>
		<imprint>
			<biblScope unit="page">111312</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Audit of Prior Screening Mammograms of Screen-Detected Cancers: Implications for the Delay in Breast Cancer Detection</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Vijayargahavan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Seminars in Ultrasound, CT and MRI</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2023">2023</date>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="62" to="69" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Artificial intelligence for digital breast tomosynthesis: Impact on diagnostic performance, reading times, and workload in the era of personalized screening</title>
		<author>
			<persName><forename type="first">V</forename><surname>Magni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schiaffino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Colarieti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sardanelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Radiology</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page">110631</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<author>
			<persName><forename type="first">D</forename><surname>Dreizin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The American Society of Emergency Radiology (ASER) AI/ML expert panel: inception, mandate, work products, and goals</title>
		<imprint>
			<date type="published" when="2023">2023</date>
			<biblScope unit="page" from="1" to="5" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Fault recognition of large-size low-speed slewing bearing based on improved deep belief network</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Vibration and Control</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">11-12</biblScope>
			<biblScope unit="page" from="2829" to="2841" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach</title>
		<author>
			<persName><forename type="first">W</forename><surname>Lotter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="244" to="249" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Contrast-enhanced mammography in breast cancer screening</title>
		<author>
			<persName><forename type="first">K</forename><surname>Coffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Jochelson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Radiology</title>
		<imprint>
			<biblScope unit="page">110513</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Comprehensive quantitative evaluation of variability in magnetic resonance-guided delineation of oropharyngeal gross tumor volumes and high-risk clinical target volumes: an R-IDEAL stage 0 prospective study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Cardenas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Radiation Oncology* Biology* Physics</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="426" to="436" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Advances in automatic delineation of target volume and cardiac substructure in breast cancer radiotherapy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncology Letters</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rodriguez-Ruiz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JNCI: Journal of the National Cancer Institute</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="916" to="922" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Artificial intelligence in breast cancer screening: evaluation of FDA device regulation and future recommendations</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Potnis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aneja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Richman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Internal Medicine</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1306" to="1312" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">Improving mass discrimination in mammogram-CAD system using texture information and super-resolution reconstruction</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boudraa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Melouah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Merouani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Evolving Systems</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="697" to="706" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Freeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">bmj</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">A Review of Spectroscopic and Non-Spectroscopic Techniques for Diagnosing Breast Cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S J</forename><surname>Isabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sunitha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Arjunan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pesala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Medical Imaging</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="535" to="545" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">H&amp;E-adversarial network: a convolutional neural network to learn stain-invariant features through Hematoxylin &amp; Eosin regression</title>
		<author>
			<persName><forename type="first">N</forename><surname>Marini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Atzori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Otlora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marchand-Maillet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the IEEE/CVF International Conference on Computer Vision</title>
		<meeting>the IEEE/CVF International Conference on Computer Vision</meeting>
		<imprint>
			<date type="published" when="2021">2021</date>
			<biblScope unit="page" from="601" to="610" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Breast cancer diagnosis based on mammary thermography and extreme learning machines</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A D</forename><surname>Santana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Research on Biomedical Engineering</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="45" to="53" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">Breast cancer diagnosis using thermography and convolutional neural networks</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ekici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical hypotheses</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page">109542</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Texture features in the Shearlet domain for histopathological image classification</title>
		<author>
			<persName><forename type="first">S</forename><surname>Alinsaif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Medical Informatics and Decision Making</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1" to="19" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">Breast mass classification in sonography with transfer learning using a deep convolutional neural network and color conversion</title>
		<author>
			<persName><forename type="first">M</forename><surname>Byra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical physics</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="746" to="755" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">Computer-aided diagnosis for breast ultrasound using computerized BI-RADS features and machine learning methods</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Alam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Garra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ahmed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ultrasound in medicine &amp; biology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="980" to="988" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">Medical breast ultrasound image segmentation by machine learning</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Carson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ultrasonics</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">Classification of mammogram for early detection of breast cancer using SVM classifier and Hough transform</title>
		<author>
			<persName><forename type="first">R</forename><surname>Vijayarajeswari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Parthasarathy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vivekanandan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Basha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Measurement</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="800" to="805" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">The power laws: Zipf and inverse Zipf for automated segmentation and classification of masses within mammograms</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hamoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Merouani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Laimeche</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Evolving systems</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="209" to="227" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">A novel deep-learning model for automatic detection and classification of breast cancer using the transfer-learning technique</title>
		<author>
			<persName><forename type="first">A</forename><surname>Saber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sakr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Abo-Seida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Keshk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Access</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="71194" to="71209" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">Automatic region of interest segmentation for breast thermogram image classification</title>
		<author>
			<persName><forename type="first">D</forename><surname>Snchez-Ruiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Olmos-Pineda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Olvera-Lpez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pattern Recognition Letters</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="72" to="81" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">Deep-wavelet neural networks for breast cancer early diagnosis using mammary termographies</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>De Freitas Barbosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>De Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K S</forename><surname>Andrade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D C F</forename><surname>De Lima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Santos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Deep learning for data analytics</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2020">2020</date>
			<biblScope unit="page" from="99" to="124" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Microcalcification detection in mammography image using computer-aided detection based on convolutional neural network</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hakim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Prajitno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Soejoko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">AIP Conference Proceedings</title>
		<imprint>
			<publisher>AIP Publishing</publisher>
			<date type="published" when="2021">2021</date>
			<biblScope unit="volume">2346</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">Applications of artificial intelligence in prostate cancer imaging</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Baltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Clauser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Urology</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="416" to="423" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Colorectal cancer in northern Tanzania: increasing trends and late presentation present major challenges</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Herman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JCO Global Oncology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="375" to="381" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Chalya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World journal of surgical oncology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main">The rise of colorectal cancer in Asia: epidemiology, screening, and management</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Onyoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W.-F</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L.-C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-M</forename><surname>Chiu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current gastroenterology reports</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main">Laporan nasional riskesdas 2018</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Kemenkes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jakarta: Kemenkes RI</title>
		<imprint>
			<biblScope unit="page" from="154" to="166" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">The utility of digital anal rectal examinations in a public health screening program for anal cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Nyitray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Stier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Clifford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Chiao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of lower genital tract disease</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="192" to="196" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main">Faecal occult blood point-of-care tests</title>
		<author>
			<persName><forename type="first">B</forename><surname>Kocielniak-Merak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Radosavljevi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zajc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Tomasik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Gastrointestinal Cancer</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="402" to="405" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">Faecal occult blood testing for colorectal cancer screening: the past or the future</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Benton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Seaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Halloran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current gastroenterology reports</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main">Novel toilet paper-based point-of-care test for the rapid detection of fecal occult blood: Instrument validation study</title>
		<author>
			<persName><forename type="first">H.-Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Medical Internet Research</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">8</biblScope>
			<date type="published" when="2020">20261. 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<monogr>
		<title level="m" type="main">Recent advances in colorectal cancer screening</title>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="139" to="147" />
		</imprint>
	</monogr>
	<note>Chronic diseases and translational medicine</note>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">Long-term colorectal-cancer incidence and mortality after lower endoscopy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Nishihara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1095" to="1105" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b182">
	<analytic>
		<title level="a" type="main">Post-colonoscopy complications: a systematic review, time trends, and metaanalysis of population-based studies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Reumkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Rondagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Winkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Masclee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sanduleanu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Official journal of the American College of Gastroenterology| ACG</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1092" to="1101" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main">Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial</title>
		<author>
			<persName><forename type="first">W</forename><surname>Atkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<imprint>
			<biblScope unit="volume">389</biblScope>
			<biblScope unit="issue">10076</biblScope>
			<biblScope unit="page" from="1299" to="1311" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">Screening for colorectal cancer: US Preventive Services Task Force recommendation statement</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bibbins-Domingo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jama</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="2564" to="2575" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main">Multitarget stool DNA testing for colorectal-cancer screening</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Imperiale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">370</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1287" to="1297" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b186">
	<monogr>
		<title level="m" type="main">Challenge of Colorectal Screening in Developing Countries</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E R</forename><surname>Antara</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main">Advances in liquid biopsy approaches for early detection and monitoring of cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Babayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pantel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome medicine</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1" to="3" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b188">
	<analytic>
		<title level="a" type="main">Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Church</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="317" to="325" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b189">
	<analytic>
		<title level="a" type="main">Blood-based screening for colon cancer: a disruptive innovation or simply a disruption?</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Prasad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jama</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="2519" to="2520" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b190">
	<analytic>
		<title level="a" type="main">The Role of Artificial Intelligence in Colonoscopy</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Parsa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Byrne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Seminars in Colon and Rectal Surgery</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2024">2024</date>
			<biblScope unit="page">101007</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b191">
	<analytic>
		<title level="a" type="main">Application of artificial intelligence in diagnosis and treatment of colorectal cancer: A novel Prospect</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Qi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Medicine</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">1128084</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b192">
	<analytic>
		<title level="a" type="main">Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Su</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computers in biology and medicine</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page">105409</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b193">
	<analytic>
		<title level="a" type="main">Artificial intelligence and polyp detection in colonoscopy: Use of a single neural network to achieve rapid polyp localization for clinical use</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Fock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D W</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Ang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of gastroenterology and hepatology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3298" to="3307" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b194">
	<analytic>
		<title level="a" type="main">Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1813" to="1819" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b195">
	<analytic>
		<title level="a" type="main">Towards novel non-invasive colorectal cancer screening methods: a comprehensive review</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Neefs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hoeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peeters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Hal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">1820</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b196">
	<analytic>
		<title level="a" type="main">Artificial intelligence as the next step towards precision pathology</title>
		<author>
			<persName><forename type="first">B</forename><surname>Acs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rantalainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hartman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of internal medicine</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="62" to="81" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b197">
	<analytic>
		<title level="a" type="main">Artificial intelligence-based technology for semi-automated segmentation of rectal cancer using high-resolution MRI</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hamabe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e0269931</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b198">
	<analytic>
		<title level="a" type="main">Artificial intelligence based real-time microcirculation analysis system for laparoscopic colorectal surgery</title>
		<author>
			<persName><forename type="first">S.-H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-M</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-R</forename><surname>Baek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-M</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Son</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Journal of Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">44</biblScope>
			<biblScope unit="page">6945</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b199">
	<analytic>
		<title level="a" type="main">Comparison of robot-assisted surgery, laparoscopicassisted surgery, and open surgery for the treatment of colorectal cancer: a network metaanalysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicine</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">34</biblScope>
			<biblScope unit="page">e11817</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b200">
	<analytic>
		<title level="a" type="main">Optimising adjuvant chemotherapy for colorectal cancer</title>
		<author>
			<persName><forename type="first">H</forename><surname>Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">ELSEVIER INC 525 B STREET, STE 1900</title>
		<meeting><address><addrLine>SAN DIEGO, CA; USA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2022">2022</date>
			<biblScope unit="page" from="92101" to="94495" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b201">
	<analytic>
		<title level="a" type="main">Recent advances in targeted drug delivery systems for resistant colorectal cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sharifi-Azad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell International</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">196</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b202">
	<analytic>
		<title level="a" type="main">Clinical evaluation of computer-aided colorectal neoplasia detection using a novel endoscopic artificial intelligence: a single-center randomized controlled trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nakashima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestion</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="193" to="201" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b203">
	<analytic>
		<title level="a" type="main">Artificial intelligence-assisted colonoscopy for colorectal cancer screening: a multicenter randomized controlled trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="337" to="346" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b204">
	<analytic>
		<title level="a" type="main">Artificial intelligence empowers the second-observer strategy for colonoscopy: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology Report</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">81</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b205">
	<analytic>
		<title level="a" type="main">Evaluation of computer aided detection during colonoscopy in the community (AI-SEE): A multicenter randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Wei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Official journal of the American College of Gastroenterology| ACG</title>
		<imprint>
			<biblScope unit="page" from="10" to="14309" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b206">
	<analytic>
		<title level="a" type="main">Evaluation of a real-time computer-aided polyp detection system during screening colonoscopy: AI-DETECT study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">04</biblScope>
			<biblScope unit="page" from="313" to="319" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b207">
	<analytic>
		<title level="a" type="main">Usefulness of a novel computer-aided detection system for colorectal neoplasia: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Z</forename><surname>Gimeno-Garca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="528" to="536" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b208">
	<analytic>
		<title level="a" type="main">Artificial intelligence and colonoscopy experience: lessons from two randomised trials</title>
		<author>
			<persName><forename type="first">A</forename><surname>Repici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="757" to="765" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b209">
	<analytic>
		<title level="a" type="main">Efficacy of a computer-aided detection system in a fecal immunochemical test-based organized colorectal cancer screening program: a randomized controlled trial (AIFIT study)</title>
		<author>
			<persName><forename type="first">E</forename><surname>Rondonotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1171" to="1179" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b210">
	<analytic>
		<title level="a" type="main">Computer-aided detection improves adenomas per colonoscopy for screening and surveillance colonoscopy: a randomized trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Shaukat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="732" to="741" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b211">
	<analytic>
		<title level="a" type="main">Identification of tumor epithelium and stroma in tissue microarrays using texture analysis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostic pathology</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b212">
	<analytic>
		<title level="a" type="main">Artificial intelligence-assisted colonoscopy: a prospective, multicenter, randomized controlled trial of polyp detection</title>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer medicine</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="7184" to="7193" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b213">
	<analytic>
		<title level="a" type="main">The single-monitor trial: an embedded CADe system increased adenoma detection during colonoscopy: a prospective randomized study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Therapeutic Advances in Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">1756284820979165</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b214">
	<analytic>
		<title level="a" type="main">Artificial intelligence-assisted colonoscopy for detection of colon polyps: a prospective, randomized cohort study</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Gastrointestinal Surgery</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2011" to="2018" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b215">
	<analytic>
		<title level="a" type="main">Computer-based classification of small colorectal polyps by using narrowband imaging with optical magnification</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1354" to="1359" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b216">
	<analytic>
		<title level="a" type="main">Novel computer-aided diagnostic system for colorectal lesions by using endocytoscopy (with videos)</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Mori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="621" to="629" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b217">
	<analytic>
		<title level="a" type="main">Effectiveness of computer-aided diagnosis of colorectal lesions using novel software for magnifying narrow-band imaging: a pilot study</title>
		<author>
			<persName><forename type="first">N</forename><surname>Tamai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy international open</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">08</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>E690-E694</note>
</biblStruct>

<biblStruct xml:id="b218">
	<analytic>
		<title level="a" type="main">Preclinical promise and clinical challenges for innovative therapies targeting liver fibrogenesis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Addissouky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of Gastroenterology Research</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="14" to="23" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b219">
	<analytic>
		<title level="a" type="main">Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">X.-Q</forename><surname>Gong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">7710</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b220">
	<analytic>
		<title level="a" type="main">Three-dimensional multifrequency magnetic resonance elastography improves preoperative assessment of proliferative hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Insights into Imaging</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">89</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b221">
	<analytic>
		<title level="a" type="main">Artificial intelligence, machine learning, and deep learning in liver transplantation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bhat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rabindranath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Chara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Simonetto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of hepatology</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1216" to="1233" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b222">
	<analytic>
		<title level="a" type="main">Von Willebrand Factor as a biomarker for liver disease-an update</title>
		<author>
			<persName><forename type="first">A</forename><surname>Elhence</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical and Experimental Hepatology</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b223">
	<analytic>
		<title level="a" type="main">The role of artificial intelligence in the detection and implementation of biomarkers for hepatocellular carcinoma: outlook and opportunities</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mansur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">2928</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b224">
	<analytic>
		<title level="a" type="main">Hepatocellular carcinoma: current therapeutic algorithm for localized and advanced disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bavetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bronte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Giunta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Manu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Oncology</title>
		<imprint>
			<biblScope unit="volume">2022</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b225">
	<monogr>
		<title level="m" type="main">Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers</title>
		<author>
			<persName><forename type="first">D</forename><surname>Gabbia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">De</forename><surname>Martin</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2023">2023</date>
			<publisher>MDPI</publisher>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">9018</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b226">
	<analytic>
		<title level="a" type="main">Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Pharmacology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1150151</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b227">
	<analytic>
		<title level="a" type="main">Circulating biomarkers for the early diagnosis and management of hepatocellular carcinoma with potential application in resource-limited settings</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Truong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-H</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Dao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">676</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b228">
	<analytic>
		<title level="a" type="main">Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective</title>
		<author>
			<persName><forename type="first">T.-H</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-H</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T.-H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-M</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-J</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical and Molecular Hepatology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">230</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b229">
	<analytic>
		<title level="a" type="main">Novel biomarkers assist in detection of liver fibrosis in HCV patients</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Addissouky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A K</forename><surname>Megahed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>El Agroudy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E T El</forename><surname>Sayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M A</forename><surname>El-Torgoman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Egyptian Liver Journal</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1" to="5" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b230">
	<analytic>
		<title level="a" type="main">The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kopystecka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Patryn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leniewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Budzyska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kozio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Sciences</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">9342</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b231">
	<analytic>
		<title level="a" type="main">Molecular and functional imaging in cancertargeted therapy: current applications and future directions</title>
		<author>
			<persName><forename type="first">J.-W</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-Q</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G.-J</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Signal Transduction and Targeted Therapy</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">89</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b232">
	<analytic>
		<title level="a" type="main">Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms</title>
		<author>
			<persName><forename type="first">J.-L</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Cancer Research and Clinical Oncology</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="10161" to="10168" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b233">
	<analytic>
		<title level="a" type="main">Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learning</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Kucukkaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">7579</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b234">
	<analytic>
		<title level="a" type="main">Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study</title>
		<author>
			<persName><forename type="first">C</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Oncology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">1124069</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b235">
	<analytic>
		<title level="a" type="main">Multiparametric dynamic ultrasound approach for differential diagnosis of primary liver tumors</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Ainora</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Sciences</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">8548</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b236">
	<analytic>
		<title level="a" type="main">Can Modifications of LR-M Criteria Improve the Diagnostic Performance of Contrast-Enhanced Ultrasound LI-RADS for Small Hepatic Lesions up to 3 cm?</title>
		<author>
			<persName><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Ultrasound in Medicine</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2403" to="2413" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b237">
	<analytic>
		<title level="a" type="main">The Role of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Tuberous Vas Deferens Tuberculosis and Metastatic Inguinal Lymph Nodes</title>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">1762</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b238">
	<analytic>
		<title level="a" type="main">Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI-RADS and a Modified CEUS LI-RADS for HCC in Examinations Using Sonazoid</title>
		<author>
			<persName><forename type="first">W</forename><surname>Liao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Ultrasound in Medicine</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2501" to="2511" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b239">
	<analytic>
		<title level="a" type="main">Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bortot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mangogna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Di</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lorenzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stabile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ricci</surname></persName>
		</author>
		<author>
			<persName><surname>Biffi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Nanobiotechnology</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">155</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b240">
	<analytic>
		<title level="a" type="main">Clinical application and detection techniques of liquid biopsy in gastric cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b241">
	<analytic>
		<title level="a" type="main">The importance of detecting, quantifying, and characterizing exosomes as a new diagnostic/prognostic approach for tumor patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Logozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Orefice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Di Raimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mizzoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fais</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">2878</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b242">
	<analytic>
		<title level="a" type="main">Efficiency of alternative markers to assess liver fibrosis levels in viral hepatitis B patients</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Addissouky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>El Agroudy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>El-Torgoman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">El</forename><surname>Sayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ibrahim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedical Research</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b243">
	<analytic>
		<title level="a" type="main">An exceptional finding in an explanted liver: a case report of cirrhotomimetic hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Aby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Lou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">1181037</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b244">
	<analytic>
		<title level="a" type="main">Circulating biomarkers for early detection of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Beudeker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boonstra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Therapeutic advances in gastroenterology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">1756284820931734</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b245">
	<analytic>
		<title level="a" type="main">New advances in the diagnosis and management of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Heimbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bmj</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b246">
	<analytic>
		<title level="a" type="main">Validation of the updated hepatocellular carcinoma early detection screening algorithm in a community-based cohort of patients with cirrhosis of multiple etiologies</title>
		<author>
			<persName><forename type="first">N</forename><surname>Tayob</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1443" to="1450" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b247">
	<analytic>
		<title level="a" type="main">A novel blood-based panel of methylated DNA and protein markers for detection of early-stage hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Chalasani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2597" to="2605" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b248">
	<analytic>
		<title level="a" type="main">Liquid biopsy for early detection of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">I</forename><surname>Manea</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Medicine</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b249">
	<analytic>
		<title level="a" type="main">Application of artificial intelligence in a real-world research for predicting the risk of liver metastasis in T1 colorectal cancer</title>
		<author>
			<persName><forename type="first">T</forename><surname>Han</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell International</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">28</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b250">
	<analytic>
		<title level="a" type="main">Artificial intelligence in assessment of hepatocellular carcinoma treatment response</title>
		<author>
			<persName><forename type="first">B</forename><surname>Spieler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Abdominal Radiology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3660" to="3671" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b251">
	<analytic>
		<title level="a" type="main">Six application scenarios of artificial intelligence in the precise diagnosis and treatment of liver cancer</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Artificial Intelligence Review</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="5307" to="5346" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b252">
	<analytic>
		<title level="a" type="main">Artificial intelligence for hepatitis evaluation</title>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World journal of gastroenterology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">34</biblScope>
			<biblScope unit="page">5715</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b253">
	<analytic>
		<title level="a" type="main">Machine learning and AI in cancer prognosis, prediction, and treatment selection: a critical approach</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of multidisciplinary healthcare</title>
		<imprint>
			<biblScope unit="page" from="1779" to="1791" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b254">
	<analytic>
		<title level="a" type="main">Development and validation of a risk prediction model for incident liver cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Public Health</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">955287</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b255">
	<analytic>
		<title level="a" type="main">Artificial intelligence in the diagnosis and management of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tateishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yatomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Koike</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b256">
	<analytic>
		<title level="a" type="main">Increased cancer risk in autoimmune hepatitis: a Danish nationwide cohort study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jepsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Vilstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grnbaek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Official journal of the American College of Gastroenterology| ACG</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="129" to="137" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b257">
	<analytic>
		<title level="a" type="main">Artificial intelligence in medical imaging of the liver</title>
		<author>
			<persName><forename type="first">L.-Q</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World journal of gastroenterology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">672</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b258">
	<analytic>
		<title level="a" type="main">Artificial intelligence in liver ultrasound</title>
		<author>
			<persName><forename type="first">L.-L</forename><surname>Cao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World journal of gastroenterology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page">3398</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b259">
	<analytic>
		<title level="a" type="main">Development of an AI system for accurately diagnose hepatocellular carcinoma from computed tomography imaging data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1111" to="1121" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b260">
	<analytic>
		<title level="a" type="main">Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers</title>
		<author>
			<persName><forename type="first">J</forename><surname>Calderaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Kather</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1183" to="1193" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b261">
	<analytic>
		<title level="a" type="main">Assessing Artificial Intelligence Models to Diagnose and Differentiate Common Liver Carcinomas</title>
		<author>
			<persName><forename type="first">M</forename><surname>Thomas</surname></persName>
		</author>
		<idno>08. 30.22279347</idno>
	</analytic>
	<monogr>
		<title level="j">medRxiv</title>
		<imprint>
			<biblScope unit="page">2022</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b262">
	<analytic>
		<title level="a" type="main">Impact of a deep learning assistant on the histopathologic classification of liver cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kiani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NPJ digital medicine</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">23</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b263">
	<analytic>
		<title level="a" type="main">Liver cancer segmentation challenge</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical image analysis</title>
		<imprint>
			<biblScope unit="volume">2019</biblScope>
			<biblScope unit="page">101854</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note>PAIP</note>
</biblStruct>

<biblStruct xml:id="b264">
	<analytic>
		<title level="a" type="main">Predictors of Liver Cancer: a Review</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Sherifova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Parsadanyan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j"> </title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">230</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b265">
	<analytic>
		<title level="a" type="main">Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-Q</forename><surname>Che</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PeerJ</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e9021</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b266">
	<analytic>
		<title level="a" type="main">Potential biomarker detection for liver cancer stem cell by machine learning approach</title>
		<author>
			<persName><forename type="first">A</forename><surname>Farzane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Akbarzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ferdousi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rashidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Safdari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Contemp Med Sci|</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="306" to="312" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b267">
	<analytic>
		<title level="a" type="main">Mass Spectrometric multiplex detection of microRNA and protein biomarkers for liver cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lv</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Analytical Chemistry</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">49</biblScope>
			<biblScope unit="page" from="17248" to="17254" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b268">
	<analytic>
		<title level="a" type="main">Potential biomarkers for liver cancer diagnosis based on multi-omics strategy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Oncology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">822449</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b269">
	<analytic>
		<title level="a" type="main">An approach to the simultaneous detection of multiple biomarkers for the early diagnosis of liver cancer using quantum dot nanoprobes</title>
		<author>
			<persName><forename type="first">N</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infectious Microbes &amp; Diseases</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="40" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b270">
	<analytic>
		<title level="a" type="main">High-throughput proteomics and AI for cancer biomarker discovery</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Xiao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Advanced drug delivery reviews</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page">113844</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b271">
	<analytic>
		<title level="a" type="main">Hedgehog-like Bi 2 S 3 nanostructures: a novel composite soft template route to the synthesis and sensitive electrochemical immunoassay of the liver cancer biomarker</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemical Communications</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1766" to="1769" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b272">
	<analytic>
		<title level="a" type="main">Updating the clinical application of blood biomarkers and their algorithms in the diagnosis and surveillance of hepatocellular carcinoma: a critical review</title>
		<author>
			<persName><forename type="first">E</forename><surname>Shahini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pasculli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Solimando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tiribelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cozzolongo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Giannelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Sciences</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">4286</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b273">
	<analytic>
		<title level="a" type="main">Progress and prospects of biomarkers in primary liver cancer</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">X</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Oncology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="54" to="66" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b274">
	<analytic>
		<title level="a" type="main">Artificial intelligence models for the diagnosis and management of liver diseases</title>
		<author>
			<persName><forename type="first">N</forename><surname>Nishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kudo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ultrasonography</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">10</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b275">
	<analytic>
		<title level="a" type="main">Automatic detection of liver cancer using hybrid pre-trained models</title>
		<author>
			<persName><forename type="first">E</forename><surname>Othman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mahmoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dhahri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Abdulkader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mahmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ibrahim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sensors</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page">5429</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b276">
	<analytic>
		<title level="a" type="main">Establishment of a new non-invasive imaging prediction model for liver metastasis in colon cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American journal of cancer research</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">2482</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b277">
	<analytic>
		<title level="a" type="main">Accurate artificial intelligence method for abnormality detection of CT liver images</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dwarakanath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kathiravan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Murugesan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bharathiraja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vinoth</surname></persName>
		</author>
		<author>
			<persName><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Intelligent &amp; Fuzzy Systems</title>
		<imprint>
			<biblScope unit="page" from="1" to="16" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note type="report_type">Preprint</note>
</biblStruct>

<biblStruct xml:id="b278">
	<analytic>
		<title level="a" type="main">Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Lai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World journal of gastroenterology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">42</biblScope>
			<biblScope unit="page">6679</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b279">
	<analytic>
		<title level="a" type="main">Label-free liver tumor segmentation</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition</title>
		<meeting>the IEEE/CVF Conference on Computer Vision and Pattern Recognition</meeting>
		<imprint>
			<date type="published" when="2023">2023</date>
			<biblScope unit="page" from="7422" to="7432" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b280">
	<analytic>
		<title level="a" type="main">Cancer and ageing: a nexus at several levels</title>
		<author>
			<persName><forename type="first">L</forename><surname>Balducci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Ershler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Cancer</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="655" to="662" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b281">
	<analytic>
		<title level="a" type="main">Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020</title>
		<author>
			<persName><forename type="first">W</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-D</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-W</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W.-Q</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chinese medical journal</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">07</biblScope>
			<biblScope unit="page" from="783" to="791" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b282">
	<analytic>
		<title level="a" type="main">Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Machlowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Baj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sitarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maciejewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sitarz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International journal of molecular sciences</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">4012</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b283">
	<analytic>
		<title level="a" type="main">Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007)</title>
		<author>
			<persName><forename type="first">H</forename><surname>Katai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastric cancer</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="144" to="154" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b284">
	<analytic>
		<title level="a" type="main">Performance of different gastric cancer screening methods in Korea: a population-based study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">e50041</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b285">
	<analytic>
		<title level="a" type="main">Appearance of enhanced tissue features in narrow-band endoscopic imaging</title>
		<author>
			<persName><forename type="first">K</forename><surname>Gono</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of biomedical optics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="568" to="577" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b286">
	<analytic>
		<title level="a" type="main">Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention</title>
		<author>
			<persName><forename type="first">P</forename><surname>Correa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer research</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="6735" to="6740" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b287">
	<analytic>
		<title level="a" type="main">Helicobacter pylori infection and the development of gastric cancer</title>
		<author>
			<persName><forename type="first">N</forename><surname>Uemura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New England journal of medicine</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="784" to="789" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b288">
	<analytic>
		<title level="a" type="main">Gastric cancer screening using the serum pepsinogen test method</title>
		<author>
			<persName><forename type="first">K</forename><surname>Miki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastric cancer</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="245" to="253" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b289">
	<analytic>
		<title level="a" type="main">Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Urita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive diseases and sciences</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="795" to="801" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b290">
	<analytic>
		<title level="a" type="main">Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-&quot;ABC method</title>
		<author>
			<persName><forename type="first">K</forename><surname>Miki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the Japan Academy, Series B</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="405" to="414" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b291">
	<analytic>
		<title level="a" type="main">Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mizuno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive diseases and sciences</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="3132" to="3137" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b292">
	<analytic>
		<title level="a" type="main">Extracellular vesicle-based drug delivery systems for cancer treatment</title>
		<author>
			<persName><forename type="first">S</forename><surname>Walker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Theranostics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page">8001</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b293">
	<analytic>
		<title level="a" type="main">Shedding light on the cell biology of extracellular vesicles</title>
		<author>
			<persName><forename type="first">G</forename><surname>Van Niel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Angelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Raposo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews Molecular cell biology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="213" to="228" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b294">
	<analytic>
		<title level="a" type="main">Extracellular vesicle long non-coding RNAs and circular RNAs: Biology, functions and applications in cancer</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Letters</title>
		<imprint>
			<biblScope unit="volume">489</biblScope>
			<biblScope unit="page" from="111" to="120" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b295">
	<analytic>
		<title level="a" type="main">Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology</title>
		<author>
			<persName><forename type="first">W</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1" to="23" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b296">
	<analytic>
		<title level="a" type="main">Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer</title>
		<author>
			<persName><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of extracellular vesicles</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e12209</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b297">
	<analytic>
		<title level="a" type="main">Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell death &amp; disease</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">346</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b298">
	<analytic>
		<title level="a" type="main">Circulating tumour cell isolation, analysis and clinical application</title>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cellular Oncology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="533" to="544" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b299">
	<analytic>
		<title level="a" type="main">Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Moayyedi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bmj</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b300">
	<analytic>
		<title level="a" type="main">Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study</title>
		<author>
			<persName><forename type="first">M</forename><surname>awniczak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Journal of Gastroenterology: WJG</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page">7480</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b301">
	<analytic>
		<title level="a" type="main">Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1425" to="1432" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b302">
	<analytic>
		<title level="a" type="main">The relation between an esophageal cancer and associated cancers in adjacent organs</title>
		<author>
			<persName><forename type="first">H</forename><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wakita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yasumoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="101" to="105" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b303">
	<analytic>
		<title level="a" type="main">Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer</title>
		<author>
			<persName><forename type="first">Y.-J</forename><surname>Hsiao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Journal of Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page">2979</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b304">
	<analytic>
		<title level="a" type="main">The accuracy of artificial intelligence in the endoscopic diagnosis of early gastric cancer: pooled analysis study</title>
		<author>
			<persName><forename type="first">P.-C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-R</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-N</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-C</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of medical Internet research</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e27694</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b305">
	<analytic>
		<title level="a" type="main">Artificial intelligence in the imaging of gastric cancer: current applications and future direction</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Oncology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">631686</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b306">
	<analytic>
		<title level="a" type="main">Current treatment and recent progress in gastric cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Joshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Badgwell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA: a cancer journal for clinicians</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="264" to="279" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b307">
	<analytic>
		<title level="a" type="main">Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Dong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of oncology</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="912" to="920" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b308">
	<analytic>
		<title level="a" type="main">Dual-energy CT-based deep learning radiomics can improve lymph node metastasis risk prediction for gastric cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Radiology</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="2324" to="2333" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b309">
	<analytic>
		<title level="a" type="main">Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Surgery</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="542" to="549" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b310">
	<analytic>
		<title level="a" type="main">A deep learning risk prediction model for overall survival in patients with gastric cancer: A multicenter study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiotherapy and Oncology</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="73" to="80" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b311">
	<analytic>
		<title level="a" type="main">Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ono</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive Endoscopy</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="15" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b312">
	<analytic>
		<title level="a" type="main">Highly accurate artificial intelligence systems to predict the invasion depth of gastric cancer: efficacy of conventional white-light imaging, nonmagnifying narrow-band imaging, and indigo-carmine dye contrast imaging</title>
		<author>
			<persName><forename type="first">S</forename><surname>Nagao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="866" to="873" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b313">
	<analytic>
		<title level="a" type="main">Deep learning model for diagnosing gastric mucosal lesions using endoscopic images: development, validation, and method comparison</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Nam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal Endoscopy</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="258" to="268" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b314">
	<analytic>
		<title level="a" type="main">Application of convolutional neural network in the diagnosis of the invasion depth of gastric cancer based on conventional endoscopy</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="806" to="815" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b315">
	<analytic>
		<title level="a" type="main">Deep learning system compared with expert endoscopists in predicting early gastric cancer and its invasion depth and differentiation status (with videos)</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal Endoscopy</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="92" to="104" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b316">
	<analytic>
		<title level="a" type="main">Evaluation of the effects of an artificial intelligence system on endoscopy quality and preliminary testing of its performance in detecting early gastric cancer: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1199" to="1207" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b317">
	<analytic>
		<title level="a" type="main">Automated classification of gastric neoplasms in endoscopic images using a convolutional neural network</title>
		<author>
			<persName><forename type="first">B.-J</forename><surname>Cho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1121" to="1129" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b318">
	<analytic>
		<title level="a" type="main">Feedback from artificial intelligence improved the learning of junior endoscopists on histology prediction of gastric lesions</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Lui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy International Open</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">02</biblScope>
			<biblScope unit="page" from="139" to="E146" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b319">
	<analytic>
		<title level="a" type="main">Detecting early gastric cancer: Comparison between the diagnostic ability of convolutional neural networks and endoscopists</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ikenoyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive Endoscopy</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="141" to="150" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b320">
	<analytic>
		<title level="a" type="main">Performance of an artificial intelligence-based diagnostic support tool for early gastric cancers: Retrospective study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ishioka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive Endoscopy</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="483" to="491" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b321">
	<analytic>
		<title level="a" type="main">Imaging in local staging of gastric cancer: a systematic review</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Kwee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Kwee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of clinical oncology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2107" to="2116" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b322">
	<analytic>
		<title level="a" type="main">Application of artificial intelligence using a convolutional neural network for diagnosis of early gastric cancer based on magnifying endoscopy with narrowband imaging</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ueyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of gastroenterology and hepatology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="482" to="489" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b323">
	<analytic>
		<title level="a" type="main">Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature communications</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">4294</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b324">
	<analytic>
		<title level="a" type="main">Early diagnosis of gastric cancer based on deep learning combined with the spectral-spatial classification method</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedical optics express</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4999" to="5014" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b325">
	<analytic>
		<title level="a" type="main">Detection of frozen pork freshness by fluorescence hyperspectral image</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhuang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Food Engineering</title>
		<imprint>
			<biblScope unit="volume">316</biblScope>
			<biblScope unit="page">110840</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b326">
	<analytic>
		<title level="a" type="main">Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA: a cancer journal for clinicians</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="209" to="249" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b327">
	<analytic>
		<author>
			<persName><forename type="first">R</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Cancer incidence and mortality in China</title>
		<imprint>
			<date type="published" when="2016">2016. 2022</date>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1" to="9" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b328">
	<analytic>
		<title level="a" type="main">Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015</title>
		<author>
			<persName><forename type="first">C</forename><surname>Castro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of oncology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="283" to="290" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b329">
	<analytic>
		<title level="a" type="main">Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<imprint>
			<biblScope unit="volume">394</biblScope>
			<biblScope unit="issue">10204</biblScope>
			<biblScope unit="page" from="1145" to="1158" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b330">
	<analytic>
		<title level="a" type="main">Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015</title>
		<author>
			<persName><forename type="first">F</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer medicine</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1839" to="1847" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b331">
	<analytic>
		<title level="a" type="main">Surgical treatment of superficial esophageal cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tachibana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Langenbeck&apos;s Archives of Surgery</title>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="304" to="321" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b332">
	<analytic>
		<title level="a" type="main">Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yamashina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Official journal of the American College of Gastroenterology| ACG</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="544" to="551" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b333">
	<analytic>
		<title level="a" type="main">Effect of a deep learning-based automatic upper GI endoscopic reporting system: a randomized crossover study (with video)</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal Endoscopy</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="181" to="190" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b334">
	<analytic>
		<title level="a" type="main">Efficacy of digestive endoscope based on artificial intelligence system in diagnosing early esophageal carcinoma</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computational and Mathematical Methods in Medicine</title>
		<imprint>
			<biblScope unit="volume">2022</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b335">
	<analytic>
		<title level="a" type="main">Framework and metrics for the clinical use and implementation of artificial intelligence algorithms into endoscopy practice: Recommendations from the American Society for Gastrointestinal Endoscopy Artificial Intelligence Task Force</title>
		<author>
			<persName><forename type="first">S</forename><surname>Parasa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Repici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Berzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Leggett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sharma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="815" to="824" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b336">
	<analytic>
		<title level="a" type="main">Deep learning-based clinical decision support system for gastric neoplasms in real-time endoscopy: development and validation study</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Gong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b337">
	<analytic>
		<title level="a" type="main">China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)</title>
		<author>
			<persName><forename type="first">J</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Zhonghua Zhong liu za zhi</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="491" to="522" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Chinese Journal of Oncology</note>
</biblStruct>

<biblStruct xml:id="b338">
	<analytic>
		<title level="a" type="main">Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial</title>
		<author>
			<persName><forename type="first">Z</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="198" to="206" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b339">
	<analytic>
		<title level="a" type="main">Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H A</forename><surname>Morita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC cancer</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b340">
	<analytic>
		<title level="a" type="main">Screening for esophageal squamous cell carcinoma: recent advances</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Codipilly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="413" to="426" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b341">
	<analytic>
		<title level="a" type="main">Probe-based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist-blinded study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kollar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">United European Gastroenterology Journal</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="436" to="443" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b342">
	<analytic>
		<title level="a" type="main">Real-time automated diagnosis of precancerous lesions and early esophageal squamous cell carcinoma using a deep learning model (with videos)</title>
		<author>
			<persName><forename type="first">L</forename><surname>Guo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="41" to="51" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b343">
	<analytic>
		<title level="a" type="main">Comparison of performances of artificial intelligence versus expert endoscopists for real-time assisted diagnosis of esophageal squamous cell carcinoma (with video)</title>
		<author>
			<persName><forename type="first">H</forename><surname>Fukuda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal Endoscopy</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="848" to="855" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b344">
	<analytic>
		<title level="a" type="main">Utility of an artificial intelligence system for classification of esophageal lesions when simulating its clinical use</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tajiri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">6677</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b345">
	<analytic>
		<title level="a" type="main">Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistance</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shiroma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">7759</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b346">
	<analytic>
		<title level="a" type="main">Artificial intelligence for detecting and delineating a small flat-type early esophageal squamous cell carcinoma under multimodal imaging</title>
		<author>
			<persName><forename type="first">X</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note>S 01, pp. E141-E142</note>
</biblStruct>

<biblStruct xml:id="b347">
	<analytic>
		<title level="a" type="main">Artificial intelligence for the real-time classification of intrapapillary capillary loop patterns in the endoscopic diagnosis of early oesophageal squamous cell carcinoma: A proof-of-concept study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Everson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">United European gastroenterology journal</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="297" to="306" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b348">
	<analytic>
		<title level="a" type="main">Computer-assisted diagnosis of early esophageal squamous cell carcinoma using narrow-band imaging magnifying endoscopy</title>
		<author>
			<persName><forename type="first">Y.-Y</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">04</biblScope>
			<biblScope unit="page" from="333" to="341" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b349">
	<analytic>
		<title level="a" type="main">Classification for invasion depth of esophageal squamous cell carcinoma using a deep neural network compared with experienced endoscopists</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nakagawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="407" to="414" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b350">
	<analytic>
		<title level="a" type="main">Using a deep learning system in endoscopy for screening of early esophageal squamous cell carcinoma (with video)</title>
		<author>
			<persName><forename type="first">S.-L</forename><surname>Cai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="745" to="753" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b351">
	<analytic>
		<title level="a" type="main">Endoscopic detection and differentiation of esophageal lesions using a deep neural network</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ohmori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="301" to="309" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b352">
	<analytic>
		<title level="a" type="main">Application of artificial intelligence using convolutional neural networks in determining the invasion depth of esophageal squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Tokai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Esophagus</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="250" to="256" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b353">
	<analytic>
		<title level="a" type="main">Real-time assessment of video images for esophageal squamous cell carcinoma invasion depth using artificial intelligence</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1037" to="1045" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b354">
	<analytic>
		<title level="a" type="main">A clinically interpretable convolutional neural network for the realtime prediction of early squamous cell cancer of the esophagus: comparing diagnostic performance with a panel of expert European and Asian endoscopists</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Everson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal Endoscopy</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="273" to="281" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b355">
	<analytic>
		<title level="a" type="main">A novel deep learning system for diagnosing early esophageal squamous cell carcinoma: A multicenter diagnostic study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Tang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical and translational gastroenterology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">8</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b356">
	<analytic>
		<title level="a" type="main">Artificial intelligence diagnostic system predicts multiple Lugolvoiding lesions in the esophagus and patients at high risk for esophageal squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ikenoyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1105" to="1113" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b357">
	<analytic>
		<title level="a" type="main">Real-time artificial intelligence for endoscopic diagnosis of early esophageal squamous cell cancer (with video)</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">X</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive Endoscopy</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1075" to="1084" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b358">
	<analytic>
		<title level="a" type="main">Use of a convolutional neural network for classifying microvessels of superficial esophageal squamous cell carcinomas</title>
		<author>
			<persName><forename type="first">R</forename><surname>Uema</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2239" to="2246" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b359">
	<analytic>
		<title level="a" type="main">Usefulness of an artificial intelligence system for the detection of esophageal squamous cell carcinoma evaluated with videos simulating overlooking situation</title>
		<author>
			<persName><forename type="first">K</forename><surname>Waki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive Endoscopy</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1101" to="1109" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b360">
	<analytic>
		<title level="a" type="main">Endoscopic images by a single-shot multibox detector for the identification of early cancerous lesions in the esophagus: A pilot study</title>
		<author>
			<persName><forename type="first">Y.-K</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">321</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b361">
	<analytic>
		<title level="a" type="main">Comparative study on artificial intelligence systems for detecting early esophageal squamous cell carcinoma between narrow-band and white-light imaging</title>
		<author>
			<persName><forename type="first">B</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Journal of Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">281</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b362">
	<analytic>
		<title level="a" type="main">Artificial intelligence for detecting superficial esophageal squamous cell carcinoma under multiple endoscopic imaging modalities: a multicenter study</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="169" to="178" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b363">
	<analytic>
		<title level="a" type="main">Artificial intelligence for diagnosing microvessels of precancerous lesions and superficial esophageal squamous cell carcinomas: a multicenter study</title>
		<author>
			<persName><forename type="first">X.-L</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Surgical Endoscopy</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="8651" to="8662" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b364">
	<analytic>
		<title level="a" type="main">Artificial intelligence for detecting and delineating margins of early ESCC under WLI endoscopy</title>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical and Translational Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b365">
	<analytic>
		<title level="a" type="main"> YOLOv51  </title>
		<author>
			<persName><surname></surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chinese Journal of Oncology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">5</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>Zhonghua Zhongliu Zazhi</note>
</biblStruct>

<biblStruct xml:id="b366">
	<analytic>
		<title level="a" type="main">Artificial intelligence for detecting and delineating the extent of superficial esophageal squamous cell carcinoma and precancerous lesions under narrowband imaging (with video)</title>
		<author>
			<persName><forename type="first">X.-L</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal Endoscopy</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="664" to="672" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b367">
	<analytic>
		<title level="a" type="main">Development and validation of a serum biomarker panel for the detection of esophageal squamous cell carcinoma through RNA transcriptome sequencing</title>
		<author>
			<persName><forename type="first">S</forename><surname>Xing</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">2346</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b368">
	<analytic>
		<title level="a" type="main">Identification of novel circulating miRNA biomarkers for the diagnosis of esophageal squamous cell carcinoma and squamous dysplasia</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomarkers &amp; Prevention</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1212" to="1220" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note>Cancer Epidemiology</note>
</biblStruct>

<biblStruct xml:id="b369">
	<analytic>
		<title level="a" type="main">Dynamic changes in microRNA expression profiles reflect progression of Barrett&apos;s esophagus to esophageal adenocarcinoma</title>
		<author>
			<persName><forename type="first">O</forename><surname>Slaby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="521" to="527" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b370">
	<analytic>
		<title level="a" type="main">Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative</title>
		<author>
			<persName><forename type="first">D</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The lancet global health</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="197" to="e206" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b371">
	<analytic>
		<title level="a" type="main">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</title>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Soerjomataram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA: a cancer journal for clinicians</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="394" to="424" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b372">
	<analytic>
		<title level="a" type="main">Ant colony optimization-enabled CNN deep learning technique for accurate detection of cervical cancer</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kavitha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BioMed Research International</title>
		<imprint>
			<biblScope unit="volume">2023</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b373">
	<analytic>
		<title level="a" type="main">Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Arbyn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Global Health</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="191" to="e203" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b374">
	<analytic>
		<title level="a" type="main">Incidence and mortality of cervical cancer in China in 2015</title>
		<author>
			<persName><forename type="first">X</forename><surname>Gu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the National Cancer Center</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="70" to="77" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b375">
	<analytic>
		<title level="a" type="main">miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Doghish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathology-Research and Practice</title>
		<imprint>
			<biblScope unit="volume">244</biblScope>
			<biblScope unit="page">154386</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b376">
	<analytic>
		<title level="a" type="main">What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Gynecologic Cancer</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b377">
	<analytic>
		<title level="a" type="main">Molecular differences between squamous cell carcinoma and adenocarcinoma cervical cancer subtypes: potential prognostic biomarkers</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Campos-Parra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Oncology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="4689" to="4702" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b378">
	<analytic>
		<title level="a" type="main">Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hartwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Syrjnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dominiak-Felden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brotons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Castellsagu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC cancer</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b379">
	<analytic>
		<title level="a" type="main">Dose-risk relationships between cigarette smoking and cervical cancer: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Malevolti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer Prevention</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="171" to="183" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b380">
	<analytic>
		<title level="a" type="main">Incidence, mortality and risk factors of cervical cancer in the world</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Momenimovahed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Salehiniya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedical Research and Therapy</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1795" to="1811" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b381">
	<analytic>
		<title level="a" type="main">Cervical Cancer Detection Techniques: A Chronological Review</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Mustafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ismail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Mokhtar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Alquran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Al-Issa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">1763</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b382">
	<analytic>
		<title level="a" type="main">Estimates of the global burden of cervical cancer associated with HIV</title>
		<author>
			<persName><forename type="first">D</forename><surname>Stelzle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The lancet global health</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="161" to="e169" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b383">
	<analytic>
		<title level="a" type="main">Cervical cancer: a global health crisis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Small</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="2404" to="2412" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b384">
	<analytic>
		<title level="a" type="main">Screening for cervical cancer: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Peirson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fitzpatrick-Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ciliska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Warren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Systematic reviews</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b385">
	<analytic>
		<title level="a" type="main">Diagnostic Accuracy of Magnetic Resonance Imaging in the Pre-Operative Staging of Cervical Cancer Patients Who Underwent Neoadjuvant Treatment: A Clinical-Surgical-Pathologic Comparison</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ditto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">2061</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b386">
	<analytic>
		<title level="a" type="main">Cytologic features of gynecologic germ cell tumors and carcinomas exhibiting germ cell tumor differentiation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hodgson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Murali</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cytopathology</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="254" to="261" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b387">
	<analytic>
		<title level="a" type="main">A comparison of conventional Pap smear and liquid-based cytology for cervical cancer screening</title>
		<author>
			<persName><forename type="first">N</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bavikar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Buch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kulkarni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dharwadkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Viswanathan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gynecology and Minimally Invasive Therapy</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="77" to="82" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b388">
	<analytic>
		<title level="a" type="main">Interobserver reproducibility with LiquiPrep liquid-based cervical cytology screening in a developing country</title>
		<author>
			<persName><forename type="first">J</forename><surname>Settakorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Asian Pac J Cancer Prev</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="92" to="96" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b389">
	<analytic>
		<title level="a" type="main">Clinical utility of Liqui-PREP cytology system for primary cervical cancer screening in a large urban hospital setting in China</title>
		<author>
			<persName><forename type="first">H</forename><surname>Deshou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Changhua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Qinyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of cytology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="20" to="25" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b390">
	<analytic>
		<title level="a" type="main">Comparative evaluation of conventional cytology and a low-cost liquid-based cytology technique, EziPREP, for cervicovaginal smear reporting: A split sample study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yadav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sharda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mehrotra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gupta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytojournal</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b391">
	<analytic>
		<title level="a" type="main">MRI is more valuable than CT in the diagnosis of cervical cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Translational Research</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">2970</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b392">
	<analytic>
		<title level="a" type="main">Global elimination of cervical cancer as a public health problem</title>
		<author>
			<persName><forename type="first">M</forename><surname>Brisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Drolet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Oncology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="319" to="321" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b393">
	<analytic>
		<title level="a" type="main">Diagnostic yield and agreement on fine-needle specimens from solid pancreatic lesions: comparing the smear technique to liquid-based cytology</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Van Riet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endoscopy International Open</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">02</biblScope>
			<biblScope unit="page" from="155" to="E162" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b394">
	<analytic>
		<title level="a" type="main">Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Torigian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hellenic journal of nuclear medicine</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="254" to="268" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b395">
	<analytic>
		<title level="a" type="main">Survival effect of pre-RT PET-CT on cervical cancer: Image-guided intensity-modulated radiation therapy era</title>
		<author>
			<persName><forename type="first">C.-H</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W.-M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B.-C</forename><surname>Shia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-Y</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Oncology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">1012491</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b396">
	<analytic>
		<title level="a" type="main">Antitumor immune cycle proteins and HPV status in patients with HSIL and cervical cancer</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Kayukova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Belokrinitskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Romanyuk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gynecology</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="525" to="528" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b397">
	<analytic>
		<title level="a" type="main">Prevention strategies and early diagnosis of cervical cancer: current state and prospects</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">V</forename><surname>Kakotkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Semina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Zadorkina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Agapov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">610</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b398">
	<analytic>
		<title level="a" type="main">The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: a population-based cohort study of 0.7 million women</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer medicine</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="6896" to="6906" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b399">
	<analytic>
		<title level="a" type="main">Artificial intelligence for cervical precancer screening</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rubin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jama</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="734" to="734" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b400">
	<analytic>
		<title level="a" type="main">Artificial intelligence in cervical cancer screening and diagnosis</title>
		<author>
			<persName><forename type="first">X</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in oncology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">851367</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b401">
	<analytic>
		<title level="a" type="main">An overview of cervical cancer epidemiology and prevention in the Baltic States</title>
		<author>
			<persName><forename type="first">U</forename><surname>Kojalo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">660</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b402">
	<monogr>
		<title level="m" type="main">Thyroid Knowledge Based System</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Salman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Abu-Naser</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b403">
	<analytic>
		<title level="a" type="main">Overview of the 2022 WHO classification of thyroid neoplasms</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">W</forename><surname>Baloch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrine pathology</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="63" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b404">
	<analytic>
		<title level="a" type="main">A review on ultrasound-based thyroid cancer tissue characterization and automated classification</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">R</forename><surname>Acharya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Technology in cancer research &amp; treatment</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="289" to="301" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b405">
	<analytic>
		<title level="a" type="main">A multi-channel deep convolutional neural network for multi-classifying thyroid diseases</title>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computers in Biology and Medicine</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page">105961</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b406">
	<monogr>
		<title level="m" type="main">Cancer Facts &amp; Figures 2022</title>
		<author>
			<persName><forename type="first">A</forename><surname>Acs</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2022">2022</date>
			<publisher>American Cancer Society</publisher>
			<pubPlace>Atlanta</pubPlace>
		</imprint>
		<respStmt>
			<orgName>National Home Office</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b407">
	<analytic>
		<title level="a" type="main">Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">N</forename><surname>Zong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer communications</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b408">
	<analytic>
		<title level="a" type="main">Vitamin D receptor expression and its clinical significance in papillary thyroid cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Koo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-H</forename><surname>Nam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Technology in Cancer Research &amp; Treatment</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">15330338221089933</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b409">
	<analytic>
		<title level="a" type="main">Radiation-induced thyroid cancers: Overview of molecular signatures</title>
		<author>
			<persName><forename type="first">K</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Saenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yamashita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mitsutake</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">1290</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b410">
	<analytic>
		<title level="a" type="main">Weighty Matters: The Obesity-Thyroid Nodule Connection Unveiling the Impact of Obesity on Thyroid Cancer Risk</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Alqahtani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Altalhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Alalawi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Alfattani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Al-Sobhi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicina</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">1658</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b411">
	<analytic>
		<title level="a" type="main">Association of obesity and diabetes with thyroid nodules</title>
		<author>
			<persName><forename type="first">S</forename><surname>Buscemi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrine</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="339" to="347" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b412">
	<analytic>
		<title level="a" type="main">Association between iodine intake, thyroid function, and papillary thyroid cancer: A case-control study</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D.-W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology and Metabolism</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="790" to="799" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b413">
	<analytic>
		<title level="a" type="main">Cigarette smoking and thyroid cancer risk: a cohort study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ryu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British journal of cancer</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="638" to="645" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b414">
	<analytic>
		<title level="a" type="main">Bethesda thyroid categories and family history of thyroid disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stanii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Matea</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical endocrinology</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="468" to="472" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b415">
	<analytic>
		<title level="a" type="main">A systematic assessment of numerical association rule mining methods</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kaushik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Peious</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shahin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Yahia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Draheim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">SN Computer Science</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">348</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b416">
	<analytic>
		<title level="a" type="main">The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualization</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Dudov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC genomics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b417">
	<analytic>
		<title level="a" type="main">Genomics data sharing</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kumuthini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Genomic Data Sharing</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2023">2023</date>
			<biblScope unit="page" from="111" to="135" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b418">
	<analytic>
		<title level="a" type="main">Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Wirth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Oncologist</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="565" to="572" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b419">
	<analytic>
		<title level="a" type="main">A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients</title>
		<author>
			<persName><forename type="first">N</forename><surname>Fukuda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrine</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="70" to="77" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b420">
	<analytic>
		<title level="a" type="main">Impact of imaging cross-section on visualization of thyroid microvessels using ultrasound: Pilot study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Nayak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nawar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fatemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alizad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific reports</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">415</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b421">
	<analytic>
		<title level="a" type="main">Automated segmentation of thyroid nodule, gland, and cystic components from ultrasound images using deep learning</title>
		<author>
			<persName><forename type="first">V</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ieee Access</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="63482" to="63496" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b422">
	<analytic>
		<title level="a" type="main">Thyroid nodule segmentation and classification in ultrasound images through intra-and inter-task consistent learning</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical image analysis</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page">102443</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b423">
	<analytic>
		<title level="a" type="main">Survivability prediction for patients with tonsil cancer utilizing machine learning algorithms</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Nobin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Alam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">2022 2nd International Conference on Intelligent Cybernetics Technology &amp; Applications (ICICyTA)</title>
		<imprint>
			<publisher>IEEE</publisher>
			<date type="published" when="2022">2022</date>
			<biblScope unit="page" from="210" to="215" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b424">
	<analytic>
		<title level="a" type="main">Comparison of the cox regression to machine learning in predicting the survival of anaplastic thyroid carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Endocrine Disorders</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">129</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b425">
	<analytic>
		<title level="a" type="main">Machine learning for risk stratification of thyroid cancer patients: a 15-year cohort study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Borzooei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Briganti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Golparian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lechien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarokhian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Archives of Oto-Rhino-Laryngology</title>
		<imprint>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b426">
	<analytic>
		<title level="a" type="main">Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yokota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Surgical Research</title>
		<imprint>
			<biblScope unit="volume">246</biblScope>
			<biblScope unit="page" from="535" to="543" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b427">
	<analytic>
		<title level="a" type="main">Incidence and prognosis of thyroid cancer in children: based on the SEER database</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Shang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatric Surgery International</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="445" to="456" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b428">
	<monogr>
		<title level="m" type="main">Determinanten des Therapieerfolgs bei Radiojodtherapie der multifokalen und disseminierten Autonomie der Schilddrse</title>
		<author>
			<persName><forename type="first">D</forename><surname>Nalbach</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b429">
	<analytic>
		<title level="a" type="main">An Intelligent Disease Prediction and Drug Recommendation Prototype by Using Multiple Approaches of Machine Learning Algorithms</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Nayak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Garanayak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Swain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Panda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Godavarthi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Access</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b430">
	<analytic>
		<title level="a" type="main">Machine learning-based prediction of 1-year mortality for acute coronary syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hadanny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of cardiology</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="342" to="351" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b431">
	<analytic>
		<title level="a" type="main">Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand?</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sollini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kirienko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European journal of radiology</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b432">
	<analytic>
		<title level="a" type="main">Automatic thyroid nodule recognition and diagnosis in ultrasound imaging with the YOLOv2 neural network</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World journal of surgical oncology</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b433">
	<analytic>
		<title level="a" type="main">Comparison between linear and nonlinear machine-learning algorithms for the classification of thyroid nodules</title>
		<author>
			<persName><forename type="first">F.-S</forename><surname>Ouyang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European journal of radiology</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="251" to="257" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b434">
	<analytic>
		<title level="a" type="main">Digital medicine in thyroidology: a new era of managing thyroid disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Steinhubl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology and Metabolism</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="124" to="131" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b435">
	<analytic>
		<title level="a" type="main">Evaluation of a deep learning-based computer-aided diagnosis system for distinguishing benign from malignant thyroid nodules in ultrasound images</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical Physics</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="3952" to="3960" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b436">
	<analytic>
		<title level="a" type="main">A method of ultrasonic image recognition for thyroid papillary carcinoma based on deep convolution neural network</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroQuantology</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">5</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b437">
	<analytic>
		<title level="a" type="main">Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Oncology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="193" to="201" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b438">
	<analytic>
		<title level="a" type="main">Computer-aided diagnosis systems in diagnosing malignant thyroid nodules on ultrasonography: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Thyroid Journal</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="186" to="193" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b439">
	<analytic>
		<title level="a" type="main">Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yoon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">e0242806</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b440">
	<analytic>
		<title level="a" type="main">Classification of thyroid nodules with stacked denoising sparse autoencoder</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Endocrinology</title>
		<imprint>
			<biblScope unit="volume">2020</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b441">
	<analytic>
		<title level="a" type="main">Deep convolutional neural network for the diagnosis of thyroid nodules on ultrasound</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Ko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Head &amp; neck</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="885" to="891" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b442">
	<analytic>
		<title level="a" type="main">Automatic disease annotation from radiology reports using artificial intelligence implemented by a recurrent neural network</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Roentgenology</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="734" to="740" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b443">
	<analytic>
		<title level="a" type="main">Comparison of the particle swarm optimization with the genetic algorithms as a training for multilayer perceptron technique to diagnose thyroid functional disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sharifi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alizadeh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Shiraz E-Medical Journal</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b444">
	<analytic>
		<title level="a" type="main">Recommendation of food items for thyroid patients using content-based KNN method</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Vairale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shukla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Data Science and Security: Proceedings of IDSCS 2020</title>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2021">2021</date>
			<biblScope unit="page" from="71" to="77" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b445">
	<analytic>
		<title level="a" type="main">Diagnosis of thyroid neoplasm using support vector machine algorithms based on platelet RNA-seq</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrine</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="758" to="783" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b446">
	<analytic>
		<title level="a" type="main">Machine learning algorithms for the prediction of central lymph node metastasis in patients with papillary thyroid cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in endocrinology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">577537</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b447">
	<analytic>
		<title level="a" type="main">Factors associated with physicians&apos; recommendations for managing low-risk papillary thyroid cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Mcdow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Surgery</title>
		<imprint>
			<biblScope unit="volume">222</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="111" to="118" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b448">
	<analytic>
		<title level="a" type="main">ARB: Knowledge Discovery and Disease Diagnosis on Thyroid Disease Diagnosis integrating Association Rule with Bagging Algorithm</title>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Engineering Letters</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b449">
	<analytic>
		<title level="a" type="main">Thyroid diseases forecasting using a hybrid decision support system based on ANFIS, k-NN and information gain method</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iqbal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saeed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Environ Biol Sci</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="78" to="85" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b450">
	<analytic>
		<title level="a" type="main">Classification of thyroid ultrasound images based on shape features analysis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Nugroho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nugroho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Frannita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ardiyanto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">2017 10th Biomedical Engineering International Conference</title>
		<imprint>
			<publisher>IEEE</publisher>
			<date type="published" when="2017">2017</date>
			<biblScope unit="page" from="1" to="5" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b451">
	<analytic>
		<title level="a" type="main">Machine learning and feature selection applied to SEER data to reliably assess thyroid cancer prognosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mourad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific reports</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">5176</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b452">
	<analytic>
		<title level="a" type="main">Rapid identification of papillary thyroid carcinoma and papillary microcarcinoma based on serum Raman spectroscopy combined with machine learning models</title>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Photodiagnosis and Photodynamic Therapy</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page">102647</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b453">
	<analytic>
		<title level="a" type="main">ThyroScreen system: high resolution ultrasound thyroid image characterization into benign and malignant classes using novel combination of texture and discrete wavelet transform</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">R</forename><surname>Acharya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Faust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Sree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Molinari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Suri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computer methods and programs in biomedicine</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="233" to="241" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b454">
	<analytic>
		<title level="a" type="main">Computer aided diagnosis for thyroid cancer system based on internal and external characteristics</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Nugroho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Frannita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ardiyanto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Choridah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of King Saud University-Computer and Information Sciences</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="329" to="339" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b455">
	<analytic>
		<title level="a" type="main">The value of the computer-aided diagnosis system for thyroid lesions based on computed tomography images</title>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Quantitative imaging in medicine and surgery</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">642</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b456">
	<analytic>
		<title level="a" type="main">Analysis for the prediction of thyroid disease by using ICA and optimal Kernel SVM approach</title>
		<author>
			<persName><forename type="first">I</forename><surname>Kalaimani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Emerging Technology and Innovative Engineering</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">3</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b457">
	<analytic>
		<title level="a" type="main">Thyroid nodules risk stratification through deep learning based on ultrasound images</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Bai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical Physics</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="6355" to="6365" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b458">
	<analytic>
		<title level="a" type="main">Ultrasound-based differentiation of malignant and benign thyroid Nodules: An extreme learning machine approach</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computer methods and programs in biomedicine</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="37" to="49" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b459">
	<analytic>
		<title level="a" type="main">Diagnosis of cervical cancer based on ensemble deep learning network using colposcopy images</title>
		<author>
			<persName><forename type="first">V</forename><surname>Chandran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BioMed Research International</title>
		<imprint>
			<biblScope unit="volume">2021</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b460">
	<analytic>
		<title level="a" type="main">Diagnostic value of machine learning-based quantitative texture analysis in differentiating benign and malignant thyroid nodules</title>
		<author>
			<persName><forename type="first">B</forename><surname>Colakoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Alis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yergin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of oncology</title>
		<imprint>
			<biblScope unit="volume">2019</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b461">
	<analytic>
		<title level="a" type="main">Combining radiomics with ultrasound-based risk stratification systems for thyroid nodules: An approach for improving performance</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Radiology</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="2405" to="2413" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b462">
	<analytic>
		<title level="a" type="main">An ensemble deep learning for automatic prediction of papillary thyroid carcinoma using fine needle aspiration cytology</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">T</forename><surname>Duc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Systems with Applications</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page">115927</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b463">
	<analytic>
		<title level="a" type="main">Deep learning based classification of ultrasound images for thyroid nodules: a large scale of pilot study</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Guan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of translational medicine</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">7</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b464">
	<analytic>
		<title level="a" type="main">Deep Learning Fast Screening Approach on Cytological Whole Slides for Thyroid Cancer Diagnosis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">2021</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note>ed: s Note: MDPI stays neutral with regard to jurisdictional</note>
</biblStruct>

<biblStruct xml:id="b465">
	<analytic>
		<title level="a" type="main">Machine learning-assisted system for thyroid nodule diagnosis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="858" to="867" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b466">
	<analytic>
		<title level="a" type="main">Application of machine learning to ultrasound images to differentiate follicular neoplasms of the thyroid gland</title>
		<author>
			<persName><forename type="first">I</forename><surname>Shin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ultrasonography</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">257</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b467">
	<analytic>
		<title level="a" type="main">A comparative analysis of two machine learning-based diagnostic patterns with thyroid imaging reporting and data system for thyroid nodules: diagnostic performance and unnecessary biopsy rate</title>
		<author>
			<persName><forename type="first">C.-K</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="470" to="481" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b468">
	<analytic>
		<title level="a" type="main">Ultrasound image classification of thyroid nodules using machine learning techniques</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">V</forename><surname>Vadhiraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Simpkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>O'connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Singh Ospina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maraka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>O'keeffe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicina</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">527</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b469">
	<analytic>
		<title level="a" type="main">Risk stratification of indeterminate thyroid nodules using ultrasound and machine learning algorithms</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Gild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gajera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lurie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gandomkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Clifton-Bligh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Endocrinology</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="646" to="652" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b470">
	<analytic>
		<title level="a" type="main">A pre-trained convolutional neural network based method for thyroid nodule diagnosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ultrasonics</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="221" to="230" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b471">
	<analytic>
		<title level="a" type="main">Ultrasound image-based thyroid nodule automatic segmentation using convolutional neural networks</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International journal of computer assisted radiology and surgery</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1895" to="1910" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b472">
	<analytic>
		<title level="a" type="main">Thyroid nodule classification in ultrasound images by fine-tuning deep convolutional neural network</title>
		<author>
			<persName><forename type="first">J</forename><surname>Chi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Walia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Babyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eramian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of digital imaging</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="477" to="486" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b473">
	<monogr>
		<title level="m" type="main">An image augmentation method using convolutional network for thyroid nodule classification by transfer learning</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fei</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017. 2017</date>
			<publisher>IEEE</publisher>
			<biblScope unit="page" from="1819" to="1823" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b474">
	<analytic>
		<title level="a" type="main">Computer-aided system for diagnosing thyroid nodules on ultrasound: A comparison with radiologist-based clinical assessments</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Head &amp; neck</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="778" to="783" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b475">
	<analytic>
		<title level="a" type="main">Deep learning-based artificial intelligence model to assist thyroid nodule diagnosis and management: a multicentre diagnostic study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Peng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Digital Health</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="250" to="e259" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b476">
	<analytic>
		<title level="a" type="main">Extraction of calcification in ultrasonic images based on convolution neural network</title>
		<author>
			<persName><forename type="first">D</forename><surname>Zuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biomedical Engineering= Shengwu Yixue Gongchengxue Zazhi</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="679" to="687" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>Sheng wu yi xue Gong Cheng xue za zhi=</note>
</biblStruct>

<biblStruct xml:id="b477">
	<analytic>
		<title level="a" type="main">Deep neural networks could differentiate Bethesda class III versus class IV/V/VI</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Sang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Deyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of translational medicine</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">11</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b478">
	<analytic>
		<title level="a" type="main">An efficient deep convolutional neural network model for visual localization and automatic diagnosis of thyroid nodules on ultrasound images</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Quantitative Imaging in Medicine and Surgery</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">1368</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b479">
	<analytic>
		<title level="a" type="main">Deep convolutional neural network for classification of thyroid nodules on ultrasound: Comparison of the diagnostic performance with that of radiologists</title>
		<author>
			<persName><forename type="first">Y.-J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Radiology</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page">110335</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b480">
	<analytic>
		<title level="a" type="main">Application of deep learning to the diagnosis of cervical lymph node metastasis from thyroid cancer with CT</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European radiology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="5452" to="5457" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b481">
	<analytic>
		<title level="a" type="main">Mapping driver mutations to histopathological subtypes in papillary thyroid carcinoma: applying a deep convolutional neural network</title>
		<author>
			<persName><forename type="first">P</forename><surname>Tsou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-J</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of clinical medicine</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">1675</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b482">
	<analytic>
		<title level="a" type="main">Application of deep learning in the prediction of benign and malignant thyroid nodules on ultrasound images</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Access</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="221468" to="221480" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b483">
	<analytic>
		<title level="a" type="main">Ultrasonographic thyroid nodule classification using a deep convolutional neural network with surgical pathology</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">I</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G.-H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-C</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of digital imaging</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1202" to="1208" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b484">
	<analytic>
		<title level="a" type="main">Using deep convolutional neural networks for enhanced ultrasonographic image diagnosis of differentiated thyroid cancer</title>
		<author>
			<persName><forename type="first">W.-K</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedicines</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">1771</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b485">
	<analytic>
		<title level="a" type="main">Comparison study of radiomics and deep learning-based methods for thyroid nodules classification using ultrasound images</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ieee Access</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="52010" to="52017" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b486">
	<analytic>
		<title level="a" type="main">Global cancer statistics</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lortet-Tieulent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA: a cancer journal for clinicians</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="87" to="108" />
			<date type="published" when="2012">2012. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b487">
	<analytic>
		<title level="a" type="main">Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Strom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncology</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="222" to="232" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b488">
	<analytic>
		<title level="a" type="main">Artificial intelligence at the intersection of pathology and radiology in prostate cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Harmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tuncer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sanford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Choyke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Trkbey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostic and Interventional Radiology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">183</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b489">
	<analytic>
		<title level="a" type="main">Cancer statistics</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Giaquinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="12" to="49" />
			<date type="published" when="2024">2024. 2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b490">
	<analytic>
		<title level="a" type="main">Digital rectal examination for prostate cancer screening in primary care: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Naji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Annals of Family Medicine</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="149" to="154" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b491">
	<analytic>
		<title level="a" type="main">Value of digital rectal examination in patients with suspected prostate cancer: a prospective cohort analysis study</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ying</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Translational Andrology and Urology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">1666</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b492">
	<analytic>
		<title level="a" type="main">Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Merriel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC medicine</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">54</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b493">
	<analytic>
		<title level="a" type="main">Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis</title>
		<author>
			<persName><forename type="first">W.-J</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-L</forename><surname>Ying</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-H</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-H</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of cancer research and therapeutics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">Suppl 3</biblScope>
			<biblScope unit="page" from="218" to="C221" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b494">
	<analytic>
		<title level="a" type="main">Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rubio-Briones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Actas Urolgicas Espaolas (English Edition)</title>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="217" to="223" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b495">
	<analytic>
		<title level="a" type="main">Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Chevli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of urology</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1743" to="1748" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b496">
	<analytic>
		<title level="a" type="main">Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam</title>
		<author>
			<persName><forename type="first">S</forename><surname>Carlsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European urology</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="693" to="699" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b497">
	<analytic>
		<title level="a" type="main">A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Van As</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European urology</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="981" to="988" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b498">
	<analytic>
		<title level="a" type="main">Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tanimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shinmoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kuribayashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="146" to="152" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b499">
	<analytic>
		<title level="a" type="main">Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Urology</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="859" to="863" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b500">
	<analytic>
		<title level="a" type="main">PIRADS 2.0: what is new?</title>
		<author>
			<persName><forename type="first">B</forename><surname>Turkbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Choyke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostic and Interventional Radiology</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">382</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b501">
	<analytic>
		<title level="a" type="main">Prostate HistoScanning: a screening tool for prostate cancer?</title>
		<author>
			<persName><forename type="first">V</forename><surname>De Coninck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Braeckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michielsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Urology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1184" to="1190" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b502">
	<analytic>
		<title level="a" type="main">Screening and detection of prostate cancer-review of literature and current perspective</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sivaraman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R S</forename><surname>Bhat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian journal of surgical oncology</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="160" to="168" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b503">
	<analytic>
		<title level="a" type="main">Circulating microRNAs as stable blood-based markers for cancer detection</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Mitchell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">30</biblScope>
			<biblScope unit="page" from="10513" to="10518" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b504">
	<analytic>
		<title level="a" type="main">Tumor suppressor microRNAs, miR-100 and-125b, are regulated by 1, 25-dihydroxyvitamin D in primary prostate cells and in patient tissue</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Giangreco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer prevention research</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="483" to="494" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b505">
	<analytic>
		<title level="a" type="main">Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Matsukawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Urology Oncology</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b506">
	<analytic>
		<title level="a" type="main">Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Crawford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of urology</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1726" to="1731" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b507">
	<analytic>
		<title level="a" type="main">Development and validation of a clinical decision support system based on PSA, microRNAs, and MRI for the detection of prostate cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mazzetti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Radiology</title>
		<imprint>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b508">
	<analytic>
		<title level="a" type="main">Prostate cancer screening in African American men: a review of the evidence</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kensler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JNCI: Journal of the National Cancer Institute</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="52" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b509">
	<analytic>
		<title level="a" type="main">Using an artificial intelligence model to detect and localize visible clinically significant prostate cancer in prostate magnetic resonance imaging: a multicenter external validation study</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Quantitative Imaging in Medicine and Surgery</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">43</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b510">
	<analytic>
		<title level="a" type="main">Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results</title>
		<author>
			<persName><forename type="first">T</forename><surname>Auer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World journal of urology</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="687" to="693" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b511">
	<analytic>
		<title level="a" type="main">Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Salomon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European urology</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1354" to="1362" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b512">
	<analytic>
		<title level="a" type="main">Elastography in the detection of prostatic cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Cochlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ganatra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Griffiths</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical radiology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1014" to="1020" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b513">
	<analytic>
		<title level="a" type="main">Biomarkers in prostate cancer: what&apos;s new?</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Sartori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current opinion in oncology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="259" to="264" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b514">
	<analytic>
		<title level="a" type="main">A review of artificial intelligence in prostate cancer detection on imaging</title>
		<author>
			<persName><forename type="first">I</forename><surname>Bhattacharya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Therapeutic Advances in Urology</title>
		<imprint>
			<date type="published" when="2022">2022</date>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">17562872221128791</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b515">
	<analytic>
		<title level="a" type="main">An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pantanowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Digital Health</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="407" to="e416" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b516">
	<analytic>
		<title level="a" type="main">A cascaded deep learning-based artificial intelligence algorithm for automated lesion detection and classification on biparametric prostate magnetic resonance imaging</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mehralivand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Academic radiology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1159" to="1168" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b517">
	<analytic>
		<title level="a" type="main">Independent real-world application of a clinical-grade automated prostate cancer detection system</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Da Silva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of pathology</title>
		<imprint>
			<biblScope unit="volume">254</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="147" to="158" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b518">
	<analytic>
		<title level="a" type="main">Freely available, fully automated ai-based analysis of primary tumour and metastases of prostate cancer in whole-body [18f]-psma-1007 pet-ct</title>
		<author>
			<persName><forename type="first">E</forename><surname>Trgrdh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">2101</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b519">
	<analytic>
		<title level="a" type="main">Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3 T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Fennessy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Magnetic resonance imaging</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="886" to="894" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b520">
	<analytic>
		<title level="a" type="main">Deep learning for real-time, automatic, and scanner-adapted prostate (zone) segmentation of transrectal ultrasound, for example, magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Van Sloun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European urology focus</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="78" to="85" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b521">
	<analytic>
		<title level="a" type="main">AI model for prostate biopsies predicts cancer survival</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sandeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">1031</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b522">
	<analytic>
		<title level="a" type="main">An artificial intelligence model based on transrectal ultrasound images of biopsy needle tract tissues to differentiate prostate cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Postgraduate Medical Journal</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b523">
	<analytic>
		<title level="a" type="main">A novel artificial intelligence-powered method for prediction of early recurrence of prostate cancer after prostatectomy and cancer drivers</title>
		<author>
			<persName><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JCO Clinical Cancer Informatics</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e2100131</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b524">
	<analytic>
		<title level="a" type="main">Evaluating the clinical acceptability of deep learning contours of prostate and organs-at-risk in an automated prostate treatment planning process</title>
		<author>
			<persName><forename type="first">J</forename><surname>Duan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical Physics</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="2570" to="2581" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b525">
	<analytic>
		<title level="a" type="main">Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Plos one</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">8</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note>p. e0236553</note>
</biblStruct>

<biblStruct xml:id="b526">
	<analytic>
		<title level="a" type="main">Artificial intelligence for clinical diagnosis and treatment of prostate cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Rabaan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancers</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page">5595</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b527">
	<analytic>
		<title level="a" type="main">Artificial intelligence applications in prostate cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Baydoun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Prostate and Prostatic Diseases</title>
		<imprint>
			<date type="published" when="2024">2024</date>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="37" to="45" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b528">
	<analytic>
		<title level="a" type="main">A randomized controlled trial to assess and compare the outcomes of twocore prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Baco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European urology</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="149" to="156" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b529">
	<monogr>
		<title level="m" type="main">The Surgeon General&apos;s call to action to prevent skin cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Garnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Guy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Holman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b530">
	<analytic>
		<title level="a" type="main">Opportunities and challenges: Classification of skin disease based on deep learning</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chinese Journal of Mechanical Engineering</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b531">
	<analytic>
		<title level="a" type="main">Skin Cancer Detection Using Deep Learning-A Review</title>
		<author>
			<persName><forename type="first">M</forename><surname>Naqvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Q</forename><surname>Gilani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Syed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Marques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-C</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">1911</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b532">
	<analytic>
		<title level="a" type="main">Double AMIS-ensemble deep learning for skin cancer classification</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sethanan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Systems with Applications</title>
		<imprint>
			<biblScope unit="volume">234</biblScope>
			<biblScope unit="page">121047</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b533">
	<analytic>
		<title level="a" type="main">Review of deep learning: Concepts, CNN architectures, challenges, applications, future directions</title>
		<author>
			<persName><forename type="first">L</forename><surname>Alzubaidi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of big Data</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1" to="74" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b534">
	<analytic>
		<title level="a" type="main">Epidemiology and prevention of cutaneous cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>O'leary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Otolaryngologic Clinics of North America</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="247" to="257" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b535">
	<analytic>
		<title level="a" type="main">Facilitating clinically relevant skin tumor diagnostics with spectroscopy-driven machine learning</title>
		<author>
			<persName><forename type="first">E</forename><surname>Andersson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Iscience</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">5</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b536">
	<analytic>
		<title level="a" type="main">An Extensive Investigation into the Use of Machine Learning Tools and Deep Neural Networks for the Recognition of Skin Cancer: Challenges, Future Directions, and a Comprehensive Review</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Hussain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Toscano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Symmetry</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">366</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b537">
	<analytic>
		<title level="a" type="main">Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation</title>
		<author>
			<persName><forename type="first">I</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-Y</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes &amp; diseases</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="188" to="198" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b538">
	<analytic>
		<title level="a" type="main">Use of noninvasive imaging in the management of skin cancer</title>
		<author>
			<persName><forename type="first">R</forename><surname>Giuffrida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Conforti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Di Meo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Deinlein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Zalaudek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Oncology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="98" to="105" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b539">
	<analytic>
		<title level="a" type="main">Photonic non-invasive mmw and THz imaging for non-melanoma skin cancer detection</title>
		<author>
			<persName><forename type="first">I</forename><surname>Mohammad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">2022 Fifth International Workshop on Mobile Terahertz Systems (IWMTS)</title>
		<imprint>
			<publisher>IEEE</publisher>
			<date type="published" when="2022">2022</date>
			<biblScope unit="page" from="1" to="5" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b540">
	<analytic>
		<title level="a" type="main">Uncertainty quantification in skin cancer classification using three-way decision-based Bayesian deep learning</title>
		<author>
			<persName><forename type="first">M</forename><surname>Abdar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computers in biology and medicine</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page">104418</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b541">
	<analytic>
		<title level="a" type="main">Automatic Classification of Melanoma Skin Cancer with Deep Convolutional Neural Networks</title>
		<author>
			<persName><forename type="first">K</forename><surname>Aljohani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Turki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ai</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="512" to="525" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b542">
	<analytic>
		<title level="a" type="main">Pre-trained deep learning models for brain MRI image classification</title>
		<author>
			<persName><forename type="first">S</forename><surname>Krishnapriya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Karuna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Human Neuroscience</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">1150120</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b543">
	<analytic>
		<title level="a" type="main">A scoping review of transfer learning research on medical image analysis using ImageNet</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Morid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Borjali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Del Fiol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computers in biology and medicine</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page">104115</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b544">
	<analytic>
		<title level="a" type="main">A multi-class skin Cancer classification using deep convolutional neural networks</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Chaturvedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Tembhurne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Diwan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Multimedia Tools and Applications</title>
		<imprint>
			<date type="published" when="2020">2020</date>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="28477" to="28498" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b545">
	<analytic>
		<title level="a" type="main">MDDC: Melanoma detection using discrete wavelet transform and convolutional neural network</title>
		<author>
			<persName><forename type="first">O</forename><surname>Asadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yekkalam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Manthouri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Ambient Intelligence and Humanized Computing</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="12959" to="12966" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b546">
	<analytic>
		<title level="a" type="main">Dermatologist-level classification of skin cancer using cascaded ensembling of convolutional neural network and handcrafted features based deep neural network</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Access</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="17920" to="17932" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b547">
	<analytic>
		<title level="a" type="main">Effect of human related factors on requirements change management in offshore software development outsourcing: A theoretical framework</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zulfqar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Soft Computing and Machine Intelligence</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="36" to="52" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b548">
	<analytic>
		<title level="a" type="main">Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Menzies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Digital Health</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="679" to="e691" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b549">
	<analytic>
		<title level="a" type="main">Human-computer collaboration for skin cancer recognition</title>
		<author>
			<persName><forename type="first">P</forename><surname>Tschandl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b550">
	<analytic>
		<title level="a" type="main">A comprehensive analysis of dermoscopy images for melanoma detection via deep CNN features</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Gajera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Nayak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Zaveri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedical Signal Processing and Control</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page">104186</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b551">
	<analytic>
		<title level="a" type="main">Wavelet transform based deep residual neural network and ReLU based Extreme Learning Machine for skin lesion classification</title>
		<author>
			<persName><forename type="first">F</forename><surname>Alenezi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Armghan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Polat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Systems with Applications</title>
		<imprint>
			<biblScope unit="volume">213</biblScope>
			<biblScope unit="page">119064</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b552">
	<analytic>
		<title level="a" type="main">Skin disease detection using deep learning</title>
		<author>
			<persName><forename type="first">S</forename><surname>Inthiyaz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Advances in Engineering Software</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page">103361</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b553">
	<analytic>
		<title level="a" type="main">Melanoma detection using deep learning-based classifications</title>
		<author>
			<persName><forename type="first">G</forename><surname>Alwakid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gouda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Humayun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">U</forename><surname>Sama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Healthcare</title>
		<imprint>
			<publisher>MDPI</publisher>
			<date type="published" when="2022">2022</date>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">2481</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b554">
	<analytic>
		<title level="a" type="main">A multi-stage melanoma recognition framework with deep residual neural network and hyperparameter optimization-based decision support in dermoscopy images</title>
		<author>
			<persName><forename type="first">F</forename><surname>Alenezi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Armghan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Polat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Systems with Applications</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="page">119352</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b555">
	<analytic>
		<title level="a" type="main">Detection and Classification of Malignant Melanoma Using Deep Features of NASNet</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">SN Computer Science</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">21</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b556">
	<analytic>
		<title level="a" type="main">Deep learning-based transfer learning for classification of skin cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Singhania</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tripathy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Nasr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Aboudaif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Kamrani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sensors</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page">8142</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b557">
	<analytic>
		<title level="a" type="main">Machine Learning and Deep Learning Algorithms for Skin Cancer Classification from Dermoscopic Images</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bechelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Delhommelle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioengineering</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="97" to="97" />
			<date type="published" when="2022">2022</date>
			<pubPlace>Basel, Switzerland</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b558">
	<monogr>
		<title level="m" type="main">Early detection of skin cancer using deep learning architectures: resnet-101 and inception-v3</title>
		<author>
			<persName><forename type="first">A</forename><surname>Demir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yilmaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kose</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019">2019</date>
			<publisher>IEEE</publisher>
			<biblScope unit="page" from="1" to="4" />
		</imprint>
	</monogr>
	<note>in 2019 medical technologies congress (TIPTEKNO</note>
</biblStruct>

<biblStruct xml:id="b559">
	<analytic>
		<title level="a" type="main">Skin cancer disease detection using transfer learning technique</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rashid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Applied Sciences</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">5714</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b560">
	<analytic>
		<title level="a" type="main">InSiNet: a deep convolutional approach to skin cancer detection and segmentation</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Reis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Turk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Khoshelham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical &amp; Biological Engineering &amp; Computing</title>
		<imprint>
			<biblScope unit="page" from="1" to="20" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b561">
	<analytic>
		<title level="a" type="main">Skin lesion segmentation and multiclass classification using deep learning features and improved moth flame optimization</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sharif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Akram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Damaeviius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maskelinas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">811</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b562">
	<analytic>
		<title level="a" type="main">Intelligent fusionassisted skin lesion localization and classification for smart healthcare</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Muhammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sharif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Akram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kadry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neural Computing and Applications</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="37" to="52" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b563">
	<analytic>
		<title level="a" type="main">Combining Stateof-the-Art Pre-Trained Deep Learning Models: A Noble Approach for Skin Cancer Detection Using Max Voting Ensemble</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hossain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hossain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Arefin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Akhtar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Blake</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagnostics</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">89</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b564">
	<monogr>
		<title level="m" type="main">ed: s Note: MDPI stays neu-tral with regard to jurisdictional claims in </title>
		<author>
			<persName><forename type="first">W</forename><surname>Gouda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Al-Waakid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Humayun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jhanjhi</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1183">Healthcare 2022, 10, 1183. 2022</date>
		</imprint>
	</monogr>
	<note>Detection of Skin-Cancer Based on Skin Lesion Images Using Deep Learning</note>
</biblStruct>

<biblStruct xml:id="b565">
	<analytic>
		<title level="a" type="main">A patient-centric dataset of images and metadata for identifying melanomas using clinical context</title>
		<author>
			<persName><forename type="first">V</forename><surname>Rotemberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific data</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">34</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b566">
	<analytic>
		<title level="a" type="main">Light field image dataset of skin lesions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>De Faria</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)</title>
		<imprint>
			<publisher>IEEE</publisher>
			<date type="published" when="2019">2019</date>
			<biblScope unit="page" from="3905" to="3908" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b567">
	<analytic>
		<title level="a" type="main">Characteristics of publicly available skin cancer image datasets: a systematic review</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet Digital Health</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="64" to="e74" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b568">
	<analytic>
		<title level="a" type="main">Lack of transparency and potential bias in artificial intelligence data sets and algorithms: a scoping review</title>
		<author>
			<persName><forename type="first">R</forename><surname>Daneshjou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Rotemberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA dermatology</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1362" to="1369" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b569">
	<analytic>
		<title level="a" type="main">Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts</title>
		<author>
			<persName><forename type="first">S</forename><surname>Haggenmller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="202" to="216" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b570">
	<analytic>
		<title level="a" type="main">Systematic review of machine learning for diagnosis and prognosis in dermatology</title>
		<author>
			<persName><forename type="first">K</forename><surname>Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Iversen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Titlestad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Winther</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Dermatological Treatment</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="496" to="510" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b571">
	<analytic>
		<title level="a" type="main">Diversity, race, and health</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Adamson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="6" to="10" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b572">
	<analytic>
		<title level="a" type="main">BLOCKCHAIN-POWERED ACCOUNTABILITY IN PHARMACEUTICAL SUPPLY CHAINS</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Zia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gilani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mehmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ullah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Anwar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Agricultural Sciences Journal</title>
		<imprint>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="145" to="159" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
